Skip to main content
SpringerLink
Log in

Medikamentöse Therapie

  • Chapter
Rheumatologie A

Part of the book series: Handbuch der inneren Medizin ((INNEREN 6,volume 6 / 2 / A))

Zusammenfassung

Die Zahl der schon im Handel befindlichen und der derzeit noch in Erprobung stehenden antirheumatischen Substanzen nimmt jährlich rasch weiter zu und die Entwicklung auf diesem Gebiet ist nur noch sehr schwer zu überblicken. In Anbetracht dieser Tatsache und des begrenzten zur Verfügung stehenden Raumes, wird bei der Besprechung der einzelnen Substanzen nur auf die wesentlichen Daten betreffend Pharmakologie, Pharmakokinetik, Indikation und vor allem auch Nebenwirkungen eingegangen werden. Eine solche Beschränkung widerspricht zwar dem Charakter eines Handbuches, ist aber unter den gegebenen Umständen nicht zu vermeiden. Dieser Tatsache soll dadurch Rechnung getragen werden, daß, wo immer möglich, Hinweise auf entsprechend weiterführende Literatur (Monographien, Symposionsberichte etc.) gegeben werden. Die verschiedenen chemischen, pharmakologischen und pharmakokinetischen Angaben über die einzelnen Substanzen wurden vorwiegend aus in Fachzeitschriften veröffentlichten Publikationen, zum Teil aber auch, wo solche nicht vorlagen, nach Angaben der verschiedenen Herstellerfirmen zusammengestellt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aarbakke J (1978) Clinical pharmacokinetics of phenylbutazone. Clin Pharmacokin 3: 369–380

    CAS  Google Scholar 

  • Aaseth J, Jellum E, Munthe E (1980) The effect of penicillamine and 2,3-dimercaptosuccinic acid on urinary excretion and tissue distribution of gold. Scand J Rheumatol 9: 157–160

    PubMed  CAS  Google Scholar 

  • Abele I, Bruckschen EG, Henze F (1981) Ergebnisse einer Feldstudie mit Lonazolac-Ca. (IrritrenR), einem neuen nicht-steroidalen Antiphlogistikum/Antirheumatikum. Therapiewoche 31: 5895–5901

    Google Scholar 

  • Abeles M, Urman JD, Rothfield NF (1978) Aseptic necrosis of bone in systemic lupus erythematosus: Relationship to corticosteroid therapy. Arch Intern Med 138: 750–754

    PubMed  CAS  Google Scholar 

  • Aberg G, Larsson KS (1970) Pharmakological properties of some antirheumatic salicylates. Acta Pharmacol Toxicol (Kbh) 28: 249–257

    CAS  Google Scholar 

  • Abraham EP, Chain E, Baker W, Robinson R (1943) Penicillamine: A characteristic degradation product of penicillin. Nature 151: 107

    CAS  Google Scholar 

  • Abruzzo JL (1978) Newer antirheumatic drugs. Ann Intern Med 89: 131–132

    PubMed  CAS  Google Scholar 

  • Adam M (1968) Beitrag zur Vorstellung über den Mechanismus der Goldtherapie. Z Rheumaforsch 27: 102–110

    PubMed  CAS  Google Scholar 

  • Adam M, Brettschneider I, Musilova J, Praus R (1978) Effect of cartilage bonemarrow extract on articular cartilage collagen formation. Pharmacology 16: 49–53

    PubMed  CAS  Google Scholar 

  • Adams JG (1978) Pharmacokinetics of levamisole. J. Rheumatol [Suppl 4] 5: 137–142

    Google Scholar 

  • Adams SS, Buckler JW (1979) Ibuprofen and Flurbiprofen. Clin Rheum Dis 5: 359–379

    Google Scholar 

  • Adams SS, Cobb R (1958) A possible basis for the antiinflammatory activity of salicylates and other nonhormonal antirheumatic drugs. Nature 181: 773–774

    PubMed  CAS  Google Scholar 

  • Adams SS, McCullough KF, Nicholson JS (1975) Some biological properties of flurbiprofen, an antiinflammatory, analgesic and antipyretic agent. Arzneim Forsch/Drug Res 25: 1786–1791

    CAS  Google Scholar 

  • Adler E, Wolf E, Taustein I (1970) A double blind trial with cartilage and bone marrow extract in degenerative gonarthrosis. Acta Rheum Scand 16: 6–11

    PubMed  CAS  Google Scholar 

  • Adrian RW, Walker FS, Noel PRB (1976) Toxicological studies on Azapropazone. Spec Issue zu Nr 1. Curr Med Res Opin 4: 17–34

    PubMed  CAS  Google Scholar 

  • Adverse reactions to Dapsone (Leading Article) (1981). Lancet 2: 184–185

    Google Scholar 

  • Albers JW, Hodach RJ, Kimmel DW, Treacy WL (1980) Penicillamine-associated myasthenia gravis. Neurology 30: 1246–1250

    PubMed  CAS  Google Scholar 

  • Alving AS, Eichelberger L, Craige B, Jones R jr, Whorton CM, Pullman TN (1948) Studies on the chronic toxicity of chloroquine (SN-7618). J Clin Invest 27: 60–65

    Google Scholar 

  • Ammitzbol F (1979) Fenbufen and Indomethacin in the treatment of rheumatoid arthritis. A comparative double-blind, crossover study. Scand J Rheumatol [Suppl] 23: 5–10

    Google Scholar 

  • Amor B, Mery C (1980) Chlorambucil in rheumatoid arthritis. Clin Rheum Dis 6: 567 – 584

    Google Scholar 

  • Amor B, Mery C, Gery A de (1980) La Tiopronine, nouvel anti-rhumatismal ä action lente dans la polyarthrite rhumatoide. Rev Rhumatisme 47: 157–162

    CAS  Google Scholar 

  • Anderson J (1977) Disorders of metabolism. I. In: Davies DM (ed) Textbook of adverse drug reactions. Oxford University Press, London, p 217–227

    Google Scholar 

  • Anderson LG, Bina PRC (1980) Vergleichende crossover-Doppelblindstudie mit Fenbufen und Acetylsalizylsäure bei chronischer Polyarthritis. Arzneim Forsch/Drug Res 30: 735–739

    CAS  Google Scholar 

  • Andreasen PB, Fraland A, Skovsted L, Andersen SA, Hauge M (1973) Diphenylhydantoin half-life in man and its inhibition by phenylbutazone: The role of genetic factors. Acta Med Scand 193: 561–564

    PubMed  CAS  Google Scholar 

  • Andrews FM, Golding DN, Freeman AM, Golding JR, Day AT, Hill AGS, Camp AV, Lewis-Faning E, Lyle WH (1973) Controlled trial of D(— penicillamine in severe rheumatoid arthritis. Lancet 1: 275–280

    Google Scholar 

  • Ansell BM, Moran H, Arden GP (1977) Penicillamine and woundhealing in rheumatoid arthritis. Proc R Soc Med [Suppl 3] 70: 75–76

    Google Scholar 

  • Ansell BM, Simpson C (1977) The effect of penicillamine on growth as height in juvenile chronic polyarthritis. Proc R Soc Med [Suppl 3] 70: 123–124

    Google Scholar 

  • Ansell BM, Symoens J (1978) International Symposion on Levamisole in rheumatoid arthritis. J Rheumatol [Suppl 4] 5: 1–153

    Google Scholar 

  • Antilla M, Haataja M, Kasanen A (1980) Pharmakokinetics of Naproxen in subjects with normal and impaired renal function. Eur J Clin Pharmacol 18: 263–268

    Google Scholar 

  • Aparicio L (1977) Some aspects of the pharmacology of Butibufen, a non steroidal anti inflammatory agent. Arch Int Pharmacodyn Ther 227: 133–141

    Google Scholar 

  • Appelboom T, Maubeuge J de, Unger J, Famaey JP (1978) Cutaneous lupus induced by penicillamine. Scand J Rheumatol 7: 64

    PubMed  CAS  Google Scholar 

  • Arman CG van, Risley EA, Nuss GW, Hucker HB, Duggan DE (1976) Pharmacology of Sulindac. In: Huskisson EC, Franchimont P (eds) Clinoril in the treatment of rheumatic disorders. Raven Press New York, pp 9–36

    Google Scholar 

  • Arrigoni-Martelli E, Restelli A (1972) Release of lysosomal enzymes in experimental inflammations; Effects of anti-inflammatory drugs. Eur J Pharmacol 19: 191–198

    PubMed  CAS  Google Scholar 

  • Atkinson JP, Frank MM (1973) Effect of cortisone therapy on serum complement components. J Immunol 111: 1061–1066

    PubMed  CAS  Google Scholar 

  • Austad WR (1970) Nitritoid reactions to gold treatment for arthritis. JAMA 211, 2158

    PubMed  CAS  Google Scholar 

  • Autran P, Garbe L, Pommier de Santi P, Baralis G, Charpin J (1977) Un cas d’accident rare de la chrysotherapie. Une miliaire pulmonaire allergique. Rev Franc Mai Respir 5: 713

    Google Scholar 

  • Aylward M, Parker RJ, Holly F, Maddock J, Davies DBS (1975) Long-term study of indomethacin and alclofenac in treatment of rheumatoid arthritis. Br Med J 2: 7–9

    PubMed  CAS  Google Scholar 

  • Aylward M (1975a) Clinical studies on alclofenac in the treatment of rheumatic diseases: A drug in question. Curr Med Res Opin 3: 274–285

    PubMed  CAS  Google Scholar 

  • Aylward M (1975 b) A review of possible mechanisms of action of the antirheumatic drug, alclofenac. Curr Med Res Opin 3: 249–263

    Google Scholar 

  • Aylward M, Maddock J (1974) Plasma L-tryptophan concentrations in chronic rheumatic diseases and the effects of some antirheumatic drugs on the binding of the amino acid to plasmaproteins in vitro and in vivo. Rheumatol Rehabil 13: 62–74

    PubMed  CAS  Google Scholar 

  • Aylward M, Maddock J, Rees P, Thomas GM, Wheeldon R, Holly F (1976) Simultaneous pharmacokinetics of Benorylate in plasma and synovial fluid of patients with rheumatoid arthritis. Scand J Rheum [Suppl 13] 9–12

    Google Scholar 

  • Aylward M, Parker RJ, Maddock J (1974) Studies on 4-allyloxy-3-chlorophenylacetic acid (Alclofenac): A double-blind comparison of Alclofenac and Aspirin in rheumatoid arthritis, and effects of therapy on serum immunoglobulins and rheumatoid factor. Ann Rheum Dis 33: 268–272

    PubMed  CAS  Google Scholar 

  • Ayres JW, Weidler DJ, Sakmar E, Wagner JG (1977 a) Linear and non-linear assessment of tolmetin pharmacokinetics. Res Commun Chem Pathol Pharmacol 17: 583–593

    Google Scholar 

  • Ayres JW, Weidler DJ, MacKichan J, Sakmar E, Hallmark MR, Lemanowicz EF, Wagner JG (1977 b) Pharmacokinetics of tolmetin with and without concomittant administration of antacid in men. Eur J Clin Pharmacol 12: 421–428

    Google Scholar 

  • Baas EU, Ewe K, Höhn P (1976) Granulomatose Kolitis nach Naproxen. Dtsch Med Wochenschr 101: 1434

    PubMed  CAS  Google Scholar 

  • Bach GL (1977) Ketophenylbutazon (Kebuzon), ein wirksames, nichtsteroidales symptomatisches Antirheumatikum. Therapiewoche 27: 9392–9395

    Google Scholar 

  • Bach GL (1978) Therapie der chronischen Polyarthritis mit nichtsteroidalen symptomatisch wirkenden Antirheumatika; Quo vadis? Ther Ggw 117: 1782–1794

    PubMed  CAS  Google Scholar 

  • Bach GL (1979) Die medikamentöse Therapie der Arthrosen. Euromed, Heft 1

    Google Scholar 

  • Bach GL (1981) Persönliche Mitteilung

    Google Scholar 

  • Bach GL, Fotiades P (1978) Klinischer Wirkungsvergleich zweier Dosierungsschemata von Pyrazinobutazon in der Therapie rheumatischer Erkrankungen. Therapiewoche 28: 7264–7269

    Google Scholar 

  • Bach GL, Panse P, Zeiller P (1977) Glycosaminoglycanpolysulfat (GAGPS, ArteparonR) zur Basistherapie der Arthrose. III. Biochemisch-diagnostische und klinische Untersuchungen zur intramuskulären Anwendung von GAGPS. Z Rheumatol 36: 269–274

    PubMed  CAS  Google Scholar 

  • Bach GL, Rau E, Schmid C, Fotiades P (1977) Glycosaminoglycanpolysulfat (GAGPS, Arteparon) zur Basistherapie der Arthrose. I. Vergleichende Untersuchungen, Arteparon forte und physikalische Therapie vs. nur physikalische Behandlung. Z Rheumatol 36: 260–264

    PubMed  CAS  Google Scholar 

  • Bacon PA, Myles AB, Beardwell CG, Daly JR, Savage O (1966) Corticosteroid withdrawal in rheumatoid arthritis. Lancet 2: 935–937

    PubMed  CAS  Google Scholar 

  • Bacon PA, Tribe CR, Mackenzie JC, Verrier Jones J, Cumming RH, Amer B (1976) Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study. Q J Med 45: 661–684

    PubMed  CAS  Google Scholar 

  • Baenkler HW, Scheiffarth F (1971) Lymphozytentransformation und Immunglobuline unter Goldbehandlung. Z Rheumaforsch 30: 236–239

    PubMed  CAS  Google Scholar 

  • Bagnall AW (1957) The value of chloroquine in rheumatoid disease. A four-year study of continuous therapy. Can Med Assoc J 77: 182–194

    PubMed  CAS  Google Scholar 

  • Bagnall AW (1960) Antimalarial compounds in rheumatoid arthritis. Can Med Assoc J 82: 1167–1169

    PubMed  CAS  Google Scholar 

  • Baici A, Fehr K (1980) Hemmung menschlicher lysosomaler Elastase durch Arteparon®. In: Dettmer N, Greiling H, Sensch KH (Hrsg) Internationales Arzneimittelsymposium Arteparon. Congress series, Eular, Basel, S 19–26

    Google Scholar 

  • Baici A, Salgam P, Fehr K, Böni A (1981) Inhibition of human lysosomal elastase by the cartilage bone marrow extract Rumalon®. Z Rheumatol 40: 44–46

    PubMed  CAS  Google Scholar 

  • Baier H (1973) Panmyelophthise als Folge einer Behandlung der primär chronischen Polyarthritis mit Gold und D-Penicillamin. Schweiz Med Wochenschr 103: 1849–1852

    PubMed  CAS  Google Scholar 

  • Baldwin JL, Storb R, Thomas ED, Mannik M (1977) Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthritis Rheum 20: 1043–1048

    PubMed  CAS  Google Scholar 

  • Balint G, El-Ghobarey A, Capell H, Madkour M, Dick WC, Ferguson MM, Anwar-Ul-Haq M (1977) Sjogren’s syndrome: A contraindication to levamisole treatment? Br Med J 2: 1386–1387

    PubMed  CAS  Google Scholar 

  • Balint G, Szobor A, Temesväri P, Zahumenszky Z, Bozsoky S (1975) Myasthenia gravis developed under D-Penicillamin Treatment. Scand J Rheumatol [Suppl 8] Workshop 21, Abst 12

    Google Scholar 

  • Bandilla K, Tausch G (1981) Oral Gold therapy with Auranofin (SKF 39162) — a multicenter longterm open study in patients with rheumatoid arthritis. Abstract, Symposium Auranofin in Rheumatoid Arthritis. 15. Int Rheumatologie Kongress Paris, 21.–27.6. 1981, p 1

    Google Scholar 

  • Barhous I, Müller W, Stojan B (1975) Die Bedeutung der Serum-Goldspiegel-Bestimmungen während Chrysotherapie bei chronischer Polyarthritis. Med Klin 70: 1516–1521

    Google Scholar 

  • Barnardo DE, Currey HLF, Mason RM, Fox WR, Weatherall M (1966) Mefenamic acid and Flufenamic Acid compared with Aspirin and Phenylbutazone in Rheumatoid Arthritis. Br Med J 2: 342–343

    CAS  Google Scholar 

  • Barnetson RS, Barnetson C, Pearson JMH, Rees RJW (1976) Evidence for Prevention of borderline leprosy reactions by Dapsone. Lancet II: 1171–1172

    Google Scholar 

  • Barnett AJ, Whiteside MG (1976) Marrow aplasia and penicillamine. Lancet 2: 682–683

    Google Scholar 

  • Barranco VP (1974) Inhibition of lysosomal enzymes by Dapsone. Arch Dermatol 110: 563 – 566

    PubMed  CAS  Google Scholar 

  • Bartholomew LE, Duff IF (1963) Amopyroquin (Propoquin) in rheumatoid arthritis. Arthritis Rheum 6: 356–363

    PubMed  CAS  Google Scholar 

  • Barzilai D, Dickstein D, Enat RG, Bassan H, Lichtig C, Gellei B (1978) Cholestatic jaundice caused by D-Penicillamine. Ann Rheum Dis 37: 98–100

    PubMed  CAS  Google Scholar 

  • Basch ChM, Spitler LE, Engleman EP (1978) A review of short and longterm effects on articular manifestations. J Rheumatol [Suppl 4] 5: 11–16

    Google Scholar 

  • Baum J (1979) Editorial. A continuing look at penicillamine. J Rheumatol 6: 3–6

    PubMed  CAS  Google Scholar 

  • Bäumer A (1971) The mechanism of action of chloroquine. In: Müller W, Harwerth H-G, Fehr K (eds) Academic Press, London New York, pp 609–613

    Google Scholar 

  • Bäumer A, Schwiete W (1958) Zur Dauerbehandlung der chronischen Polyarthritis mit Resochin. Med Klin 53: 298–301

    Google Scholar 

  • Baxter JD, Forsham PH (1972) Tissue effects of glucocorticoids. Am J Med 53: 573–589

    PubMed  CAS  Google Scholar 

  • Beckmann R, Flohe L (1981) The pathogenic role of superoxide radicals in inflammation. Efficacy of exogenous superoxide dismutase. Bull Eur Physiopath Resp [Suppl] 17: 275–285

    CAS  Google Scholar 

  • Behrend T, Rodenhäuser JH (1969) Augenaffektionen bei parenteraler Goldbehandlung der chronischen Polyarthritis. Z Rheumaforsch 28: 441–447

    PubMed  CAS  Google Scholar 

  • Bekemeier H, Hirschelmann R, Giesler AJ (1975) Peroxydase-Aktivität in der Pfote der Ratte bei Adjuvans-Arthritis und ihre Beeinflussung durch Antiphlogistika in vitro. Z Rheumatol 34: 71–75

    PubMed  CAS  Google Scholar 

  • Bennett WM, Muther RS, Parker RA, Feig P, Morrison G, Golper TA, Singer I (1980) Drug therapy in renal failure: Dosing guide lines for adults. Part II: Sedatives, hypnotics and tranquilizers; cardiovascular, antihypertensive and diuretic agent; miscelaneous agents. Ann Intern Med 93: 286–325

    PubMed  CAS  Google Scholar 

  • Benoxaprofen (1979) Eur J Rheumatol Inflamm 3: 1–36

    Google Scholar 

  • Bensen WG, Laskin CA, Paton ThW, Little HA, Fam AG (1979) Twice-daily dosing of enteric-coated aspirin in patients with rheumatic diseases. J Rheumatol 6: 351–356

    PubMed  CAS  Google Scholar 

  • Berger W, Spring P (1970) Beeinflussung der blutzuckersenkenden Wirkung oraler Antidiabetica durch andere Medikamente und Niereninsuffizienz. Internist 11: 436–441

    PubMed  CAS  Google Scholar 

  • Berglöf FE, Berglöf K, Walz DT (1978) Auranofin: An oral chrysotherapeutic agent for the treatment of rheumatoid arthritis. J Rheumatol 5: 68–74

    PubMed  Google Scholar 

  • Berglund K, Johansson BG, Laurell A-B, Sjöholm A, Sturfelt G (1978) Inflammatory parameters in rheumatoid arthritis during and after administration of an anti-mitotic agent (podophyllum lignan derivatives). Scand J Rheumatol 7: 61–63

    PubMed  CAS  Google Scholar 

  • Bernstein RM, Hall MA, Gostelow BE (1981) Morphea-like reaction to D-Penicillamine therapy. Ann Rheum Dis 40: 42–44

    PubMed  CAS  Google Scholar 

  • Bernstein HN, Ginsberg J (1964) The pathology of chloroquine retinopathy. Arch Ophthalmol 71: 238–245

    PubMed  CAS  Google Scholar 

  • Berntsen CA, Freyberg RH (1961) Rheumatoid patients after five or more years of corticosteroid treatment: a comparative analysis of 183 cases. Ann Intern Med 54: 938–953

    Google Scholar 

  • Berry H, Fernandes L, Ford-Hutchinson AW, Evans SJW, Hamilton EBD (1978) Alclofenac and D-Penicillamine. Comparative trial in rheumatoid arthritis. Ann Rheum Dis 37: 93–97

    PubMed  CAS  Google Scholar 

  • Berry H, Liyanage SP, Durance RA, Barnes CG, Berger LA, Evans S (1976) Azathioprine and penicillamine in treatment of rheumatoid arthritis: A controlled trial. Br Med J 1: 1052–1054

    PubMed  CAS  Google Scholar 

  • Berry H, Liyanage SP, Durance RA, Goode JD, Swannell AJ (1981) A double blind study of benorylate and chlormezanone in muskuloskeletal disease. Rheumatol Rehabil 20: 46–49

    PubMed  CAS  Google Scholar 

  • Bettendorf U, Neuhaus R (1974) Penicillamin-induzierte Polymyositis. Dtsch Med Wochenschr 99: 2522–2525

    Google Scholar 

  • Bettendorf U, Pötters R (1975) Moschcowitz-Syndrom nach D-Penizillamin-Medikation. Med Welt 26: 291–295

    PubMed  CAS  Google Scholar 

  • Bianchi C, Lumachi B, Marazzi-Uberti E (1972) Pharmacological investigations of 4-prenyl-l,2- diphenyl-3,5-pyrazolidinedione (DA 2370 ). Part 1: antiinflammatory, analgesic and antipyretic properties. Arzneim Forsch (Drug Res) 22: 183

    Google Scholar 

  • Bianchi C (1972) Survey of the biological properties of 4-prenyl-l,2-diphenyl-3,5-pyrazolidinedione (DA 2370) a novel agent in the class of anti inflammatory drugs. Arzneim Forsch (Drug Res) 22: 249–253

    CAS  Google Scholar 

  • Binderup L, Bramm E, Arrigoni-Martelli E (1980) Effect of D-Penicillamine in vitro and in vivo on macrophage phagocytosis. Biochem Pharmacol 29: 2273–2278

    PubMed  CAS  Google Scholar 

  • Binns TB (1969) Allergy to Synacthen Depot. Lancet II: 1081

    Google Scholar 

  • Blais JA, Demers R (1962) The use of norethynodrel (Enovid) in the treatment of rheumatoid arthritis. (Preliminary report). Arthritis Rheum 5: 284

    Google Scholar 

  • Blau SP (1973) Metabolism of gold during lactation. Arthritis Rheum 16: 777–778

    PubMed  CAS  Google Scholar 

  • Block WD, Buchanan OH, Freyberg RH (1944) Metabolism, toxicity, and manner of action of goldcompounds used in treatment of arthritis. V. A comparative study of the rate of absorption, the retention and the rate of excretion of gold administered in different compounds. J Pharmacol Exp Ther 82: 391–398

    CAS  Google Scholar 

  • Blocka K, Fürst DE, Landau E, Bömberg A, Dromgoole S, Paulus HE (1981) Pharmacokinetics of a single dose of Auranofin in rheumatoid arthritis. Abstract Symposium “Auranofin in Rheumatoid Arthritis” 15. Internat Rheumatologie-Kongress, Paris, 21.–27.6. 1981, p 4

    Google Scholar 

  • Blumberger W, Rechziegler H, Spechtmeyer H (1980) Multizentrische Langzeitprüfung von Acemetacin. Arzneim Forsch/Drug Res 30 (11): 1463–1468

    CAS  Google Scholar 

  • Blumberger W, Tepe H-J (1980) Einsparung oraler Antirheumatika durch lokale Anwendung von Etofenamat Gel. Therapiewoche 30: 4949–4954

    Google Scholar 

  • Boada JN, Zubiaur P, Presser E, Blanco JR (1977) Effect of levamisole on carrageenin-induced foot edema of normal and adrenal ectomized rats. II Farmaco 32: 512–515

    CAS  Google Scholar 

  • Boardman PL, Hart FD (1967) Clinical measurement of the anti-inflammatory effects of salizylates in rheumatoid arthritis. Br Med J 4: 264–268

    Google Scholar 

  • Bole GG jr, Friedlaender MH, Smith CK (1969) Rheumatic symptoms and serological abnormalities induced by oral contraceptives. Lancet 1: 323–326

    PubMed  Google Scholar 

  • Bollet AJ (1968) Stimulation of protein-chondroitin sulfate synthesis by normal and osteoarthritic articular cartilage. Arthritis Rheum 11: 663–673

    PubMed  CAS  Google Scholar 

  • Boltze K-H, Kreisfeld H (1977) Zur Chemie von Etofenamat, einem Antiphlogistikum aus der Klasse der N-Arylanthranilsäurederivate. Arzneim Forsch/Drug Res 27(I): 1300–1312

    Google Scholar 

  • Borel J-F (1981) Cyclosporin A. Triangel 20: 97–105

    CAS  Google Scholar 

  • Borga O, Odar-Cederlof I, Ringberger V-A, Norlin A (1976) Proteinbinding of salicylates in uremic and normal plasma. Clin Pharmacol Ther 20: 464–475

    PubMed  CAS  Google Scholar 

  • Börngen U, Goebel KM, Storck U, Lonauer G, Wagner H (1980) Langzeitbehandlung aktivierter Polyarthrosen. Schwerpunkt Medizin 3: 33–36

    Google Scholar 

  • Boström H, Berntsen K, Whitehouse MW (1964) Biochemical properties of anti-inflammatory drugs. II-Some effects of sulphate 35s metabolism in vivo. Biochem Pharmacol 13: 413–420

    Google Scholar 

  • Bouchard Ph, Kuttenn F, Nahoul K, Mavier Ph, Schaison G, Mauvais-Jarvis P (1979) Déviation du metabolisme du Cortisol induite par la rifampicine. Nouv Presse Méd 8: 1651–1654

    PubMed  CAS  Google Scholar 

  • Bourke B, Maini RN, Griffiths ID, Scott JT (1976) Fatal marrow aplasia in patient on penicillamine. Lancet 2: 515

    Google Scholar 

  • Box J, Box P, Turner R, Pisko E (1978) Piroxicam and rheumatoid arthritis: a double blind 16-week study comparing Piroxicam and Phenylbutazon. Royal Soc Med Intern Congr Symp Ser 1 Piroxicam, 41–46

    Google Scholar 

  • Brackertz D (1978) Comparison of Clofezone and Diclofenac in the treatment of out-patients suffering from activated (painful) osteoarthrosis. Z Rheumatol 37: 342–-349

    Google Scholar 

  • Bragstad A (1978) A comparative double-blind trial with Proquazone and Naproxen in the treatment of rheumatoid arthritis. Scand J Rheumatol [Suppl 21] 33–35

    Google Scholar 

  • Braidman IP, Collins K, Jones C, Morris K, Jayson MI (1980) Evidence for a steroid receptor in rheumatoid synovial tissue cells. Agents Actions [Suppl] 7: 233–236

    CAS  Google Scholar 

  • Bregeon Ch (1977) Traitements récents de la polyarthrite rhumatoide. Bilan provisoire. Rhumatologie (Paris) 7: 53–60

    Google Scholar 

  • Brennecke FE, Alving AS, Arnold MJ, Bergenstal DM, de Wind LT (1951) A preliminary report on the effect of certain 8-Aminoquinolines in the treatment of rheumatoid artritis. J Lab Clin Med 38: 795–796

    Google Scholar 

  • Brewerton D (1976) D-Penicillamine. Br Med J 2: 1507

    PubMed  CAS  Google Scholar 

  • Brezin JH, Katz SM, Schwartz AB, Chinitz JL (1979) Reversible renal failure and nephrotic syndrome associated with non-steroidal anti-inflammatory drugs. N Engl J Med 301: 1271–1273

    PubMed  CAS  Google Scholar 

  • Brock N, Hohorst HJ (1963) Über die Aktivierung von Cyclophosphamid in vivo und in vitro. Arzneim Forsch/Drug Res 13: 1021–1031

    CAS  Google Scholar 

  • Brogard JM, Comte F, Madon M, Audhy B, Spach MO (1981) Pharmacokinetic profile of Benoxa- profen in subjects with normal and impaired renal function: plasma levels prediction. Curr Ther Res 30: 161–171

    Google Scholar 

  • Brogden RN, Heel RC, Speight TM, Avery GS (1978) Tolmetin: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases. Drugs 15: 429–450

    PubMed  CAS  Google Scholar 

  • Brogden RN, Heel RC, Pakes GE, Speight TM, Avery GS (1980) Diclofenac sodium: A review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Drugs 20: 24–48

    PubMed  CAS  Google Scholar 

  • Bröhr H J, Kalbhen DA (1968) Wirkung verschiedener Antirheumatika auf die Sulfomucopolysaccharid-Synthese im Knorpel. Arch Int Pharmacodyn Ther 176: 380–394

    PubMed  Google Scholar 

  • Bröll H, Altmann H, Kocsis F, Tausch G (1978 a) Über den Wirkungsmechanismus von D-Penicill- amin bei chronischer Polyarthritis. 1. Proteinsynthesehemmung in Zellen der Synovialflüssigkeit. Z Rheumatol 37: 51–55

    Google Scholar 

  • Bröll H, Tausch G, Tuschl P, Eberl R (1977) Klinische Erfahrungen und Ergebnisse klinisch experimenteller Untersuchungen mit Bumadizon-Kalzium (Eumotol®) im Rahmen der Langzeittherapie der chronischen Polyarthritis. Therapiewoche 27: 8843–8849

    Google Scholar 

  • Brooke JW (1976) Fenoprofen therapy in large-joint osteoarthritis: double-blind comparison with Aspirin and long-term experience. J Rheumatol [Suppl 2] 3: 71–75

    Google Scholar 

  • Brooks SM, Werk EE, Ackerman SJ, Sullivan I, Thrasher BS (1972) Adverse effects of phénobarbital on corticosteroid metabolism in patients with bronchial asthma. N Engl J Med 286: 1125–1128

    PubMed  CAS  Google Scholar 

  • Brooks PM, Bell MA, Lee P, Rooney PJ, Dick WC (1974a) The effect of Frusemide on Indomethacin plasma levels. Br J Clin Pharmacol 1: 485–489

    Google Scholar 

  • Brooks PM, Bell MA, Sturrock RD, Famaey JP, Dick WC (1974b) The clinical significance of indomethacin-probenecid interaction. Br J Clin Pharmacol 1: 287–290

    Google Scholar 

  • Brooks PM, Cossum PA, Boyd GW (1980) Rebound rise in renin concentrations after sessation of salizylates. N Engl J Med 303: 562–564

    PubMed  CAS  Google Scholar 

  • Bruchhausen Vv, Lohmann H, O’Sváth J (1978) The pharmacokinetic profile of Pyrazinobutazone in man. Arzneim Forsch/Drug Res 28(II): 2337–2343

    Google Scholar 

  • Brune K, Peskar BA, Rainsford KD (1979) Prostaglandin release from macrophages: Modulation by antiinflammatory drugs. In: Rainsford KD, Ford-Hutchinson AW (Hrsg) Prostaglandins and Inflammations. Birkhäuser, Basel Boston Stuttgart, p 159–165

    Google Scholar 

  • Brune K, Graf P, Rainsford KD (1977) A pharmacokinetic approach to the understanding of therapeutic effects and sideeffects of salizylates. In: Rainsford KD, Brune K, Whitehouse W (Hrsg) Aspirin and related Drugs: Their actions and uses. Agents and Actions Supplement 1. Birkhäuser, Basel Stuttgart, p 9–26

    Google Scholar 

  • Bruni G, Groppi W, Fanfani A, Sacchetti G (1980) Indoprofen: A review of human studies. Clin Rheum Dis 6: 499–524

    Google Scholar 

  • Buchanan JD, Fairley KF, Barrie JU (1975) Return of spermatogenesis after stopping cyclophosphamide therapy. Lancet 2: 156–157

    PubMed  CAS  Google Scholar 

  • Buchanan WW, Rooney PJ, Rennie JAN (1979) Aspirin and the Salicylates. Clin Rheum Dis 5: 499–539

    Google Scholar 

  • Buckingham RB (1977/78a) Interactions involving antirheumatic agents, parti. Bull Rheum Dis 28: 960–965

    Google Scholar 

  • Buckingham RB (1977/78 b) Interactions involving antirheumatic agents, part II. Bull Rheum Dis 28: 966–971

    Google Scholar 

  • Bucknall RC (1977) Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis. Proc R Soc Med [Suppl 3] 70: 114–117

    Google Scholar 

  • Bucknall RC, Dixon AStJ, Glick EN, Woodland J, Zutshi DW (1975) Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis. Br Med J 1: 600–602

    PubMed  CAS  Google Scholar 

  • Buerklin EM, Ballard JM (1979) A double-blind comparison of fentiazac and phenylbutazone in the treatment of acute tendinitis and bursitis. Curr Med Res Opin [Suppl] 6: 90–96

    Google Scholar 

  • Buffington GA, Dominguez JH, Piering WF, Hebert LA, Kauffman HM, Lemann J (1976) Interaction of Rifampicin and Glucocorticoids. JAMA 236: 1958–1960

    PubMed  CAS  Google Scholar 

  • Bunch TW, O’Duffy JD, Tompkins RB, O’Fallon WM (1981) Penicillamine and hydroxychloroquine single and in combination in the treatment of rheumatoid arthritis. 44th Meeting of the Am Rheum Ass Atlanta, May 1980. Zit nach Schattenkirchner (1981)

    Google Scholar 

  • Buniva G, Cattö G, Chierichetti S, Granata D, Manien G (1972) Clinical pharmacology of 4-prenyl- l,2-diphenyl-3,5-pyrazolidinedione (DA 2370). Arzneim Forsch/Drug Res 22 Ia: 258

    Google Scholar 

  • Burger HR, Briner J, Spycher MA (1979) Auffällige Häufung membranöser Glomerulonephritiden nach Goldtherapie bei chronischer Polyarthritis. -Eine Nebenwirkung eines neuen Präparates? Schweiz Med Wochenschr 109: 423–431

    PubMed  CAS  Google Scholar 

  • Buriot D, Prieur A-M, Lebranchu Y, Messerschmitt J, Griscelli C (1979) Leucémie aigué chez trois enfants atteints d’arthrite chronique juvenile traités par le chlorambucil. Arch Fr Pediatr 36: 592–598

    PubMed  CAS  Google Scholar 

  • Burkhardt H, Rommel K, Burkhardt F, Welter D (1971) Der Einfluß von Gold auf den Kollagenstoffwechsel von Haut und Knochen der Ratte. Z Rheumaforsch 30: 98–104

    PubMed  CAS  Google Scholar 

  • Burns CA (1968) Indomethacin: Reduced retinal sensitivity, and corneal deposits. Am J Ophthalmol 66: 825

    PubMed  CAS  Google Scholar 

  • Burns J, Rose RK, Chenkin T, Goldman A, Schulert A, Brodie BB (1953) The physiological disposition of phenylbutazone ( Butazolidin) in man and a method for its estimation in biological material. J Pharmacol Exp Ther 109: 346–357

    Google Scholar 

  • Burns JJ, Rose RK, Goodwin S, Reichenthal J, Horning EC, Brodie BB (1955) The metabolic fate of phenylbutazone (Butazolidin) in man. J Pharmacol Exp Ther 113: 481–489

    PubMed  CAS  Google Scholar 

  • Burns RP (1966) Delayed onset of chloroquine retinopathy. N Engl J Med 275: 693–696

    PubMed  CAS  Google Scholar 

  • Butler WT, Rossen RD (1973) Effects of corticosteroids on Immunity in man. I. Decreased serum IgG concentration caused by 3 or 5 days of high doses of methylprednisolone. J Clin Invest 52: 2629–2640

    PubMed  CAS  Google Scholar 

  • Buttinoni A, Cuttica A, Franceschini J, Mandelli V, Orsini G, Passerini N, Turba C, Tommasini R (1973) Pharmacological study on a new analgesic-anti-inflammatory drug: a-[4-(l-Oxo-2-Iso- Indolinyl)-Phenyl]-Propionic acid or K 4277. Arzneim Forsch/Drug Res 23: 1100–1107

    CAS  Google Scholar 

  • Calin A, Bennett R, Jacox R, Kaplan D, O’Brien W, Paulus HE, Roth SH, Weiss T (1981) Auranofin: 1 mg vs. 9 mg. The search for the apropriate dose. Mitteilung auf dem Symposium „Therapeutic innovation in Rheumatoid Arthritis: World Wide Auranofin Symposium 20.–21.10.1981, Montreal

    Google Scholar 

  • Cambiaggi A (1957) Unusual ocular lesions in a case of systemic lupus erythematosus. Arch Ophthalmol 57: 451–453

    CAS  Google Scholar 

  • Cambray GJ, Murphy G, Reynolds JJ (1981) The effects of Dexamethasone in vitro on the production of collagenase and inhibitor by synovial and cartilage expiants from the joints of rabbits with a proliferative arthritis. Rheumatol Int 1: 69–72

    PubMed  CAS  Google Scholar 

  • Camus JP, Jaffe I A, Crouzet J, Prier A, Mercier A, Dubois A (1978) La pyrithioxine nouveau traitement de fond de la polyarthrite rhumatoide. Etude ouverte de soixantedouze cas avec un recul de six mois. Rev Rhum Mal Osteoartic 45: 95–100

    PubMed  CAS  Google Scholar 

  • Camus JP, Jaffe IA, Chaouat Y, Massias P, Le Chevallier P-L, Crouzet J, Prier A (1979) Traitement de la poliarthrite rhumatoide par la pyrithioxine. Etude pluricentrique ouverte sur 150 cas. Méd Hyg 37: 4522–4525

    Google Scholar 

  • Camus JP, Jaffe I-A, Chaouat Y, Massias P, Le Chevallier P-L, Crouzet J, Prier A (1980) Pyrithioxin (Encephabol®) als Basistherapeutikum bei chronischer Polyarthritis. Akt Rheumatol 5: 107–108

    Google Scholar 

  • Camus J-P, Homberg J-C, Crouzet J, Mery C, Delrieu F, Massias P, Abuaf N (1981) Autoantibody formation in D-Penicillamine treated rheumatoid arthritis. J Rheumatol [Suppl 7] 8: 80–83

    Google Scholar 

  • Capell HA, Rennie JAN, Rooney PJ, Murdoch RM, Hole DJ, Dick WC, Buchanan WW (1979) Patient compliance: A novel method of testing nonsteroidal antiinflammatory analgesic in rheumatoid arthritis. J Rheumatol 6: 584–593

    PubMed  CAS  Google Scholar 

  • Carson S, Vogin EE, Huber W, Schulte TL (1973) Safety tests of orgotein, an anti-inflammatory protein. Toxicol Appl Pharmacol 26: 184–202

    PubMed  CAS  Google Scholar 

  • Carter ME, James VHT (1972) Effect of alternate day, single dose corticosteroid therapy on pituitary adrenal function. Ann Rheum Dis 31: 379–383

    PubMed  CAS  Google Scholar 

  • Caruso I, Fumagalli M, Montrone F, Vernazza M, Bianchi Porro G, Petrillo M (1978) Controlled, double-blind study comparing acetylsalicylic acid and diflunisal in the treatment of osteoarthritis of the hip and/or knee, long-term gastroscopic study. In: Miehlke K (ed) Diflunisal in clinical practice. Futura Publ Co, Mt Kisco New York, p 63–73

    Google Scholar 

  • Caruso I, Corvi G, Fuccella LM, Moro E, Sacchetti G, Tamassia V, Tosolini GP (1977) Pharmacokinetic studies of indoprofen in healthy volunteers and in patients. Int J Clin Pharmacol Biopharm 15: 411–416

    PubMed  CAS  Google Scholar 

  • Caruso I, Moro E, Patrono C, Sacchetti G, Tamassia V, Tosoline GP (1980) Plasma and synovial fluid pharmacokinetics and prostaglandin inhibitory effect of indoprofen in patients with rheumatoid arthritis. Scand J Rheumatol 9: 123–126

    PubMed  CAS  Google Scholar 

  • Cashin CH, Dawson W, Kitchen EA (1977) The pharmacology of Benoxaprofen (2-[4-Chlorophenyl]- Alpha-Methyl-5-Benzoxazole acetic acid), LRCL 3794, a new compound with antiinflammatory activity apparently unrelated to inhibition of prostaglandin synthesis. J Pharm Pharmacol 29: 330–336

    PubMed  CAS  Google Scholar 

  • Castor CW (1972) Connective tissue Activation. IV. Regulatory Effects of Antirheumatic Drugs. Arthritis Rheum 15: 504–514

    PubMed  CAS  Google Scholar 

  • Cathcart ES, Scheinberg MA, Idelson BA, Couser WG (1976) Beneficial effects of methylprednisolone “pulse” therapy in diffuse proliferative lupus nephritis. Lancet 1: 163–166

    PubMed  CAS  Google Scholar 

  • Cavaretta CP (1981) A long-term, double-blind comparison of Pirprofen and acetylsalizylic acid in rheumatoid arthritis. Mitteilung gehalten auf dem Rengasil-Symposion, Paris, 15. Internat Rheumatologie Kongreß, 1981

    Google Scholar 

  • Cawley MID, McAllister JM, Thould AK, Balme HW (1969) Uptake of P32-labelled cyclophosphamide from arthritic knee joints. Ann Rheum Dis 28: 624–629

    PubMed  CAS  Google Scholar 

  • Chalmers IM, Cathcart BJ, Kumar EB, Dick WC, Buchanan WW (1972) Clinico-pharmacological studies and clinical evaluation of flurbiprofen. A new non-steroidal antirheumatic agent. Ann Rheum Dis 31: 319–324

    PubMed  CAS  Google Scholar 

  • Champion GD, Day RO, Graham GG, Pauli PD (1975) Salicylates in rheumatoid arthritis. Clin Rheum Dis 2: 245–265

    Google Scholar 

  • Chang YH (1977) Adjuvant polyarthritis. II. Suppression by tilorone. J Pharmacol Exp Ther 203: 156–161

    PubMed  CAS  Google Scholar 

  • Chaouat Y (1973) Vergleichende Doppelblinduntersuchung über die therapeutische Wirkung von AE17 und Phenylbutazon. Klinisches Gutachten. Archiv der Firma Delalande, Arzneimittel GmbH, Köln

    Google Scholar 

  • Charhon S, Rouillat M, Bouvier M (1980) Hepatite aurique: Une observation. Rev Rhum Mal Osteoartic 47: 205–207

    PubMed  CAS  Google Scholar 

  • Chart JJ, Maier R (1981) Eine kurze Übersicht über die präklinische Pharmakologie von Pirprofen. In: van der Korst (Hrsg) Ein neues antirheumatisch-analgetisches Medikament: Pirprofen (®Rengasil) Huber, Bern Stuttgart Wien, p 14–22

    Google Scholar 

  • Cherie-Ligniere G, Colombo B, Carrabba M, Ferrari P, Robotti E (1972) Clinical and laboratory evaluation of 4-prenyl-l,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in rheumatoid arthritis and ankylosing spondylitis. Arzneim Forsch/Drug Res 22: 253–258

    CAS  Google Scholar 

  • Cherner R, Groppe CW, Rupp JJ (1963) Prolonged Tolbutamide-Induced Hypoglycemia. JAMA 185: 883–884

    PubMed  CAS  Google Scholar 

  • Chernish SM, Rubin A, Rodda BE, Ridolfo AS, Gruber CM (1972) The physiological disposition of fenoprofen in man: IV. The effects of position of subject, food ingestion and antacid ingestion on the plasma levels of orally administered fenoprofen. J Med 3: 249–257

    PubMed  CAS  Google Scholar 

  • Chierichetti S, Bianchi G, Cerri B (1975) Comparison of Feprazone and Phenylbutazone interaction with Warfarin in men. Curr Ther Res 18: 568–572

    PubMed  CAS  Google Scholar 

  • Chlud K (1972) Diskussionsbemerkung. In: D-Penicillamin bei der chronischen Polyarthritis, Symposium, Wien, November 1972. Biochemie GmbH, Wien, p 70–71

    Google Scholar 

  • Chlud K (1976) Untersuchungen zur Wechselwirkung von Diclofenac und Glibenclamid. Z Rheumatol 35: 377–382

    PubMed  CAS  Google Scholar 

  • Chlud K (1977) Was hat sich bewährt in der Rheumatherapie? Zytostatika. Therapiewoche 27: 292–325

    Google Scholar 

  • Chlud K (1978) Zur Wirkung von Cyclophosphamid (Endoxan) bei der experimentellen Arthritis des Kaninchen. Z Rheumatol 37: 174–199

    PubMed  CAS  Google Scholar 

  • Chlud K (1980) Zur gleichzeitigen Verabreichung von Zytostatika (ZSt) und DPA bei chronischer Polyarthritis (cP). In: Chlud K (Hrsg) D-Penicillamin 1970–1980. Internationales Expertenge¬spräch Wien, 12.–14.6. 1980. Ein kritischer Vergleich — Konsequenzen für die Praxis. Knoll Ludwigshafen und Heyl, Berlin, p 145–147

    Google Scholar 

  • Chlud K, Kaik B (1977) Doppelblindstudie zur Frage einer möglichen Interaktion zwischen Tolectin und Glibenclamid. Therapiewoche 27: 6701–6702

    Google Scholar 

  • Chlud K, Kaik B, Pangerl S (1978) Indometacin-Glucosamid in der Behandlung der chronischen Polyarthritis. Arzneim Forsch/Drug Res 28: 1200

    CAS  Google Scholar 

  • Chlud K, Kaik B, Pangerl S (1980) Doppelblind-crossover-Untersuchung von Fenbufen und Phenylbutazon bei Patienten mit chronischer Polyarthritis. Verh Dtsch Ges Rheumatol 6: 340–342

    Google Scholar 

  • Chlud K, Kotz R, Zeitlhofer J (1972) Die intraartikuläre Zytostatikaanwendung bei chronischer Polyarthritis. Tierexperimentelle und klinische Untersuchungen mit Endoxan. Therapiewoche 22: 2740–2750

    Google Scholar 

  • Chlud K, Prohaska E, Zeitlhofer J, Pfaller Ch, Friza B (1968) Immunosuppressive Behandlung der progressiv-chronischen Polyarthritis. Erfahrungen mit einem Antimitotikum aus der Podophyllinreihe (Proresid). Muench Med Wochenschr 110: 88–97

    CAS  Google Scholar 

  • Ciba Foundation (1979) Symposium 65 ( New Series ): Oxygen free radicals and tissue damage. Exc Medica, Amsterdam Oxford New York

    Google Scholar 

  • Ciccolunghi SN, Chaudri HA (1977) Resultate aus weltweit durchgeführten klinischen Prüfungen mit Voltaren. In: Wagenhäuser FJ (Hrsg) Polyarthritiden. Huber, Bern Stuttgart Wien, S 345–358

    Google Scholar 

  • Ciccolunghi SN, Chaudri HA, Schubiger BI, Reddrop R (1978) Report on a long-term tolerability study of up to two years with Diclofenac sodium (Voltaren). Scand J Rheum [Suppl 22] 86–96

    Google Scholar 

  • Clara R, Germanes J (1977) Levamisole and agranulocytosis. Lancet 1: 47–48

    PubMed  CAS  Google Scholar 

  • Clements PJ, Yu DTY, Levy J, Paulus HE, Barnett EV (1974) Effects of cyclophosphamide on B- and T-lymphocytes in rheumatoid arthritis. Arthritis Rheum 17: 347–353

    PubMed  CAS  Google Scholar 

  • Clemmensen OJ, Siggaard-Andersen J, Worm AM, Stahl D, Frost F, Bloch I (1980) Psoriatic arthritis treated with oral zinc sulphate. Br J Dermatol 103: 411–415

    PubMed  CAS  Google Scholar 

  • Clercq ED, Dann O (1980) Diaryl amidine derivatives as oncornaviral DNA polymerase inhibitors. J Med Chem 23: 787–795

    PubMed  CAS  Google Scholar 

  • Cline MJ, Melmon KL (1966) Plasma Kinin and Cortisol: A possible explanation of the anti-inflammatory action of Cortisol. Science 153: 1135–1138

    PubMed  CAS  Google Scholar 

  • Coblyn JS, Weinblatt M, Holdsworth D, Glass D (1981) Gold-induced Thrombopenia. A clinical and immunogenetic study of twenty-three patients. Ann Int Med 95: 178–181

    PubMed  CAS  Google Scholar 

  • Cohen DL, Orzel J, Taylor A (1981) Infants of mothers receiving goldtherapy. Arthritis Rheum 24: 104–105

    PubMed  CAS  Google Scholar 

  • Cohen SN, Yielding KL (1965) Spectrophotometry studies of the interaction of chloroquine with desoxyribonucleic acid. J Biol Chem 240: 3123–3131

    PubMed  CAS  Google Scholar 

  • Collier HO J (1969) A pharmacological analysis of aspirin. Adv Pharmacol Chemother 7: 17–19, 333–405

    Google Scholar 

  • Collier HO J, Shorley PG (1960) Analgesic antipyretic drugs as antagonists of bradykinin. Br J Pharmacol 15: 601–610

    CAS  Google Scholar 

  • Collins E, Turner G (1975) Maternal effects of regular salicylate ingestion in pregnancy. Lancet 2: 335–338

    PubMed  CAS  Google Scholar 

  • Collins G, Outerbridge E, Manku MS, Horrobin DF (1976) Chloroquine as prostaglandin antagonist in treatment of patent ductus arteriosus. Lancet 2: 810

    PubMed  CAS  Google Scholar 

  • Collum LMT, Bowen DI (1971) Ocular side-effects of ibuprofen. Br J Ophthalmology 55: 472–477

    CAS  Google Scholar 

  • Combs RJ, Dentino MM, Lehrman L, Szwed JJ (1976) Gold toxicity and peritoneal dialysis. Arthritis Rheum 19: 936–938

    PubMed  CAS  Google Scholar 

  • Conney AH, Pantuck EJ, Pantuck CB, Buening M, Jerina DM, Fortner JG, Alvares AP, Anderson KE, Kappas A (1979) Role of environment and diet in the regulation of human drug metabolism. In: Estabrook RW, Lindenlaub E (Hrsg) The Induction of drug metabolism. Symposia Medica Hoechst 14. Schattauer, Stuttgart New York, p 583–605

    Google Scholar 

  • Cooperating Clinics Committee of the American Rheumatism Association (1970) A controlled trial of cyclophosphamide in rheumatoid arthritis. N Engl J Med 283: 883–889

    Google Scholar 

  • Corcos JM, Soler-Bechara J, Mayer K, Freyberg RH, Goldstein R, Jaffe I (1964) Neutrophilic Agranulocytosis During Administration of Penicillamine. JAMA 189: 265–268

    PubMed  CAS  Google Scholar 

  • Covelli M, Lapadula G, Numo R (1981) Effects of levamisole on Tμ and Tγ cellsubpopulation. R 11: 335–339

    Google Scholar 

  • Crawhall JC, Scowen EF, Watts RWE (1963) Effect of penicillamine on cystinuria. Br Med J 1: 588–590

    PubMed  CAS  Google Scholar 

  • Crevoisier C, Ziegler WH (1980) Pharmacocinetique du carprofene. Daten der Fa Hoffmann La Roche

    Google Scholar 

  • Crilly RG, Marshall DH, Nordin BEC (1979) Metabolic effects of corticosteroid therapy in postmenopausal women. J Steroid Biochem 11: 429–433

    PubMed  CAS  Google Scholar 

  • Crout JE, Hepburn B, Ritts RE (1975) Suppression of lymphocyte transformation after aspirin ingestion. N Engl J Med 292: 221–223

    PubMed  CAS  Google Scholar 

  • Cruz-Filho A, Gomes IJ, Budaruiche JS (1979) Reaktion gegen Natrium-Auro-thiomalat bei der Behandlung der rheumatoiden Arthritis. Z Rheumatol 38: 381–384

    PubMed  CAS  Google Scholar 

  • Cudkowicz L, Jacobs JH (1953) Phenylbutazone (Butazolidine) in the treatment of chronic arthritis. Lancet 264: 223–224

    CAS  Google Scholar 

  • Cuisinaud G, Legheand J, Llorca G, Belkahir C, Lejeune E, Sassard J (1979) Pharmacokinetics of Fenbufen in man. Eur J Clin Pharmacol 16: 59–61

    PubMed  CAS  Google Scholar 

  • Currey HLF (1965) Intraarticular thiotepa in rheumatoid arthritis. Ann Rheum Dis 24: 382–388

    PubMed  CAS  Google Scholar 

  • Currey HLF, Harris J, Mason RM, Woodland J, Beveridge T, Roberts CJ, Vere DW, Dixon AStJ, Davies J, Owen-Smith B (1974) Comparison of Azathioprine, Cyclophosphamide, and gold in treatment of rheumatoid arthritis. Br Med J 3: 763–766

    PubMed  CAS  Google Scholar 

  • Dahl MGC, Gregory MM, Scheuer PJ (1971) Liver damage due to methotrexate in patients with psoriasis. Br Med J 1: 625–630

    PubMed  CAS  Google Scholar 

  • Dale DC, Fauci AS, Wolff SM (1974) Alternate-day prednisone, leucocyte kinetics and susceptibility to infections. N Engl J Med 291: 1154–1158

    PubMed  CAS  Google Scholar 

  • Dall JLC, Keane JA (1959) Disturbances of pigmentation with chloroquine. Br Med J 1: 1387–1389

    PubMed  CAS  Google Scholar 

  • Dameshek W, Schwartz R (1960) Treatment of certain “autoimmune” diseases with antimetabolites; a preliminary report. Trans Assoc Am Physicians 73: 113–127

    PubMed  CAS  Google Scholar 

  • David DS, Grieco H, Cushman P jr (1970) Adrenal glucocorticoids after twenty years: A review of their clinically relevant consequences. J Chronic Dis 22: 637–711

    PubMed  CAS  Google Scholar 

  • Davies P, Allison AC (1976) Secretion of Macrophage enzymes in relation to the pathogenesis of chronic inflammation. In: Nelson DS (ed) Immunobiology of the macrophage. Academic Press, New York, p 427–461

    Google Scholar 

  • Davis P, Barraclough D (1977) Interaction of D-penicillamine with goldsalts. In vivo studies on gold chelation and in vitro studies on protein binding. Arthritis Rheum 20: 1413–1418

    Google Scholar 

  • Davis P, Harth M (1979) International Workshop and Symposium on gold salts in the rheumatic diseases. J Rheumatol [Suppl 5] 6: 1–164

    Google Scholar 

  • Davis P, Hughes GRV (1974) Significance of eosinophilia during gold therapy. Arthritis Rheum 17: 964–968

    PubMed  CAS  Google Scholar 

  • Davis P, Russell AS, Miller C (1981) Mechanisms of action of Auranofin: Effects on Phagozytosis. Mitteilung auf dem Symposium „Therapeutic innovation in Rheumatoid Arthritis: World Wide Auranofin Symp. 20./21. Oktober 1981, Montreal

    Google Scholar 

  • Davison AM, Golding JR, Thomson D (1977) Effect of Penicillamine on the kidney. Proc R Soc Med [Suppl 3] 70: 109–112

    Google Scholar 

  • Davison S (1980) Late appearing nitritoid reactions. Arthritis Rheum 23: 1067

    PubMed  CAS  Google Scholar 

  • Dayer J-M, Krane SM, Rüssel RGG, Robinson DR (1976) Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells. Proc Natl Acad Sci 73: 945–949

    PubMed  CAS  Google Scholar 

  • DeBosset PhL, Bitter Th (1973) Near-cytotoxic gold salt therapy in long standing drug–refractory rheumatoid arthritis. A prospective investigation. Schweiz Med Wochenschr 103: 1153–1158

    CAS  Google Scholar 

  • Deby C, Bracq Z-M, Simon D (1973) In vitro inhibition of the biosynthesis of a prostaglandin by gold and silver. Biochem Pharmakol 22: 3141–3143

    CAS  Google Scholar 

  • Degos MMR, Touraine R, Belaich S, Revuz J (1969) Pemphigus chez un malade traité par penicillamine pour maladie de Wilson. Bull Soc Franc Derm Syph 76: 751–753

    PubMed  CAS  Google Scholar 

  • Delbarre F, Labrousse C, Braun S (1968) La synoviorthèse par le thiotépa. Rev Rhumatisme 35: 6–8

    CAS  Google Scholar 

  • Delbarre F, Mery C, deGery A (1977) Étude à court terme de l’effet d’un traitement par l’indoprofene dans la polyarthrite rhumatoïde (comparaison à un placebo et à l’indométacine). R 7: 471–480

    Google Scholar 

  • Delbarre F, Pellegrini P, Derouaux G (1971) Un nouvel anti-inflammatoire: la Pyrazinobutazone (sel équimoléculaire de phénylbutazone et de pipérazine). Enseignements à tirer de l’analyse par ordinateur de 3.000 observations cliniques en rhumatologie. Rev Rheumatol 1: 189–202

    Google Scholar 

  • Delbarre F, Roucayrol JC, Amor B, Ingrand J, Bourat G, Fournel J, Courjaret J (1976) Pharmakokinetic study of Ketoprofen (19583 RP) in man using the tritiated compound. Scand J Rheumatol [Suppl 14] 45–52

    Google Scholar 

  • Dell H-D, Doersing M, Fischer W, Jacobi H, Kamp R, Köhler G, Schöllnhammer G (1980) Metabolismus und Pharmakokinetik von Acemetacin beim Menschen. Arzneim Forsch/Drug Res 30 (II): 1391–1398

    Google Scholar 

  • Dell H-D, Doersing M, Fischer, W, Fiedler J, Jacobi H, Kamp R (1981) Zum Metabolismus von Etofenamat. Identifizierung und Analytik der Metaboliten, deren pharmakologische Eigenschaften sowie Speziesabhängigkeit des Etofenamat-Metabolismus. Arzneim Forsch/Drug Res 31 (1): 9–16

    CAS  Google Scholar 

  • Dell H-D, Fiedler J, Jakobi H, Wäsche B (1977) Zur Biochemie und Pharmakokinetik von Etofenamat. Untersuchungen am Menschen. Arzneim Forsch/Drug Res 27(1): 1322–1325

    Google Scholar 

  • Delrieu F, Job Ch, Roswag D (1980) Nécrose cutanée après une injection intra-musculaire de phénylbutazone. R 10: 119–120

    Google Scholar 

  • Delrieu F, Menkes CJ, Sainte-Croix A, Babinet P, Chesneau A-M, Delbarre F (1976) Myasthénie et thyroidite autoimmune au cours du traitement de la polyarthrite rhumatoïde par la D-Penicill- amine. Étude anatomo-clinique d’un cas. Ann Méd Interne (Paris) 127: 739–743

    CAS  Google Scholar 

  • Denson LJ, Thompson MD (1960) A new salicylate therapy for treatment of arthritic diseases. J Med Soc NJ 57: 314

    CAS  Google Scholar 

  • Deodhar SD, Dick WC, Hodgkinson R, Buchanan WW (1973) Measurement of clinical response to anti-inflammatory drug therapy in rheumatoid arthritis. Q J Med (New series) 42: 387–401

    CAS  Google Scholar 

  • Deodhar SD, McLeod MM, Dick WC, Buchanan WW (1977) A short-term comparative trial of salsalate and indomethacin in rheumatoid arthritis. Curr Med Res Opin 3: 185–188

    Google Scholar 

  • Dequeker J, Mardjuardi A (1981) Treatment of rheumatoid arthritis with flurbiprofen: a comparison with enteric-coated aspirin. Curr Med Res Opin 7: 418–422

    PubMed  CAS  Google Scholar 

  • Dequeker J, Stevens E, Wuyts L (1980) A controlled trial of magnesium dithiosalicylate compared with aspirin in rheumatoid arthritis. Curr Med Res Opin 6: 589–592

    PubMed  CAS  Google Scholar 

  • Desai SN (1973) Sudden gigantism of breasts: Drug induced? Br J Plast Surg 26: 371–372

    PubMed  CAS  Google Scholar 

  • Deshayes P, Rénier J-C, Bregeon Ch, Houdent G (1971) Incidents et accidents des thérapeutiques à visée immuno dépressive dans la polyarthrite rhumatoide. Rev Rhumatism 38: 797–806

    CAS  Google Scholar 

  • Dettmer N (1966) Betrachtungen zum Wirkungsmechanismus von Mucopolysaccharid-Polyschwefel- säureestern an arthrotischen Knorpeln. Z Rheumaforsch 25: 122–130

    PubMed  CAS  Google Scholar 

  • Dettmer N (1979) Der Therapieeffekt von Glycosaminoglycanpolysulfat (Arteparon) bei Arthrosen in Abhängigkeit von der Applikationsart (intraartikulär oder intramuskulär). Z Rheumatol 38: 163–181

    PubMed  CAS  Google Scholar 

  • Dettmer N, Greiling H, Sensch KH (1980) Internationales Arzneimittelsymposium Arteparon®. Congress Series. Eular-Verlag, Basel

    Google Scholar 

  • Deitmer N, Josenhans G (1967) Über die intraartikuläre Anwendung von Mucopolysacchariden bei Gelenkserkrankungen. Med Welt 18: 2697–2702

    Google Scholar 

  • Deutsch HF, Morton JI (1957) Dissociation of human serum macroglobulins. Science 125: 600

    PubMed  CAS  Google Scholar 

  • Deyo RA, Inui TS, Sullivan B (1981) Noncompliance with arthritis drugs: Magnitude, correlates, and clinical implications. J Rheumatol 8: 931–936

    PubMed  CAS  Google Scholar 

  • Dieppe PA, Huskisson EC (1978) Diflunisal and Acetylsalicylic acid: A comparison of efficacy in osteoarthritis; of nephrotoxicity, and of anti-inflammatory activity in the rat. In: Miehlke K (ed) Diflunisal in clinical practice. Futura Publ Co, Mt Kisco New York, pp 57–61

    Google Scholar 

  • Di Perri T zit nach Mowat (1979) In: Mowat AG, Vischer TL (ed) Levamisole “Immunmodulation” — a new approach to basic therapy of rheumatoid arthritis. Eular Monograph Series, Nr 5, Eular Publ, Basel, p 7

    Google Scholar 

  • Di Perri T, Auteri A, Laghi-Pasini F, Mattiolo F (1978) A weakly oral dose of levamisole in the treatment of rheumatoid arthritis associated with E-rosette lymphocyte reduction. Eur J Rheumatol Inflamm 1: 155–164

    Google Scholar 

  • Di Rosa M, Willoughby DA (1971) Screens of antiinflammatory drugs. J Pharmacy Pharmacol 23: 297–298

    Google Scholar 

  • Dittrich P, Knapp E, Staudinger E (1970) Arzneimittelfieber nach Azathioprinmedikation. Wien Klin Wochenschr 82: 316

    PubMed  CAS  Google Scholar 

  • Dixon AStJ, Davies J, Dormandy TL, Hamilton EBD, Holt PJL, Mason RM, Thompson M, Weber JCP, Zutshi DW (1975) Synthetic D(-penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen. Ann Rheum Dis 34: 416–421

    PubMed  CAS  Google Scholar 

  • Dodd M J, Griffiths ID, Thompson M (1980) Adverse reactions to D-penicillamine after gold toxicity. Br Med J 280: 1498–1500

    PubMed  CAS  Google Scholar 

  • Dolin R, Reichman RC, Mazur MH, Whitley RJ (1978) Herpes zoster — Varizella infections in immunosuppressed patients. Ann Intern Med 89: 375–388

    PubMed  CAS  Google Scholar 

  • Domenjoz R (1971) The pharmacology of antirheumatic agents. In: Müller W, Harwerth H-G, Fehr K (eds) Rheumatoid Arthritis. Academic Press, London New York, pp 513–550

    Google Scholar 

  • Douwes FR (1974) The Effect of Anti-Inflammatory Drugs on Phagozytosis and Lysosomal Enzymes in Granulocytic Leucocytes. Int J Clin Pharmacol 9: 243–246

    CAS  Google Scholar 

  • Downie WW, Lowe JR, Pickup ME (1977) The effects of antacids on the absorption of enteric-coated phenylbutazone (Butacote). J Int Med Res [Suppl 2] 5: 20–25

    Google Scholar 

  • Dresse A, Delapierre D, Baudinet G, Kramp R (1978) Pharmakokinetics of Diflunisal administered orally at a dosage of 500 mg twice daily for 10 days. In: Symposium on Diflunisal. New Perspectives in Analgesia, Abstract 1. Zit nach Winzum C van, Verhaest L (1979)

    Google Scholar 

  • Droste U (1982) Benoxaprofen in der Behandlung der chronischen Polyarthritis. Akt Rheumatol 7: 52–54

    Google Scholar 

  • Duchange E (1956) Étude critique des effets de la nivaquine dans la PCE. Thèse, Paris

    Google Scholar 

  • Dugal R, Dupuis C, Bertrand M, Gagnon MA (1980) The effect of puffering on oxyphenbutazone absorption, kinetics and systemic availability. Biopharm Drug Dispos 1: 307–321

    PubMed  CAS  Google Scholar 

  • Duggan DE, Hogans AF, Kwan KC, McHahon FG (1972) The metabolism of indomethacin in men. J Pharmacol Exp Ther 181: 563–575

    PubMed  CAS  Google Scholar 

  • Duggan DE, Hooke KF, Noll RM, Kwan KC (1975) Enterohepatic circulation of Indomethacin and its role in intestinal irritation. Biochem Pharmacol 25: 1749–1754

    Google Scholar 

  • Dürrigl T, Vitaus M, Pucar I, Miko M (1976) Diclofenac Natrium (Voltaren): Ergebnisse einer vergleichenden Multicenter-Prüfung bei rheumatoider Arthritis des Erwachsenen. Therapiewoche 26: 2922–2928

    Google Scholar 

  • Dwosch IL, Stein HB, Urowitz MB, Smythe HA, Hunter T, Ogryzlo MA (1977) Azathioprine in early rheumatoid arthritis. Comparison with gold and chloroquine. Arthritis Rheum 20: 685–692

    Google Scholar 

  • Eakins KE, Higgs GA, Mugridge KG, Moncada S, Vane JR (1979) Low doses of indomethacin or the salicylates enhance leukocyte migration in vivo. Zit nach Higgs et al. (1979 a)

    Google Scholar 

  • Eastmond CJ (1976) Diffuse alveolitis as complication of penicillamine treatment for rheumatoid arthritis. Br Med J 1: 1506

    PubMed  CAS  Google Scholar 

  • Eberhard A, Laas U, Vojtisek O, Greiling H (1972) Zur Bedeutung und Herkunft von lysosomalen Enzymen in der Synovialflüssigkeit bei chronischen Gelenkerkrankungen. Z Rheumaforsch 31: 105–118

    PubMed  CAS  Google Scholar 

  • Eberl R (1974) Goldbehandlung der Polyarthritis chronica. I. Klinischer Teil. Goldtherapie und Nebenwirkungen von Goldpräparaten. II. Biochemischer Teil. Untersuchungen über den Wirkungsmechanismus der Chrysotherapie und ihrer Nebenwirkungen. Wien Klin Wochenschr [Suppl 25] 86: 3–22

    Google Scholar 

  • Eberl R (1975) Über Komplikationen der Chrysotherapie bei 268 Patienten. Acta Med Austriaca 2: 125–127

    PubMed  CAS  Google Scholar 

  • Eberl R, Altmann H (1970) Über die Transportform von Gold im Blutserum nach intravenöser bzw. intramuskulärer Verabreichung verschiedener Goldsalze. Z Klin Chem Klin Biochem 8: 99

    PubMed  CAS  Google Scholar 

  • Eberl R, Tausch G, Klein W, Kocsis F, Altmann H (1974) Einfluß von D-Penicillamin auf die semikonservative DNS-Synthese und DNS-Reparatur. Z Rheumatol 33: 148–151

    PubMed  CAS  Google Scholar 

  • Ebringer A, Colville P (1967) Chloroquine neuromyopathy associated with keratopathy and retinopathy. Br Med J 2: 219–220

    Google Scholar 

  • Editorial (1971) Gold for rheumatoid arthritis. Br Med J 1: 471–472

    Google Scholar 

  • Ehrlich GE (1979) Tolmetin sodium: Meeting the clinical challange. Clin Rheum Dis 5: 481–497

    Google Scholar 

  • Eisenmenger E, Hofecker G, Niebauer G, Niedermüller H (1977) Untersuchungen über die Einbaurate von subkutan injiziertem Tritium-markiertem Eleparon in experimentell geschädigte Gelenke von Ratten. Wien Tieraerztl Monatsschr 64: 148–153

    CAS  Google Scholar 

  • El-Ghobarey AF, Kirkwood E, Forrester JB, Ansari AF, Lawrence JR, Dick WC (1980) Effect of levamisole on cell mediated immunity, and leucocyte cyclic nucleotides in patients with rheumatoid arthritis. R 10: 367–373

    Google Scholar 

  • El-Ghobarey AF, Chaudhuri AKR, Kirkwood E, Dick WC (1979) Levamisole and severe varicella infection in a patient with rheumatoid arthritis. R 8: 399–401

    Google Scholar 

  • Elling H, Kiilerich S, Sabro J, Elling P (1980) Influence of a non-steroid antirheumatic drug on serum and urinary zinc in healthy volunteers. Scand J Rheumatol 9: 161–163

    PubMed  CAS  Google Scholar 

  • Ellison MR, Flatt AE (1971) Intra-articular thiotepa in rheumatoid disease. A clinical analysis of 123 injected MP and PIP joints. Arthritis Rheum 14: 212–222

    PubMed  CAS  Google Scholar 

  • Elman A, Gullberg R, Nilsson E, Rendali I, Wachtmeister L (1976) Chloroquine retinopathy in patients with rheumatoid arthritis. Scand J Rheumatol 5: 161–166

    PubMed  CAS  Google Scholar 

  • Emori HW, Champion GD, Bluestone R, Paulus HE (1973) Simultaneous pharmacokinetics of indomethacin in serum and synovial fluid. Ann Rheum Dis 32: 433–435

    PubMed  CAS  Google Scholar 

  • Empire Rheumatism Council (1957) Multi-centre controlled trial comparing cortisone acetate and acetylsalicylic acid in the long-term treatment of rheumatoid arthritis: Results of three year’s treatment. Ann Rheum Dis 16: 277–289

    Google Scholar 

  • Endres W (1981) D-Penicillamine in pregnancy — to ban or not to ban? Klin Wochenschr 59: 535–537

    PubMed  CAS  Google Scholar 

  • Enislidis AC (1972) Gewebsverteilung von Tritium-markiertem Glycosaminoglykanpolysulfat nach intraartikulärer Injektion. Med Welt 23: 733–735

    PubMed  CAS  Google Scholar 

  • Ennis RS, Granda JL, Posner AS (1968) Effect of gold salts and other drugs on the release and activity of lysosomal hydrolases. Arthritis Rheum 11: 756–764

    PubMed  CAS  Google Scholar 

  • Erhardt R, Fischer U, Fischer B, Kern J (1978) Hirnorganisches Syndrom bei Goldtherapie. Fortschr Med 96: 581–585

    PubMed  CAS  Google Scholar 

  • Erkrath KD, Adebahr G, Klöppel A (1980) Folgenschwere Verwechslung von Penicillamin mit Penicillin. Allergie vom Spättyp mit protrahiertem Schock als tödliche Komplikation der Therapie mit D-Penicillamin bei rheumatoider Arthritis im Kindesalter. Dtsch Med Wochenschr 105: 1121–1123

    PubMed  CAS  Google Scholar 

  • Erlsbacher O, Geisberger H, Popp A (1956) Antientzündliche Therapie mit Stickstofflost. Med Welt 166–169

    Google Scholar 

  • Essigman WK, Chamberlain MA, Wright V (1979) Diflunisal in osteoarthrosis of the hip and knee. Ann Rheum Dis 38: 148–151

    PubMed  CAS  Google Scholar 

  • Estes D, Kaplan K (1980) Lack of platelet effect with the aspirin analogue salsalate. Arthritis Rheum 23: 1303–1307

    PubMed  CAS  Google Scholar 

  • Eylau O (1960) Zur Pathogenese und causalen Behandlung der Kniegelenkarthrose. Med Klin 55: 2367–2370

    PubMed  CAS  Google Scholar 

  • Eylau O (1966) Intraartikuläre Arthrosebehandlung mit einem Mucopolysaccharidschwefelsäureester. Z Aerztl Fortbild (Jena) 55: 142–148

    Google Scholar 

  • Eyring EJ, Engleman EP (1963) Interaction of gold and penicillamin. Arthritis Rheum 6: 216–223

    CAS  Google Scholar 

  • Faber U, Walther D (1966) Tierexperimentelle Untersuchungen über die Regenerationsfähigkeit des hyalinen Knorpels und über Möglichkeiten einer Stimulierung der Knorpelregeneration. Arch Orthop Unfallchir 59: 401–408

    PubMed  CAS  Google Scholar 

  • Faludi G, Mills LC, Chayes ZW (1964) Effect of steroid on muscel. Acta Endocrinol (Kbh) 45: 68–78

    CAS  Google Scholar 

  • Famaey J-P (1973) Interactions between non-steroidal anti-inflammatory drugs and biological membranes. I. High amplitude pseudo-energized mitochondrial swelling and membrane permeability changes induced by various non-steroidal anti-inflammatory drugs. Biochem Pharmacol 22: 2693–2705

    PubMed  CAS  Google Scholar 

  • Famaey JP, Colinet E (1976) A double-blind trial of Ketoprofen in the treatment of osteoarthritis of the hip. Scand J Rheumatol [Suppl 14] 129–132

    Google Scholar 

  • Famaey J-P, Whitehouse MW (1973) Interactions between nonsteroidal anti-inflammatory drugs and biological membranes. II. Swelling and membrane-permeability changes induced in some immunocompetent cells by various non-steroidal anti-inflammatory drugs. Biochem Pharmacol 22: 2707–2717

    PubMed  CAS  Google Scholar 

  • Fan PT, Yu DTY, Clements PJ, Fowlston S, Eisman J, Bluestone R (1978) Effect of corticosteroids on the human immune response: Comparison of one and three daily 1 gm intravenous pulses of methylprednisolone. J Lab Clin Med 91: 625–634

    PubMed  CAS  Google Scholar 

  • Farquet J-J, Dayer J-M, Miescher PA (1978) Anémie auto-immunohémolytique induite par l’acide mefenamique. Schweiz Med Wochenschr 108: 1510–1512

    PubMed  CAS  Google Scholar 

  • Fauci AS (1978) Mechanisms of action of glucocorticosteroids. Ann Rep Med Chemistry 13: 179–183

    CAS  Google Scholar 

  • Fauci AS (1978-79) Mechanisms of the immunosuppressive and anti-inflammatory effects of glucocorticosteroids. J Immunopharmacol 1: 1–25

    Google Scholar 

  • Fauci AS (1978) Alternate-day corticosteroid therapy. Am J Med 64: 729–731

    PubMed  CAS  Google Scholar 

  • Fauci AS (1979) Glucocorticoid effects on circulating human mononuclear cells. J Reticuloendothel Soc 26: 727–738

    PubMed  CAS  Google Scholar 

  • Fauci AS, Dale DC (1974) The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J Clin Invest 53: 240–246

    PubMed  CAS  Google Scholar 

  • Fauci AS, Dale DC (1975) Alternate-day prednisone therapy and human lymphocyte subpopulations. J Clin Invest 55: 22–32

    PubMed  CAS  Google Scholar 

  • Faust-Tinnefeldt G, Gilfrich H J (1977) Digitoxin-Kinetik unter antirheumatischer Therapie mit Azapropazon. Arzneim Forsch/Drug Res 27(II): 2009–2011

    Google Scholar 

  • Faust-Tinnefeldt G, Geißler HE, Mutschier E (1977 a) Azapropazon-Plasmaspiegel unter rheumatologischer Kombinationstherapie mit D-Penicillamin und Immunsuppressiva. Arzneim Forsch/Drug Res 27: 2153–2157

    Google Scholar 

  • Faust-Tinnefeldt G, Geißler HE, Mutschier E (1977 b) Azapropazon-Plasmaspiegel unter Begleitmedikation mit einem Antacidum oder Laxans. Arzneim Forsch/Drug Res 27(II): 2411–2414

    Google Scholar 

  • Faust-Tinnefeldt G, Geißler HE (1977) Azapropazon und rheumatologische Basistherapie mit Chloroquin unter dem Aspekt der Arzneimittelinteraktion. Arzneim Forsch/Drug Res 27: 2170–2173

    CAS  Google Scholar 

  • Faust-Tinnefeldt G, Geißler HE (1978) Azapropazon und rheumatologische Kombinationstherapie unter dem Aspekt der Arzneimittelinteraktionen: Azapropazon/Aurothioglukose und Azapropazon/Prednisolon. Arzneim Forsch/Drug Res 28: 337–341

    CAS  Google Scholar 

  • Favreau M (1977) Hepatic toxicity associated with gold therapy. Ann Intern Med 87: 717–719

    PubMed  CAS  Google Scholar 

  • Fee JA, Teitelbaum HD (1972) Evidence that superoxide dismutase plays a role in protecting red blood cells against peroxidative hemolysis. Biochem Biophys Res Commun 49: 150–158

    PubMed  CAS  Google Scholar 

  • Feldmann JL, Mery C, Amor B, Kahan A, Gery A de, Delbarre F (1981) Effectiveness of levamisole in rheumatoid arthritis: Immune changes and long-term results. Scand J Rheumatol 10: 1–8

    PubMed  CAS  Google Scholar 

  • Fellet A (1979) Fentiazac in rheumatoid arthritis: a multicentre study. Curr Med Res Opin [Suppl] 6: 64–70

    Google Scholar 

  • Feltkamp TEW (1979) Fundamental studies on penicillamine for rheumatoid diseases. Scand J Rheumatol [Suppl 28] 5–107

    Google Scholar 

  • Felts JH, King JSt Jr, Boyce WH (1968) Nephrotic syndrome after treatment with d-penicillamine. Lancet 1: 53–54

    PubMed  CAS  Google Scholar 

  • Fenech FF, Bannister WH, Grech JL (1967) Hepatitis with biliverdinaemia in association with indomethacin-therapy. Br Med J 2: 155–156

    Google Scholar 

  • Fenner H (1982) Interaktionen mit nichtSteroiden Antirheumatika. Rheuma-Therapie Aktuell 2/1: 2–8

    Google Scholar 

  • Fenner H (1982) Suxibuzon (Solurol)-Verkauf in Japan eingestellt. Rheuma-Therapie Aktuell 2/1: 8

    Google Scholar 

  • Fenner H, Eberl R (1977) Azapropazon bei Erkrankungen des rheumatischen Formenkreises. Rheumaforum, Sondernummer 1. Braun, Karlsruhe

    Google Scholar 

  • Fernandes L, Swinson DR, Hamilton EBD (1977) Dermatomyositis complicating penicillamine treatment. Ann Rheum Dis 36: 94–95

    PubMed  CAS  Google Scholar 

  • Ferreira SH (1972) Prostaglandins, Aspirin-like drugs and analgesia. Nature New Biol 240: 200

    PubMed  CAS  Google Scholar 

  • Ferreira SH, Vane JR (1974) New aspects of the mode of action of nonsteroidal anti-inflammatory drugs. Ann Rev Pharmacol 14: 67–73

    Google Scholar 

  • Ferreira SH, Vane JR (1979) Mode of action of anti-inflammatory agents which are prostaglandinsyn- thetase inhibitors. In: Vane JR, Ferreira SH (eds) Anti-inflammatory drugs. Handbuch exp Pharma, 50/2. Springer, Berlin Heidelberg New York, p 348–398

    Google Scholar 

  • Fiegel G (1979) Kortikoid-Nebenerscheinungen. Schattauer, Stuttgart New York

    Google Scholar 

  • Fikrig SM, Smithwick EM (1968) Effect of gold salts on in vitro lymphocyte response to streptolysin- S. Arthritis Rheum 9: 478–479

    Google Scholar 

  • Finkelstein AE, Walz DT, Batista V, Mizraji M, Roisman F, Misher A (1976) Auranofin, new oral gold compound for treatment of rheumatoid arthritis. Ann Rheum Dis 35: 251–257

    PubMed  CAS  Google Scholar 

  • Finkelstein AE, Roisman FR, Ladizesky MG, Walz DT (1981) Mechanisms of action of Auranofin: Effects on lysosomal enzymes. Mitteilung auf dem Symposium „Therapeutic innovation in Rheumatoid Arthritis: World Wide Auranofin Symp, 20/21.10.1981, Montreal

    Google Scholar 

  • Finkelstein AE, Roisman FR, Walz DT (1977) Effect of Auranofin, a new antiarthritic agent on immune complex-induced release of lysosomal enzymes from human leukocytes. Inflammation 2: 143–150

    PubMed  CAS  Google Scholar 

  • Finkenbein GF, Schönhaber E, Fries G (1981) Erfahrungen mit Orgotein bei der konservativen Behandlung der Gonarthrose: Ergebnisse einer multizentrischen Studie. Akt Rheumatol 6: 138–141

    Google Scholar 

  • Fitzcharles MA, Halsey J, Currey HLF (1982) Conversion from daily to alternate daily corticosteroids, in rheumatoid arthritis. Ann Rheum Dis 41: 66–68

    PubMed  CAS  Google Scholar 

  • Flatt AE (1962) Intra-articular thiothepa in rheumatoid disease of the hands. Rheumatism 18: 70

    PubMed  CAS  Google Scholar 

  • Fleischhacker H, Dittrich H (1951) Die Behandlung der Polyarthritis mit Stickstoff-Lost. Med Klinik 46: 494–496

    CAS  Google Scholar 

  • Flohe L, Loschen G (1981) Der therapeutische Wirkungsmechanismus von exogen zugeführter Super- oxiddismutase: Befunde und Ausblicke. Eur J Rheumatol Inflamm 4: 183–200

    PubMed  CAS  Google Scholar 

  • Flower RJ, Gryglewski R, Herbaczynska C, Edro K, Vane JR (1972) Effects of anti-inflammatory drugs on prostaglandin biosynthesis. Nature 238: 104–106

    CAS  Google Scholar 

  • Flower RJ, Cheung HS, Cushman DW (1973) Quantitative determination of Prostaglandins and Malondialdehyde formed by the Arachidonate Oxygenase (Prostaglandin-Synthetase) system of bovine seminal vesicle. Prostaglandins 4: 325–341

    PubMed  CAS  Google Scholar 

  • Flower RJ, Blackwell GJ (1979) Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature 278: 456–459

    PubMed  CAS  Google Scholar 

  • Fluproquazone (1981) Arzneim Forsch/Drug Res 31(1): 871–940

    Google Scholar 

  • Forbes I J, Smith JL (1967) Effect of antiinflammatory drugs on lymphocytes. Lancet 2: 334–335

    PubMed  CAS  Google Scholar 

  • Ford-Hutchinson AW, Bray MA, Cunningham FM, Davidson EM, Smith MJH (1981) Isomers of leukotriene B4 possess different biological potencies. Prostaglandins 21: 143–152

    PubMed  CAS  Google Scholar 

  • Forestier MJ (1929) L’aurotherapie dans les rhumatismes chroniques. Bull Mem Soc Med Hop Par 53: 324–327

    Google Scholar 

  • Forestier MJ (1935) Rheumatoid arthritis and its treatment by gold salts. The results of six years experience. J Lab Clin Med 20: 827–840

    Google Scholar 

  • Forssman O, Mulder J (1973) Hypersensitivity to different ACTH peptides. Acta Med Scand 193: 557–559

    PubMed  CAS  Google Scholar 

  • Fossgreen J, Kirchheiner B, Petersen FO, Tophoj E, Zachariae E (1976) Clinical evaluation of Ketoprofen (19.583 RP) in rheumatoid arthritis. Double blind cross-over comparison with Indo-metacin. Scand J Rheumatol [Suppl 14] 93–98

    Google Scholar 

  • Fossgreen J (1976) Ketoprofen. A Survey of Current Publications. Scand J Rheumatol [Suppl 14] 7–32

    Google Scholar 

  • Fossgreen J, Brown-Thomsen J (1976) Ketoprofen. A new non-steroidal anti-inflammatory agent. Scand J Rheumatology [Suppl 14] 5–134

    Google Scholar 

  • Fowler PD (1979) Voltarol: Diclofenac Sodium. Clin Rheum Dis 5: 427–464

    Google Scholar 

  • Francois J, De Rouck A, Cambie E, De Laey J J (1972) Retinopathy caused by chloroquine. Bull Soc Beige Opthal 160: 581–590

    CAS  Google Scholar 

  • Frank O (1975) Nichtsteroidale antirheumatische Therapie und Leber. Acta Med Austriaca 2: 145–148

    PubMed  CAS  Google Scholar 

  • Frank O, Kiemmayer K (1974) Zur Behandlung der schweren Coxarthrose mit Ketoprofen. Schweiz Rundschau Med (Praxis) 63: 1003–1004

    CAS  Google Scholar 

  • Frankl R, Kottusch H (1971) Kombinationstherapie mit einem neuen Antirheumatikum. Therapiewoche 21: 2650–2653

    Google Scholar 

  • Frech EG, Keßler H (1975) Klinische Erfahrungen mit Perclusone in der balneologisch-physikalischen Rheumatherapie. Med Welt 26: 611–613

    PubMed  CAS  Google Scholar 

  • Freedman A, Bach F (1952) Mepacrine and rheumatoid arthritis. Lancet 2: 321–322

    PubMed  CAS  Google Scholar 

  • Freedman A, Steinberg VL (1960) Chloroquine in rheumatoid arthritis: A double blind fold trial of treatment for one year. Ann Rheum Dis 19: 243–250

    PubMed  CAS  Google Scholar 

  • Freise J, May B, Schmidt E (1976) Cholestatischer Ikterus nach Azathioprin. Dtsch Med Wochenschr 101: 1223–1226

    PubMed  CAS  Google Scholar 

  • Freyberg RH (1966) Goldtherapy for rheumatoid arthritis. In: Hollander J.L. (ed) Arthritis and allied Conditions. Lea and Febiger, Philadelphia, p 302

    Google Scholar 

  • Freyberg RH, Block WD, Levey S (1941) Metabolism, toxicity and manner of action of gold compounds used in the treatment of arthritis. I. Human plasma and synovial, fluid concentration and urinary excretion of gold during and following treatment with gold sodium thiomalate, gold sodium thiosulphate, and colloidal gold sulfide. J Clin Invest 20: 401–412

    PubMed  CAS  Google Scholar 

  • Frölich JC, Hollifield JW, Dormois JC, Frölich BL, Seyberth H, Michelakis AM, Oates JA (1976) Suppression of plasma renin activity by Indomethacin in man. Circ Res 39: 447–452

    PubMed  Google Scholar 

  • Fromm E, Frederiksen P (1976) Pemphigus vulgaris following d-penicillamine. Dermatologica 152: 358–362

    Google Scholar 

  • Frömming KH, Schwabe L (1976) Die in-vitro Auflösungsgeschwindigkeit von mikroverkapselter Acetylsalicylsäure (Colfarit®) in Abhängigkeit vom Alkoholgehalt des Auflösungsmediums. Arch Pharmacol 309: 995–1000

    Google Scholar 

  • Fujimoto K, Ueno R (1973) Die intraartikuläre Behandlung der Arthrosis deformans des Kniegelenks mit einem Mucopolisaccharidschwefelsäureester. Z Orthop 111: 310–314

    PubMed  CAS  Google Scholar 

  • Fulghum DE, Catalano PM (1973) Stevens-Johnson-Syndrome from Clindamycin. A case report. JAMA 223: 318–319

    Google Scholar 

  • Gabka J (1978) Analgetische und antiphlogistische Wirksamkeit von Biarison®. Klinisch-experimentelle Untersuchungen. Muench Med Wochenschr 120: 331–334

    CAS  Google Scholar 

  • Garber E, Craig RM, Bahu RM (1975) Aspirin hepatotoxicity. Ann Intern Med 82: 592–593

    PubMed  CAS  Google Scholar 

  • Garrett R, Paulus H (1980) Complications of intravenous methylprednisolone pulse therapy (Abstract). Arthritis Rheum 23: 677

    Google Scholar 

  • Gary NE, Dodelson R, Esinger RP (1980) Indomethacin-associated acute renal failure. Am J Med 69: 135–136

    PubMed  CAS  Google Scholar 

  • Gaucher A, Netter P, Faure G, Tamisier J-N, Purel J, Maillard A, Royer R-J (1976) A propos des interactions des salicylés et des autres anti inflammatoires non steroidiens; étude pharmacocinétique de l’association phénylbutazone-aspirine chez l’homme. Rev Rhumatism 43: 425–429

    CAS  Google Scholar 

  • Geißler H, Pevny I (1974) Allergologische Hauttests mit D-Penicillamin bei Penicillin-Allergikern. In: Ott VR, Schmidt KL (Hrsg) Die Behandlung der rheumatoiden Arthritis mit D-Penicillamin. Symposion Berlin 1973. Der Rheumatismus, Bd 42. Steinkopff, Darmstadt, S 138–141

    Google Scholar 

  • Gerber RC, Paulus HE (1975) Gold therapy. Clin Rheum Dis 1: 307–318

    Google Scholar 

  • Gerber RC, Paulus HE, Jennrich RI, Lederer M, Bluestone R, Blahd WH, Pearson CM (1974) Goldkinetics following aurothiomalate therapy. Use of a whole body radiation counter. J Lab Clin Med 83: 778–789

    PubMed  CAS  Google Scholar 

  • Gerdes H, Schmitz-Moormann P (1968) Nekrotisierende Arteriitis bei steroidbehandelter rheumatoider Polyarthritis mit sekundärer Amyloidose. Muench Med Wochenschr 28: 1363–1367

    Google Scholar 

  • Gerlis LS, Gumpel JM (1981) Isoxepac in rheumatoid arthritis: a double-blind comparison with aspirin. Rheumatol Rehabil 20: 50–53

    PubMed  CAS  Google Scholar 

  • Gerster JC, De Kalbermatten A, De Peyer R, Toussaint M, Carrel J (1976) Réactions toxiques aux sels d’or avec enterocolite grave chez un homme atteint d’une polyarthrite rhumatoide. Schweiz Med Woschenschr 106: 1606–1608

    CAS  Google Scholar 

  • Gessa GL, Loddo B, Brotzu G, Schivo ML, Tagliamonte A, Spanedda A, Bo G, Ferrari W (1966) Selective inhibition of poliovirus growth by D-Penicillamine in vitro. Virology 30: 618–622

    PubMed  CAS  Google Scholar 

  • Ghishan FK, La Brecque DR, Younoszai K (1978) Intrahepatic cholestasis after gold therapy in juvenile rheumatoid arthritis. J Pediatr 93: 1042–1043

    PubMed  CAS  Google Scholar 

  • Gibbs K, Walshe JM, (1971) Studies in 35S-labelled DL-Penicillamine in patients with Wilson’s disease. QJ Med 40: 275–287

    CAS  Google Scholar 

  • Frank O, Kiemmayer K (1974) Zur Behandlung der schweren Coxarthrose mit Ketoprofen. Schweiz Rundschau Med (Praxis) 63: 1003–1004

    CAS  Google Scholar 

  • Frankl R, Kottusch H (1971) Kombinationstherapie mit einem neuen Antirheumatikum. Therapiewoche 21: 2650–2653

    Google Scholar 

  • Frech EG, Keßler H (1975) Klinische Erfahrungen mit Perclusone in der balneologisch-physikalischen Rheumatherapie. Med Welt 26: 611–613

    PubMed  CAS  Google Scholar 

  • Freedman A, Bach F (1952) Mepacrine and rheumatoid arthritis. Lancet 2: 321–322

    PubMed  CAS  Google Scholar 

  • Freedman A, Steinberg VL (1960) Chloroquine in rheumatoid arthritis: A double blind fold trial of treatment for one year. Ann Rheum Dis 19: 243–250

    PubMed  CAS  Google Scholar 

  • Freise J, May B, Schmidt E (1976) Cholestatischer Ikterus nach Azathioprin. Dtsch Med Wochenschr 101: 1223–1226

    PubMed  CAS  Google Scholar 

  • Freyberg RH (1966) Goldtherapy for rheumatoid arthritis. In: Hollander J.L. (ed) Arthritis and allied Conditions. Lea and Febiger, Philadelphia, p 302

    Google Scholar 

  • Freyberg RH, Block WD, Levey S (1941) Metabolism, toxicity and manner of action of gold compounds used in the treatment of arthritis. I. Human plasma and synovial, fluid concentration and urinary excretion of gold during and following treatment with gold sodium thiomalate, gold sodium thiosulphate, and colloidal gold sulfide. J Clin Invest 20: 401–412

    PubMed  CAS  Google Scholar 

  • Frölich JC, Hollifield JW, Dormois JC, Frölich BL, Seyberth H, Michelakis AM, Oates JA (1976) Suppression of plasma renin activity by Indomethacin in man. Circ Res 39: 447–452

    PubMed  Google Scholar 

  • Fromm E, Frederiksen P (1976) Pemphigus vulgaris following d-penicillamine. Dermatologica 152: 358–362

    Google Scholar 

  • Frömming KH, Schwabe L (1976) Die in-vitro Auflösungsgeschwindigkeit von mikroverkapselter Acetylsalicylsäure (Colfarit®) in Abhängigkeit vom Alkoholgehalt des Auflösungsmediums. Arch Pharmacol 309: 995–1000

    Google Scholar 

  • Fujimoto K, Ueno R (1973) Die intraartikuläre Behandlung der Arthrosis deformans des Kniegelenks mit einem Mucopolisaccharidschwefelsäureester. Z Orthop 111: 310–314

    PubMed  CAS  Google Scholar 

  • Fulghum DE, Catalano PM (1973) Stevens-Johnson-Syndrome from Clindamycin. A case report. JAMA 223: 318–319

    Google Scholar 

  • Gabka J (1978) Analgetische und antiphlogistische Wirksamkeit von Biarison®. Klinisch-experimentelle Untersuchungen. Muench Med Wochenschr 120: 331–334

    CAS  Google Scholar 

  • Garber E, Craig RM, Bahu RM (1975) Aspirin hepatotoxicity. Ann Intern Med 82: 592–593

    PubMed  CAS  Google Scholar 

  • Garrett R, Paulus H (1980) Complications of intravenous methylprednisolone pulse therapy (Abstract). Arthritis Rheum 23: 677

    Google Scholar 

  • Gary NE, Dodelson R, Esinger RP (1980) Indomethacin-associated acute renal failure. Am J Med 69: 135–136

    PubMed  CAS  Google Scholar 

  • Gaucher A, Netter P, Faure G, Tamisier J-N, Purel J, Maillard A, Royer R-J (1976) A propos des interactions des salicylés et des autres anti inflammatoires non steroidiens; étude pharmacocinétique de l’association phénylbutazone-aspirine chez l’homme. Rev Rhumatism 43: 425–429

    CAS  Google Scholar 

  • Geißler H, Pevny I (1974) Allergologische Hauttests mit D-Penicillamin bei Penicillin-Allergikern. In: Ott VR, Schmidt KL (Hrsg) Die Behandlung der rheumatoiden Arthritis mit D-Penicillamin. Symposion Berlin 1973. Der Rheumatismus, Bd 42. Steinkopff, Darmstadt, S 138–141

    Google Scholar 

  • Gerber RC, Paulus HE (1975) Gold therapy. Clin Rheum Dis 1: 307–318

    Google Scholar 

  • Gerber RC, Paulus HE, Jennrich RI, Lederer M, Bluestone R, Blahd WH, Pearson CM (1974) Goldkinetics following aurothiomalate therapy. Use of a whole body radiation counter. J Lab Clin Med 83: 778–789

    PubMed  CAS  Google Scholar 

  • Gerdes H, Schmitz-Moormann P (1968) Nekrotisierende Arteriitis bei steroidbehandelter rheumatoider Polyarthritis mit sekundärer Amyloidose. Muench Med Wochenschr 28: 1363–1367

    Google Scholar 

  • Gerlis LS, Gumpel JM (1981) Isoxepac in rheumatoid arthritis: a double-blind comparison with aspirin. Rheumatol Rehabil 20: 50–53

    PubMed  CAS  Google Scholar 

  • Gerster JC, De Kalbermatten A, De Peyer R, Toussaint M, Carrel J (1976) Réactions toxiques aux sels d’or avec enterocolite grave chez un homme atteint d’une polyarthrite rhumatoide. Schweiz Med Woschenschr 106: 1606–1608

    CAS  Google Scholar 

  • Gessa GL, Loddo B, Brotzu G, Schivo ML, Tagliamonte A, Spanedda A, Bo G, Ferrari W (1966) Selective inhibition of poliovirus growth by D-Penicillamine in vitro. Virology 30: 618–622

    PubMed  CAS  Google Scholar 

  • Ghishan FK, La Brecque DR, Younoszai K (1978) Intrahepatic cholestasis after gold therapy in juvenile rheumatoid arthritis. J Pediatr 93: 1042–1043

    PubMed  CAS  Google Scholar 

  • Gibbs K, Walshe JM, (1971) Studies in 35S-labelled DL-Penicillamine in patients with Wilson’s disease. QJ Med 40: 275–287

    CAS  Google Scholar 

  • Gill GN (1976) ACTH regulation of the adrenal cortex. Pharmacol Ther [B] 2: 313–338

    CAS  Google Scholar 

  • Gillberg R, Korsan-Bengtsen K, Magnusson B, Nyberg G (1981) Gastrointestinal blood loss. Gastroscopy and coagulation factors in normal volunteers during administration of acetylsalicylic acid and Fluproquazone. Scand J Rheumatol 10: 342–346

    PubMed  CAS  Google Scholar 

  • Girard J, Lipchitz L, Nars PW (1973) Allergene Eigenschaften von ACTH. In: Schuppli R (Hrsg) ACTH — Eine Standortbestimmung für die Praxis. Huber, Bern Stuttgart Wien, S 98–112

    Google Scholar 

  • Girdwood RH (1974) Death after taking medicaments. Br Med J 1: 501–504

    PubMed  CAS  Google Scholar 

  • Glass RC, Swannell AJ (1978) Concentrations of Ibuprofen in serum and synovial fluid from patients with arthritis. Br J Clin Pharmacol 6: 453P–454 P

    PubMed  CAS  Google Scholar 

  • Goebel KM (1981) Pirprofen und Indometacin bei chronischer Polyarthritis — eine randomisierte Doppelblindstudie mit Placebokontrolle. In: Korst JK van der (Hrsg) Ein neues antirheumatisch- analgetisches Medikament: Pirprofen (®Rengasil). Huber, Bern Stuttgart Wien, S 77–84

    Google Scholar 

  • Goebel KM, Hahn E, Hausmann L, Storck U, Kaffarnik H, Neurath F (1979) Aktuelle Aspekte der rheumatoiden Arthritis. Ergebnisse einer vergleichenden Doppelblind-Studie. Fortschr Med 97: 1793–1798

    PubMed  CAS  Google Scholar 

  • Goerz G, Merk H (1981) Medikamentöse Immunsuppression in der Dermatologie. Z Hautkr 56: 975–990

    PubMed  CAS  Google Scholar 

  • Goldberg AAJ, Godfrey KE (1980) Fenclofenac. Clin Rheum Dis 6: 647–674

    Google Scholar 

  • Golding JR, Andrews FM, Camp V, Day AT, Freeman AM, Golding DN, Hill AGS, Lyle WH, Mowat AG (1973) Controlled trial of Penicillamine in severe rheumatoid arthritis. Ann Rheum Dis 32: 385

    PubMed  CAS  Google Scholar 

  • Golding JR, Day AT, Tomlinson MR, Brown RM, Hassan MO, Langstaff SR (1977) Rheumatoid arthritis treated with small doses of penicillamine. Proc R Soc Med [Suppl 3] 70: 131–133

    Google Scholar 

  • Golding J, Day AT, Wilson MA (1978) Effect of penicillamine after gold-treatment. Br Med J I: 858

    Google Scholar 

  • Goldstein G (1978) Mode of action of levamisole. J Rheumatol [Suppl 4] 5: 142–148

    Google Scholar 

  • Goldstein S, DeMeo R, Shemano I (1968) Antiinflammatory activity of 2,4-Dinitrophenol following local administration at the site of inflammation. Proc Soc Exp Biol Med 128: 980–982

    CAS  Google Scholar 

  • Gordon BL, Yanagihara R (1977) Treatment of systemic lupus erythematosus with the T-cell immunopotentiator levamisole: a follow-up report of 16 patients under treatment for a minimum period of four months. Ann Allergy 39: 227–236

    PubMed  Google Scholar 

  • Gorin G, Doughty G, Gideon R (1967) Equilibria in Thiol-Disulphide Interchanges. Part V. Reaction of some Aminoethanethiols with 4,4/-Dithiobis (benzenesulphonic acid). J Chem Soc [B] 729–736

    Google Scholar 

  • Gottlieb NL, Brown HE jr (1977) Acute myocardial infarction following goldsodium thiomalate induced vasomotor (nitritoid) reaction. Arthritis Rheum 20: 1026–1028

    PubMed  CAS  Google Scholar 

  • Gottlieb NL (1976/1977) Chrysotherapy. Bull Rheum Dis 27: 912–917

    Google Scholar 

  • Gottlieb NL (1979) Goldexcretion and retention during Auranofin treatment: A preliminary report. J Rheumatol [Suppl 5] 6: 61–67

    Google Scholar 

  • Gottlieb NL (1981) Comparative pharmacokinetics of gold compounds. Vortrag, auf Symposium Therapeutic innovation in Rheumatoid Arthritis: World Wide Auranofin-Symposium. 20./21. Oktober 1981, Montreal

    Google Scholar 

  • Gottlieb NL, Smith PM, Smith EM (1972) Tissue goldconcentration in an rheumatoid arthritis receiving goldtherapy. Arthritis Rheum 15: 16–22

    PubMed  CAS  Google Scholar 

  • Gottlieb NL, Smith PM, Smith EM (1974a) Pharmacodynamics of 195Au labelled aurothiomalate in blood. Correlation with course of rheumatoid arthritis, gold-toxicity and gold excretion. Arthritis Rheum 17: 171–183

    PubMed  CAS  Google Scholar 

  • Gottlieb NL, Smith PM, Penneys NS, Smith EM (1974b) Goldconcentrations in hair, nail and skin during chrysotherapy. Arthritis Rheum 17: 56–62

    PubMed  CAS  Google Scholar 

  • Graber H, Takacs L, Vedrödy K (1976) Agranulozytosis due to levamisole. Lancet 2: 1248

    PubMed  CAS  Google Scholar 

  • Graham JW, Fletcher AA (1943) Gold therapy in rheumatoid arthritis. Can Med Assoc J 49: 483–487

    PubMed  CAS  Google Scholar 

  • Greaves MW, McDonald-Gibson WJ (1972) Inhibitions of prostaglandin biosynthesis by corticosteroids. Br Med J 2: 83–84

    PubMed  CAS  Google Scholar 

  • Green M, Rankin A, Gerard GF, Grandgenett DP, Green MR (1975) Inhibition of purified DNA polymerase of RNA tumor viruses by fluoranthene derivatives and analogues of tilorone hydrochloride. J Natl Cancer Inst 55: 433–442

    PubMed  CAS  Google Scholar 

  • Green MH, Young T, Clark WH jr (1981) Malignant melanoma in renal-transplant recipients. Lancet 1: 1196–1199

    Google Scholar 

  • Greenwald A, Moy WW (1979) Inhibition of collagen gelation by action of the superoxide radical. Arthritis Rheum 22: 251–259

    PubMed  CAS  Google Scholar 

  • Greiling H (1971) Diskussionsbemerkung. In: Müller W, Harwerth HG, Fehr K (Hrsg) Rheumatoid arthritis. Academic Press, London New York, S 614

    Google Scholar 

  • Greiling H (1980) Biochemische Untersuchungen zur Wirkungsweise des Arteparon®. In: Dettmer N, Greiling H, Sensch KH (Hrsg) Internationales Arzneimittelsymposium Arteparon, Congress series, Eular, Basel, S 11–18

    Google Scholar 

  • Greiling H, Kaneko M (1973) Die Hemmung lysosomaler Enzyme durch ein Glycosaminoglycan- Polisulfat. Zur Therapie chronischer Gelenkserkrankungen mit antidegenerativ wirksamen Ver-bindungen; ein Beitrag zur Biochemie. Arzneim Forsch/Drug Res 23: 593–597

    CAS  Google Scholar 

  • Greiling H, Stuhlsatz HW (1966) Biochemische Untersuchungen zur Wirkungsweise eines Polysaccharidsulfates bei degenerativen Gelenkerkrankungen. Z Rheumaforsch 25: 116–121

    PubMed  CAS  Google Scholar 

  • Grennan DM, Ferry Don G, Ashworth ME, Kenny RE, MacKinnon M (1979) The aspirin-ibuprofen interaction in rheumatoid arthritis. Br J Clin Pharmacol 8: 497–503

    PubMed  CAS  Google Scholar 

  • Gross D (1963) Chemische Synovektomie mit Senfgas bei primär chronischer Polyarthritis. Z Rheumaforsch 22: 456–459

    PubMed  CAS  Google Scholar 

  • Gruber CM jr (1976) Clinical pharmacology of Fenoprofen: A review. J Rheumatol [Suppl 2] 3: 8–17

    Google Scholar 

  • Gryglewski RJ, Panczenko B, Korbut R, Grodzinska L, Ocetkiewicz A (1975) Corticosteroids inhibit prostaglandin release from perfused lungs of sensitized guinea pigs. Prostaglandins 10: 343–355

    PubMed  CAS  Google Scholar 

  • Gubler HU, Baggiolini M (1978) Pharmacological properties of proquazone. Scand J Rheumatol [Suppl 21] 8–11

    Google Scholar 

  • Gugler R (1979) Arzneimittelwechselwirkungen in der Therapie mit Cumarin-Derivaten. Internist 20: 238–244

    PubMed  CAS  Google Scholar 

  • Gum OB (1976) Fenoprofen in rheumatoid arthritis: a controlled crossover multi-centre study. J Rheumatology [Suppl 2] 3: 26–31

    Google Scholar 

  • Gum OB, Luders RC (1981) The Pharmacokinetics of Pirprofen. Curr Ther Res [Suppl 1] 30: 118–122

    Google Scholar 

  • Gumpel JM (1978) Deaths associated with gold treatment: A reassessment. Br Med J 1: 215–216

    PubMed  CAS  Google Scholar 

  • Gumpel JM, Hall A, Ansell B (1974) A double blind comparative trial of cyclophosphamide and gold in rheumatoid arthritis. Ann Rheum Dis 33: 574

    PubMed  CAS  Google Scholar 

  • Günther R, Egg D, Herold M (1979) Efficacy and safety of piroxicam and indomethacin in the treatment of musculo sceletal disorders. A double blind comparative study. Z Rheumatol 38: 330–334

    PubMed  Google Scholar 

  • Gwynne JT, Mahaffee D, Brewer HB, Ney RL (1976) Adrenal cholesterol uptake from plasma lipoproteins: Regulation by corticotropin. Proc Natl Acad Sci USA 73: 4329–4333

    PubMed  CAS  Google Scholar 

  • Haas P, Wendt H (1974) Nephrotisches Syndrom und Schilddrüsenschwellung nach D-Penicillamin. Wien Med Wochenschr 124: 333–334

    PubMed  CAS  Google Scholar 

  • Hadidi T, Decker JL, El-Nagdy L, Samy M (1981) Ineffectiveness of levamisole in systemic lupus erythematosus. A controlled trial. Arthritis Rheum 24: 60–63

    PubMed  CAS  Google Scholar 

  • Hahn TJ (1978) Corticosteroids-induced osteopenia. Arch Intern Med 138: 882–885

    PubMed  Google Scholar 

  • Haimovici N, Penth B (1981) Behandlung degenerativer rheumatischer Gelenkerkrankungen. Ergebnisse einer multizentrischen Studie mit Surgam®. Therapiewoche 31: 7111–7120

    Google Scholar 

  • Haining CG (1956) Inhibition of Histamine release by sodium Salicylate and other compounds. Br J Pharmacol 11: 357–363

    CAS  Google Scholar 

  • Hall ND, Blake DR, Alexander GJM, Vaisey C, Bacon PA (1981) Serum SH Reactivity: A simple assessment of D-Penicillamine absorption? Rheumatol Int 1: 39–41

    PubMed  CAS  Google Scholar 

  • Halverson PB, Kozin F, Bernhard GC, Goldman AL (1978) Toxicity of penicillamine. A serious limitation to therapy in rheumatoid arthritis. JAMA 240: 870–871

    Google Scholar 

  • Hamberg M, Samuelsson B (1974) Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci 71: 3400–3404

    PubMed  CAS  Google Scholar 

  • Hamberg M, Svensson J, Samuelsson B (1975) Thromboxanes. A new group of biologically active compounds derived from prostaglandin endoperoxides. (Platelet aggregation/rabbit aorta contracting substance/Guinea pig lung). Proc Natl Acad Sci USA 72: 2994–2998

    PubMed  CAS  Google Scholar 

  • Hammarström S, Murphy RC, Samuelsson B, Clark DA, Mioskowski C, Corey EJ (1979) Structure of leukotriene C. Identification of the amino acid part. Biochem Biophys Res Commun 91: 1266–1272

    PubMed  Google Scholar 

  • Hangarter W ( 1974 a) Die Salicylsäure und ihre Abkömmlinge. Ursprung, Wirkung und Anwendung in der Medizin. Schattauer, Stuttgart New York

    Google Scholar 

  • Hangarter W (1974 b) Die Evolution eines Jahrhundert-Pharmakons-Acetyl-Salicylsäure für die Medizin. Med Welt 25: 1968–1978

    Google Scholar 

  • Hannemann R (1974) Steroid-Therapie mit ACTH oder Corticoiden? Indikationen, Wirksamkeit und unerwünschte Wirkungen einer Therapie mit ACTH. Med Klinik 69: 513–524

    CAS  Google Scholar 

  • Hanson A, Lindroth Y, Sjöblom K-G, Wollheim FA (1979) Plasma salizylate levels in rheumatoid arthritis: A comparison between micro-encapsulated and conventional Aspirin. Scand J Rheumatol 8: 106–108

    PubMed  CAS  Google Scholar 

  • Happel P, Meyer W (1953) Die Durchführung einer Goldbehandlung bei chronisch-rheumatischen Gelenkleiden. Medizinische 6: 175–179

    PubMed  CAS  Google Scholar 

  • Haque N, Thrasher K, Werk EE, Knowles HC jr, Sholiton LJ (1972) Studies on dexamethasone metabolism in man: Effect of diphenylhydantoin. J Clin Endocrinol Metab 34: 44–50

    PubMed  CAS  Google Scholar 

  • Harpey JP, Caille B, Moulias R, Goust JM (1971) Lupus-like syndrome induced by D-Penicillamine in Wilson’s disease. Lancet 1: 292

    PubMed  CAS  Google Scholar 

  • Harrison EE, Hickman JW (1976) D-penicillamine and haemolytic anaemia. Lancet 1: 38

    PubMed  CAS  Google Scholar 

  • Harrison HL, Linshaw NA, Lindsley CB, Cuppage FE (1980) Bolus corticosteroids and cyclophosphamide for initial treatment of Wegener’s granulomatosis. JAMA 244: 1599–1600

    PubMed  CAS  Google Scholar 

  • Harrity TW, Goldlust MB (1974) Anti-complement effects of two antiinflammatory agents. Biochem Pharmacol 23: 3107–3120

    PubMed  CAS  Google Scholar 

  • Hart FD (1980) Corticosteroid therapy in the rheumatic disorders. Clin Rheum Dis 6: 533–543

    Google Scholar 

  • Hart CW, Naunton RF (1964) Ototoxicity of chloroquine phosphate. Arch Otolaryngol 80: 407–412

    PubMed  CAS  Google Scholar 

  • Harter JG, Reddy WJ, Thorn GW (1963) Studies on an intermittent corticoidsteroid dosage regimen. N Engl J Med 269: 591–596

    PubMed  CAS  Google Scholar 

  • Harth M, Hickey JP, Coulter WK, Thompson JM, Disney TF (1978) Gold-induced thrombocytopenia. J Rheumatol 5: 165–172

    PubMed  CAS  Google Scholar 

  • Harth M, Stiller CR, Evans J, Zuberi R, McGirr D, Sinclair N (1976) Effects of sodiumaurothiomalate (SATM) on human lymphocyte functions in normal controls (NC) and in patients with rheumatoid arthritis. Arthritis Rheum 19: 802–808

    Google Scholar 

  • Harwerth H-G, Wöhler F (1957) Neuere Ergebnisse über Verteilung, Verhalten und Stoffwechselwirkungen von Butazolidin. Z Rheumaforsch 16: 265–275

    PubMed  CAS  Google Scholar 

  • Hashimoto A, Yoshiharu M, Ito H, Okazaki M, Hara T (1972) Corneal chrysiasis: A clinical study in rheumatoid arthritis patients receiving gold therapy. Arthritis Rheum 15: 309–312

    PubMed  CAS  Google Scholar 

  • Haslock I, Eade A, Woolf D (1979) Diclofenac (Voltarol®) in the treatment of rheumatic diseases: A conspectus of international experience. Rheumatol Rehabil [Suppl] 2: 4–146

    Google Scholar 

  • Hassan HM, Fridovich I (1981) Chemistry and biochemistry of superoxide dismutases. Eur J Rheumatol Inflamm 4: 160–172

    PubMed  CAS  Google Scholar 

  • Hasselbacher P (1981) Inhibition of complement by gold sodium thiomalate. J Rheumatol 8: 57–61

    PubMed  CAS  Google Scholar 

  • Haynes BF, Fauci AS (1978) The differential effect of in vivo hydrocortisone on the kinetics of subpopulations of human peripheral blood thymus-derived lymphocytes. J Clin Invest 61: 703–707

    PubMed  CAS  Google Scholar 

  • Haynes RC jr, Koritz SB, Peron FG (1959) Influence of adenosine 3’,5’-monophosphate on corticoid production by rat adrenal glands. J Biol Chem 234: 1421–1423

    PubMed  CAS  Google Scholar 

  • Haynes RC jr, Murad F (1980) Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogues; inhibitors of adrenocortical steroid biosynthesis, 6-edn. In: Gilman AG, Goodman LS, Gilman A (eds). Macmillan Publishing Co Inc, New York, pp 1466–1496

    Google Scholar 

  • Heggarty H (1974) Aspirin and anaemia in childhood. Br Med J I: 491–492

    Google Scholar 

  • Heimer R, Federico OM (1958) Depolymerization of the 19S antibodies and the 22S rheumatoid factor. Clin Chim Acta 3: 496–498

    PubMed  CAS  Google Scholar 

  • Heindl I, Lorenz D, Sieberns S, Blomberger W (1977) Klinische Prüfung des neuen perkutan wirksamen Antirheumatikums Etofenamat. Zusammenfassender Bericht. Arzneim Forsch/Drug Res 27(1): 1357–1363

    Google Scholar 

  • Heiter A, Tausch G, Eberl R (1980) Kontrollierter Doppelblindvergleich von Acemetacin zu Indometazin bei Patienten mit chronischer Polyarthritis. Arzneim Forsch/Drug Res 30(11): 1427–1433

    Google Scholar 

  • Held H (1979) Eliminationshalbwertszeiten und Serumproteinbindung des Antirheumatikums Naproxen bei Niereninsuffizienz. Z Rheumatol 38: 111–119

    PubMed  CAS  Google Scholar 

  • Held H, Enderle C (1976) Elimination and serumproteins binding of phenylbutazone in patients with renal insufficiency. Clin Nephrol 6: 388–393

    PubMed  CAS  Google Scholar 

  • Helmke K, Velcovsky H, Eichhorn M, Federlin K (1974) Antinukleäre Faktoren während einer D-Penicillamintherapie. Verh Dtsch Ges Inn Med 80: 1409–1412

    PubMed  CAS  Google Scholar 

  • Helmke K, Velcosky H-G, Federlin K (1975) Klinische und prognostische Bedeutung antinukleärer Faktoren, bei einer D-Penicillamin-Therapie. Dtsch Med Wochenschr 100: 2198–2203

    PubMed  CAS  Google Scholar 

  • Hench PS, Kendall EC, Slocumb CH, Polley HF (1949) The effect of a hormone of the adrenal cortex (17-hydroxy-ll-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Staff Meet Mayo Clin 24: 181–197

    CAS  Google Scholar 

  • Henningsen B, Maintz J, Basedow M, Härders H (1973) Nephrotisches Syndrom durch Penicillamin. Dtsch Med Wochenschr 98: 1768–1772

    PubMed  CAS  Google Scholar 

  • Henson R, Lloyd-Jones JG, Nichols JD, Jordan BJ (1980) Pharmakokinetics of Fenclofenac following single and multiple doses. Eur J Drug Metab Pharmakokinet 5: 217–223

    CAS  Google Scholar 

  • Herbst KD, Stone WH, Flannery EP (1975) Chronic thrombocytopenia following gold therapy. Arch Intern Med 135: 1622

    PubMed  CAS  Google Scholar 

  • Herrlinger JD, Alsen C, Beress R, Hecker U, Seiler K-U (1981) Distribution of gold inside and outside the cells of blood during treatment with different gold compounds. Abstract Symposium Auranofin in Rheumatoid Arthritis, 15. Int Rheumatologie-Kongress, Paris. 21.–27.6. 1981, p 8

    Google Scholar 

  • Herrlinger JD, Weikert W (1981) Metabolismus von Goldkeratinat. Akt Rheumatol 6: 130–133

    Google Scholar 

  • Herrmann B (1959) Über den Stoffwechsel des Butazolidin. Med Exp 1: 170–178

    CAS  Google Scholar 

  • Herrmann B, Müller W (1979) Die Therapie der chronischen Polyarthritis mit Cyclosporin A, einem neuen Immunsuppressivum. Akt Rheumatol 4: 173–186

    Google Scholar 

  • Hersh EM (1975) Immunosuppressive agents. In: Sartorelli AC, Johns DG (eds) Antineoplastic and immunosuppressive agents, parti, vol 38. Handbuch der experimentellen Pharmakologie. Springer, Berlin, pp 577–614

    Google Scholar 

  • Hertz M, Kaplinsky N, Pras M, Frankl O (1978) Clinical and radiological findings in gold reaction enteritis: long term follow up. Fortschr Geb Roentgenstr Nuklearmed 128: 634–635

    CAS  Google Scholar 

  • Hertz F, Ranson M, Lwoff JM (1980) Pharmacological properties of a new anti-inflammatory agent: 2-(2-Isopropyl-5-indanyl)propionic acid (UP 517-03). Arzneim Forsch/Drug Res 30: 1549–1557

    CAS  Google Scholar 

  • Hess EV (Hrsg) (1981) Proceedings of the KROC-Foundation conference on drug-induced Lupus. Arthritis Rheum 24: 979–1112

    Google Scholar 

  • Hess H, Koeppen R (1980) Kontrollierte Doppelblindstudie zur Frage einer möglichen Interferenz von Acemetacin mit einer laufenden Antikoagulanzien-Therapie. Arzneim Forsch/Drug Res 30(II): 1421–1423

    Google Scholar 

  • Hess ME, Schmidt PF (1959) Cardiovascular effects of chloroquine with special reference to its antifibrillatory action. Circ Res 7: 86–92

    PubMed  CAS  Google Scholar 

  • Hewitt J, Lessana-Leibowitch M, Benveniste M, Saporta L (1971) Un cas de pemphigus induit par la d-Penicillamine. Ann Med Intern 122: 1003–1009

    Google Scholar 

  • Heykants J, Wynants J, Scheijgrond H (1975) The absorption, excretion and metabolism of levamisole in men. Janssen Pharmaceutica, unveröffentlichter klinischer Forschungsbericht über Levamisole, Nr 32

    Google Scholar 

  • Higgs GA, Eakins KE, Moncada S, Vane JR (1979 a) Arachidonic acid metabolism in inflammation and the mode of action of anti-inflammatory drugs. In: Rainsford KD, Ford-Hutchinson AW (eds) Prostaglandins and inflammation. Birkhäuser, Basel Boston Stuttgart, pp 167–175, AAS6

    Google Scholar 

  • Higgs GA, Flower RJ, Vane JR (1979 b) A new approach to anti-inflammatory drugs. Biochem Pharmacol 28: 1959–1961

    Google Scholar 

  • Higgs GA, Moncada S, Vane JR (1980) The mode of action of anti-inflammatory drugs, which prevent the peroxydation of arachidonic acid. Clin Rheum Dis 6: 675–693

    Google Scholar 

  • Hingorani K (1976) Benorylate: A report on 2 years’ experience of its use in rheumatoid arthritis and other chronic rheumatic diseases. Scand J Rheumatol [Suppl 13] 29–32

    Google Scholar 

  • Hirsh J, Street D, Cade JF, Amy H (1973) Relation between bleeding time and platelet connective tissue reaction after aspirin. Blood 41: 369–377

    PubMed  CAS  Google Scholar 

  • Hirtz J, Bartelet F (1981) Pharmacocinetique du Pirprofen. Mitteilung gehalten auf dem Rengasil- Symposion Paris, 15. Int Rheumatologie-Kongress

    Google Scholar 

  • Hjalmarson O, Hanson LÄ, Nilsson L-Ä (1977) IgA deficiency during D-penicillamine treatment. Br Med J 1: 549

    PubMed  CAS  Google Scholar 

  • Hobbs HE (1966) Discussion. Trans Opthalmol Soc UK 86: 119–124

    CAS  Google Scholar 

  • Hobbs HE, Sorsby A, Freedman A (1959) Retinopathy following chloroquine therapy. Lancet 2: 478–180

    PubMed  CAS  Google Scholar 

  • Hobkirk D, Rhodes M, Haslock I (1977) Night medication in rheumatoid arthritis: II. Combined therapy with indomethacin and diazepam. Rheumatol Rehabil 16: 125–127

    PubMed  CAS  Google Scholar 

  • Hofmann LM, Krupnick MI, Garcia HA (1972) Interactions of spironolactone and hydrochlorothiazide with Aspirin in the rat and dog. J Pharmacol Exp Ther 180: 1–5

    PubMed  CAS  Google Scholar 

  • Hoftiezer JW, Burks M, Silvoso GR, Ivey KJ (1980) Comparison of the effects of regular and enteric-coated Aspirin on gastroduodenal mucosa of man. Lancet 2: 609–612

    PubMed  CAS  Google Scholar 

  • Hollander JL, Brown EM jr, Jessar RA, Brown CY (1951) Hydrocortisone and Cortisone injected into arthritic joints. Comparative effects of and use of Hydrocortisone as a local antiarthritic agent. JAMA 147: 1629–1635

    CAS  Google Scholar 

  • Hollander JL (1961) Die Stellung der Corticosteroide in der Behandlung der chronischen Arthritis. Internist 2: 435–438

    CAS  Google Scholar 

  • Hollander JL (1979) Arthrocentesis and intrasynovial therapy. In: McCarty DJ (ed) Arthritis and allied conditions. Lea and Febiger, Philadelphia, pp 402–414

    Google Scholar 

  • Homma M, Shiokawa Y, Shichikawa K, Kageyama T, Yoshizawa H, Azuma T, Mizushima Y, Okazaki T, Sugawara S (1981) Interim results of a multicenter open study with Auranofin in Japan. Mitteilung auf dem Symposium Therapeutic innovation in Rheumatoid Arthritis: World Wide Auranofin Symposium 20./21.10.1981, Montreal

    Google Scholar 

  • Honig WJ (1978) Behandlung mit Diflunisal nach orthopädischen Operationen. Bericht über zwei Doppelblindstudien. Schweiz Med Wochenschr 108: 832–837

    PubMed  CAS  Google Scholar 

  • Hook G (1966) Klinische Prüfung der analgetischen Wirkung zweier Anthranilsäure-Derivate. Therapiewoche 16: 1066–1068

    Google Scholar 

  • Hort JF (1975) Adverse reactions to Alclofenac. Curr Med Res Opin 3: 333–337

    PubMed  CAS  Google Scholar 

  • Hossain MA, Akbar FA, Thompson M (1977) Floctafenine (Idarac) in the management of rheumatoid arthritis. Rheumatol Rehabil 16: 260–264

    PubMed  CAS  Google Scholar 

  • Huber W, Schulte TL, Carson S, Goldhamer RE, Vogin E (1968) Some chemical and pharmacological properties of a novel antiinflammatory protein.Toxicol Appl Pharmacol 12: 308

    Google Scholar 

  • Huber W, Huskisson EC (eds) (1981) Orgotein Workshop. Eur J Rheumatol Inflamm 4: 151–270

    Google Scholar 

  • Huber W, Menander-Huber KB (1980) Orgotein. Clin Rheum Dis 6: 465–498

    Google Scholar 

  • Hubsher JA, Ballard IM, Walker BR, Gold JA (1979) A multicentre double-blind comparison of Oxaprozin, Aspirin therapy on rheumatoid arthritis. J Int Med Res 7: 69–76

    PubMed  CAS  Google Scholar 

  • Hunziker H (1956) Erfahrungen mit intraartikulär injiziertem Butazolidin. Z Rheumaforsch 15: 219–227

    PubMed  CAS  Google Scholar 

  • Husain Z, Runge LA (1980) Treatment complications of rheumatoid arthritis with gold, hydroxy-chloroquine, D-penicillamine and levamisole. J Rheumatol 7: 825–830

    PubMed  CAS  Google Scholar 

  • Huskisson EC (1977 a) Is penicillamine immunostimulant? Proc R Soc Med [Suppl 3] 70: 142–143

    Google Scholar 

  • Huskisson EC (1977 b) Anti-inflammatory drugs. Semin Arthritis Rheum 7: 1–20

    Google Scholar 

  • Huskisson EC (1981) Other penicillamine-like drugs. J Rheumatol [Suppl 7] 8: 180–181

    Google Scholar 

  • Huskisson EC, Franchimont P (eds) (1976) Clinoril in the treatment of rheumatic disorders. Raven Press, New York, pp 1–190

    Google Scholar 

  • Huskisson EC, Hart FD (1979) Naproxen, five years of clinical experience in the United Kingdom. Eur J Rheumatol Inflamm 2: 1–83

    Google Scholar 

  • Huskisson EC, Scott J (1981) Orgotein in osteoarthritis of the knee joint. Eur J Rheumatol Inflamm 4: 212–218

    PubMed  CAS  Google Scholar 

  • Huskisson EC, Gibson TJ, Wykeham-Balme H, Berry H, Burry HC, Grahame R, Dudley-Hart F, Henderson DRF, Wojtulewsky JA (1974) Penicillamine or gold for rheumatoid arthritis? Multicentre trial using “blinde” observers. The first six months. Ann Rheum Dis 33: 399

    PubMed  CAS  Google Scholar 

  • Huskisson EC, Dieppe PA, Scott J, Trapnell J, Balme HW, Willoughby DA (1976 a) Immunostimulant therapy with levamisole for rheumatoid arthritis. Lancet 1: 393–395

    Google Scholar 

  • Huskisson EC, Woolf DL, Balme HW, Scott J, Franklyn S (1976b) Four new anti-inflammatory drugs: responses and variations. Br Med J 1: 1048–1049

    PubMed  CAS  Google Scholar 

  • Huskisson EC, Jaffe I A, Scott J, Dieppe PA (1980) 5-Thiopyritoxine in rheumatoid arthritis: Clinical and experimental studies. Arthritis Rheum 23: 106–110

    Google Scholar 

  • Husmann F (1981) Interaktionsprobleme bei der Therapie mit steroidfreien Antirheumatika. Fortschr Med 99: 1231–1235

    PubMed  CAS  Google Scholar 

  • Husmann F (1979) Die Wirkungsmechanismen der Antirheumatika. Eine Übersicht, Teil 1–3. Akt Rheumatol 4: 5–17; 45–57; 103–122

    Google Scholar 

  • Huston GJ (1980) Gold colitis, therapy and confirmation of mucosal recovery by measurement of rectal potential difference. Postgrad Med J 56: 875–876

    PubMed  CAS  Google Scholar 

  • Hylland RG, Cutler J, Dooley E, Bole GG (1980) D-Penicillamine toxicity: Its relationship to antecedent gold salt toxicity. Arthritis Rheum 23: 693

    Google Scholar 

  • Ignarro LJ, George WJ (1974) Mediation of immunologic discharge of lysosomal enzymes from human neutrophils by guanosine-3’, 5-monophosphate. J Exp Med 140: 225–228

    PubMed  CAS  Google Scholar 

  • Illing HPA, Fromson LM (1978) Species diferences in the disposition and metabolism of 6,11-dihy- dro-ll-oxodibenz [b, e] oxepin-2-Essigsäure (Isoxepac) in rat, rabbit, dog, rhesusmonkey and man. Drug Metab Dispos 6: 510–517

    PubMed  CAS  Google Scholar 

  • Indometacin (1971) Amuno®. Arzneim Forsch/Drug Res 21: 1759–1906

    Google Scholar 

  • Ishizaki T, Sasaki T, Suganuma T, Horai Y, Chiba K, Watanabe M, Asuke W, Hoshi H (1980) Pharmakokinetics of Ketoprofen following single oral intramuscular and rectal doses and after repeated oral administration. Eur J Clin Pharmacol 18: 407–414

    PubMed  CAS  Google Scholar 

  • Isomäki HA, Hakulinen T, Joutsenlhati U (1978) Excess risks of lymphomas, leucaemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis 31: 691–696

    PubMed  Google Scholar 

  • Iynedjian PB, Hanson RW (1977) Massenger RNA for renal phosphoenolpyruvate carboxykinase and its regulation by glucocorticoids and by changes in acid base balance. J Biol Chem 252: 8398–8403

    PubMed  CAS  Google Scholar 

  • Jacobi H, Breier P, Dell H-D, Lorenz D (1977) Pharmakologie und Toxikologie von Etofenamat, 1. Mitteilung. Arzneim Forsch/Drug Res 27: 1326–1333

    CAS  Google Scholar 

  • Jacobs JC, Pesce M (1978) Micromeasurement of plasma salizylate in arthritic children. Arthritis Rheum 21: 129–132

    PubMed  CAS  Google Scholar 

  • Jacono A, Caso P, Gualtieri S, Raucci D, Bianchi A, Vigorito C, Bergamini N, Iadevaia V (1981) Clinical study of possible interactions between indoprofen and oral anticoagulants. Eur J Rheumatol Inilamm 4: 32–35

    CAS  Google Scholar 

  • Jacotot B (1980) Wechselwirkung von Piroxicam mit oralen Anticoagulantien. Akt Rheumatol 5, Sonderheft 1: 50–52

    Google Scholar 

  • Jaffe IA (1962) Intra-articular dissociation of the rheumatoid factor. J Lab Clin Med 60: 409–421

    PubMed  CAS  Google Scholar 

  • Jaffe IA (1974) The treatment of rheumatoid arthritis with D-Penicillamine. In: Ott VR, Schmidt KL (Hrsg) Die Behandlung der rheumatoiden Arthritis mit D-Penicillamin. Steinkopff, Darmstadt, p 84–94

    Google Scholar 

  • Jaffe IA (1975) The technique of Penicillamine administration in rheumatoid arthritis. Arthritis Rheum 18: 513 – 514

    PubMed  CAS  Google Scholar 

  • Jaffe IA (1977) Penicillamine treatment of rheumatoid arthritis with a single daily dose of 250 mg. Proc R Soc Med [Suppl 3] 70: 130

    Google Scholar 

  • Jaffe IA (1977–78) D-Penicillamine. Bull Rheum Dis 28:948–952

    Google Scholar 

  • Jaffe IA (1980) Thiol compounds with Penicillamine-like activity and possible mode of action in rheumatoid arthritis. Clin Rheum Dis 6: 633–645

    Google Scholar 

  • Jaffe I, Scheinberg IH, Sternlieb I (1981) Proceedings International Symposium on Penicillamine. J Rheumatol [Suppl 7] 8: 1–181

    Google Scholar 

  • Jain A, McMahon FG, Slattery JT, Levy G (1979) Effect of Naproxen on the steady state serumconcentration and anticoagulant activity of Warfarin. Clin Pharmacol Ther 25: 61–66

    PubMed  CAS  Google Scholar 

  • Jalava S, Luukkainen R, Hämeenkorpi R, Helve T, Isomäki H (1977) Some characteristics of rheumatoid arthritis patients with and without side effects due to gold treatment. Scand J Rheumatol 6: 206–208

    PubMed  CAS  Google Scholar 

  • Jalava S, Saarimaa H, Anttila M, Sundquist H (1977) Naproxen concentrations in serum, synovial fluid and synovium. Scand J Rheumatol 6: 155–157

    PubMed  CAS  Google Scholar 

  • Jamar R, Dequeker J (1978) Oxaprozin versus aspirin in rheumatoid arthritis: a double-blind trial. Curr Med Res Opin 5: 433–438

    PubMed  CAS  Google Scholar 

  • Janssen PAJ (1976) The levamisole story. In: Jucker E (ed) Progress research. Birkhauser Verlag 20: 347–383

    Google Scholar 

  • Janssen FW, Jusko WJ, Chiang ST, Kirkman SK, Southgate PJ, Coleman AJ, Ruelius HW (1980) Metabolism and kinetics of Oxaprozin in normal subjects. Clin Pharmacol Ther 27: 352–362

    PubMed  CAS  Google Scholar 

  • Jasinski B, Weigel W (1965) Experimentelle Untersuchungen über den Mukopolysaccharidstoffwechsel in vivo (Ohrkollaps des Kaninchen nach Papain). Schweiz Med Wochenschr 95: 101–104

    PubMed  CAS  Google Scholar 

  • Jeffrey MR, Freundlich HF, Bailey DM (1958) Distribution and excretion of radiogold in animals. Ann Rheum Dis 17: 52–60

    PubMed  CAS  Google Scholar 

  • Jellum E, Munthe E, Guldal G, Seth JAA (1980) Fate of the gold and thiomalate part after intramuscular administration of aurothiomalate to mice. Ann Rheum Dis 39: 155–158

    PubMed  CAS  Google Scholar 

  • Jensen EM, Fossgreen J, Kirchheiner B, Kryger J, Holm P, Mollenbach K (1980) Treatment of rheumatoid arthritis with Carprofen (Imadyl®) or Indomethacin: A randomized multicentre trial. Curr Ther Res 28: 882–887

    Google Scholar 

  • Jensen NE, Sneddon I (1969) Allergic intolerance to tetracosactrin. Br Med J II: 383–384

    Google Scholar 

  • Jesserer H (1971) Nil nocere! Gelenkschäden durch Cortison. Muench Med Wochenschr 113: 655–660

    CAS  Google Scholar 

  • Jessop JD, Vernon-Roberts B, Harris J (1973) Effects of gold salts and prednisolone on inflammatory cells. I. Phagocytic activity of macrophages and polymorphs in inflammatory exsudâtes studied by a “scinwindow” technique in rheumatoid and control patients. Ann Rheum Dis 32: 294–300

    PubMed  CAS  Google Scholar 

  • Jimenez-Diaz C (1951) Treatment of dysreaction diseases with nitrogen mustards. Ann Rheum Dis 10: 144–152

    PubMed  CAS  Google Scholar 

  • Jimenez JFM, Martinez LA, Romero MC, Rota y Avecilla JJF de, Montilla AC, Ruda FA, Montosa JC (1978) Tratamiento de la artritis reumatoide con Butibufen. Med Klin (Ed Esp) 206: 58–62

    Google Scholar 

  • Joint Committee of the medical Research council and nuffield foundation on clinical trials of cortisone, ACTH and other therapeutic measures in chronic rheumatic diseases (1955) A comparison of cortisone and aspirin in the treatment of early cases of rheumatoid arthritis. Br Med J 2: 695–700

    Google Scholar 

  • Joint committee of the medical research council (1957) Long term results in early cases of rheumatoid arthritis treated with either cortisone or ASS. Br Med J 2: 847–850

    Google Scholar 

  • Jones CJ (1976) The pharmacology and pharmacokinetics of Azapropazone — a review. Curr Med Res Opin, Special Issue zu Nr 1 4: 3–16

    Google Scholar 

  • Jordine I (1980) Cyclophosphamide metabolic activation. Mayo Clin Proc 55: 405

    Google Scholar 

  • Joss R, Brunner K (1979) Schwangerschaften nach Tumortherapien. Schweiz Med Wochenschr 109: 904–907

    PubMed  CAS  Google Scholar 

  • Julkunen H (1969) Erfahrungen mit lokaler immunosuppressiver Therapie bei der Rheumatoiden Arthritis. Z Rheumaforsch 28: 5–7

    PubMed  CAS  Google Scholar 

  • Julou L, Guyonnet JC, Ducrot R, Fournel J (1975) Propriétés pharmacologiques de l’acide (Benzoyl- 3-phényl)-2-Propionique ou kétoprofène (19.583 RP). Eléments de phamacocinétique. Table ronde sur les anti-inflammatoires non stéroidiens, -XIIIème Congrès de la Ligue internationale contre le Rhumatisme, Kyoto, Japon, octobre 1973. In: Rev Rhumatol, No spécial Kyoto 5: 91–99

    Google Scholar 

  • Junge U, Hauswaldt Ch, Perings E (1973) Untersuchungen zur immunsuppressiven Wirkung von D-Penicillamin. Verh Dtsch Ges Inn Med 79: 616–618

    PubMed  CAS  Google Scholar 

  • Junker F (1913) Zur Goldzyanbehandlung der Lungentuberkulose. Muench Med Wochenschr 60: 1376–1377

    Google Scholar 

  • Kahn MF, Arlet J, Bloch-Michel H, Caroit M, Chaouat Y, Renier JC (1979 a) Le risque de leucose aeguës après traitement des rhumatismes inflammatoires chroniques et des connectivités par les cytotoxiques à visée immunosuppressive. Resultats d’une enquête rétrospective portant sur 2006 malades traités. Rev Rhum Mal Osteoartic 49: 163–167

    Google Scholar 

  • Kahn MF, Arlet J, Bloch-Michel H, Caroit M, Chaouat Y, Renier JC (1979 b) Leucémies aiguës après traitement par agents cytotoxiques en rhumatologie. 19 observations chez 2006 patients. Nouv Presse Méd 8: 1393–1397

    Google Scholar 

  • Kahn MF, Bedoiseau M, Six B, Goff P Le, Seze S de (1971) Le chlorambucil dans la polyarthrite rhumatoide. Rev Rhum 38: 741–748

    PubMed  CAS  Google Scholar 

  • Kaik B, Broll H, Miehlke H, Müller-Fassbender H, Schattenkirchner M, Rau R, Zeidler H (1981) Auranofîn (SKF 39162) and gold sodium thiomalate. A double blind comparative multicentre study. Abstract Symposium “Auranofîn in Rheumatoid Arthritis” 15. Int Rheumatologie Kon- gress Paris, 21.–27.6.1981, S 7

    Google Scholar 

  • Kaiser H (1973) Cortisonderivate in Klinik und Praxis. Thieme, Stuttgart

    Google Scholar 

  • Kaiser H ( 1973 a) Cortisonderivate in Klinik und Praxis. Thieme, Stuttgart, S 84

    Google Scholar 

  • Kaiser H ( 1973 c) Cortisonderivate in Klinik und Praxis. Thieme, Stuttgart, S 29

    Google Scholar 

  • Kaiser H ( 1973 d) Cortisonderivate in Klinik und Praxis. Thieme, Stuttgart, S 32

    Google Scholar 

  • Kaiser H ( 1973 e) Cortisonderivate in Klinik und Praxis. Thieme, Stuttgart, S 54–55

    Google Scholar 

  • Kaiser H (19730 Cortisonderivate in Klinik und Praxis. Thieme, Stuttgart, S 27–57

    Google Scholar 

  • Kaiser H (1975) ACTH in der Therapie der chronischen Polyarthritis. Dtsch Med Wochenschr 100: 377–381

    PubMed  CAS  Google Scholar 

  • Kaiser H (1979) Indikationen und Kontraindikationen der ACTH-Therapie. Dtsch Med Wochenschr 104: 933–934

    PubMed  CAS  Google Scholar 

  • Kaiser H (1981) Arzneimittelinteraktionen mit Kortikoiden. Fortschr Med 99: 1827–1829

    PubMed  CAS  Google Scholar 

  • Kajander A, Laine V, Gothoni G (1972) Effect of Tolfenamic acid in rheumatoid arthritis. Scand J Rheumatol 1: 91–93

    PubMed  CAS  Google Scholar 

  • Kajander A, Martio J (1978) Diclofenac sodium (Voltaren) and Naproxen in the treatment of rheuma-toid arthritis: a comparative double-blind study. Scand J Rheumatol [Suppl 22] 57–62

    Google Scholar 

  • Kajander A, Martio J, Mutru O, Gothoni G (1976) Prolonged treatment with tolfenamic acid in inflammatory rheumatic diseases. Scand J Rheumatol 5: 158–160

    PubMed  CAS  Google Scholar 

  • Kalbhen DA, Blum U, Schiller G (1976) Experimental osteoarthrosis induced by antirheumatic drugs. Naunyn Schmiedebergs Arch Pharmacol [Suppl] 293: R40, Abstr Nr 158

    Google Scholar 

  • Kalbhen DA, Domenjoz R (1977) Angriffspunkte steroidaler und nichtsteroidaler Symptomatika bei entzündlich-rheumatischen Erkrankungen. Akt Rheumatol 2: 29–37

    Google Scholar 

  • Kalbhen D, Schauer M, Wentsche B (1978) Tierexperimentelle Untersuchungen über den Einfluß intraartikulär applizierter Antiphlogistika Antirheumatika auf den Gelenkknorpel in vivo. Z Rheumatol 37: 380–394

    PubMed  CAS  Google Scholar 

  • Kaisbeck F (1960) Beiderzijdse abducensparese als oorzaak van de diplopie bij het gebruik van chloroquine. Niederl T Genesk 104: 1414–1416

    Google Scholar 

  • Kamp AV (1975) A double blind trial of Phenylbutazone and RU 15060 in rheumatoid arthritis. Mitteilung auf dem 8 Europ Rheumatologie-Kongreß, Helsinki 1.-7. Juni 1975

    Google Scholar 

  • Kantor TG (1979) Ibuprofen. Ann Intern Med 91: 877–882

    PubMed  CAS  Google Scholar 

  • Kappeler H, Schwyzer R (1961) Die Synthese eines Tetracosapeptides mit der Aminosäuresequenz eines hochaktiven Abbauproduktes des -Corticotropins (ACTH) aus Schweinehypophysen. Helv Chim Acta 44: 1136–1141

    CAS  Google Scholar 

  • Karzel K, Domenjoz R (1971) Effects of hexosamine derivatives and uronic acid derivatives on glycosaminoglycane. Metabolism of fibroblast cultures. Pharmacology 5: 337–345

    PubMed  CAS  Google Scholar 

  • Karzel K, Padberg DW (1977) Untersuchungen über den Einfluß antirheumatisch aktiver Phenylessig- säurederivate auf den Glykosaminoglykanstoffwechsel von Fibroblasten Kulturen. Arzneim Forsch/Drug Res 27: 533–538

    CAS  Google Scholar 

  • Katona G, Burgos R (1976) Experiencias con floctafenina, un nuevo analgésico de sintesis, en diversas enfermedades rheumaticas. Invest Med Int 3: 295–301

    Google Scholar 

  • Katrak SM, Pollock M, O’Brien CP, Nukada H, Allpress S, Calder C, Palmer DG, Grennan DM, McCormack PL, Laurent MR (1980) Clinical and morphological features of gold neuropathy. Brain 103: 671–693

    PubMed  CAS  Google Scholar 

  • Katz A, Little AH (1973) Gold nephropathy. An immunologic study. Arch Pathol 96:133-136 Katz E, Margalith E, Winer B (1976) Inhibition of herpes virus desoxyribonucleic acid and proteinsynthesis by tilorone hydrochloride. Antimicrob Agents Chemother 9: 189–195

    Google Scholar 

  • Kaufmann E (1977) Einfluß von Alclofenac auf den Prothrombinspiegel bei Patienten unter Antikoagulantientherapie. Schweiz Med Wochenschr 107: 882–887

    PubMed  CAS  Google Scholar 

  • Kaufmann B, Wegmann W (1981) Blasenkarzinom und malignes Melanom nach langjähriger Endoxan-Therapie einer Lymphoproliferativen Krankheit. Schweiz Med Wochenschr 111: 540–545

    PubMed  CAS  Google Scholar 

  • Kay AGL (1976) Myelotoxicity of gold. Br Med J 1: 1266–1268

    PubMed  CAS  Google Scholar 

  • Kay DR, Bole GG, Ledger WJ (1969) The use of oral contraceptives and the occurrence of antinuclear antibodies and LE-cells in women with early rheumatic disease. Arthritis Rheum 12: 306

    Google Scholar 

  • Kean WF, Dwosh IL, Anastassiades TP, Ford PM, Kelly HG (1980) The toxicity pattern of D-Penicillamine therapy. A guide to its use in rheumatoid arthritis. Arthritis Rheum 23: 158–164

    PubMed  CAS  Google Scholar 

  • Kelsey WM, Scharyj M (1967) Fatal hepatitis probably due to indomethacin. JAMA 199: 586 — 587

    PubMed  CAS  Google Scholar 

  • Kendall PH (1966) Fenamates in medicine. A symposium, London 1966. Ann Physical Med [Suppl] Bailliere, Tindall Cassell, London

    Google Scholar 

  • Keruzore A, Coste F, Delbarre F (1960) Le traitement des rhumatismes inflammatoires par les antimalariques (Chloroquine et Hydroxychloroquine). Sem Höpit Paris 36: 999–1007

    CAS  Google Scholar 

  • Keystone EC, Schabas R (1981) Hypotension with oliguria: a side-effect of Azathioprine. Arthritis Rheum 24: 1453–1454

    PubMed  CAS  Google Scholar 

  • Kieffer G (1981) Flurbiprofene. Etude multicentrique ambulatoire sur 11.500 malades. Rev Med (Paris) 22: 915–924

    Google Scholar 

  • Kimberg DY, Baerg RD, Gershon E, Graudusius RT (1971) Effect of cortisone treatment on the active transport of calcium by the small intestine. J Clin Invest 50: 1309–1321

    PubMed  CAS  Google Scholar 

  • Kindermann G (1967) Zum Kortisonentzugssyndrom. Med Klin 62: 1623 – 1627

    PubMed  CAS  Google Scholar 

  • Kinlen LJ, Sheil AGR, Peto J, Doll R (1979) Collaborative United Kingdom — Australasian Study of Cancer in patients treated with immunosuppressive drugs. Br Med J II: 1461–1466

    Google Scholar 

  • Kirchheiner B, Fossgreen J, Jensen EM, Kryger J, Holm P, Mollenbach K (1980) A new antiinflammatory agent, Carprofen (Imadyl®) in rheumatoid arthritis: a randomized multicentre comparison with Indomethacin. Curr Ther Res 28: 875–881

    Google Scholar 

  • Kirchhoff HW, Geimer R (1978) Über die Behandlung akuter und chronischer Formen von Polyarthritis mit Feprazon (DA 2370). Therapiewoche 28: 7995–8005

    Google Scholar 

  • Klatt L, Koss FW (1973) Humanpharmakokinetische Untersuchungen mit 14C-Azapropazon-Dihydrat. Arzneim Forsch/Drug Res 23: 920–921

    CAS  Google Scholar 

  • Klein G, Wottawa A (1975) Der Einfluß sogenannter Basistherapeutika und symptomatisch wirksamer Antirheumatika auf Enzyme der DNA-Synthese und DNA-Reparatur. Acta Med Austriaca 2: 153–156

    PubMed  CAS  Google Scholar 

  • Klein G, Keck M, Turanitz K (1981) Einfluß von Piroxicam auf den Schwesternchromatid-Austausch in menschlichen Lymphozyten. Therapiewoche 31: 5078–5080

    Google Scholar 

  • Klein G, Stampfel O, Rainer F, Trauner R (1979) Therapie der aktivierten Arthrose mittels Gelenkspülung und Applikation von Glycosaminoglycan. Therapiewoche 29: 6803–6806

    Google Scholar 

  • Kleine L, Khuen-Rauter U, Herrlinger JD (1982) Vergleichende Untersuchungen über die Wirkung verschiedener Gold Verbindungen auf Funktionen menschlicher Blutmonozyten in vitro. Akt Rheumatol 7: 55–59

    Google Scholar 

  • Kleinerman ES, Louie JS, Wahl LM, Muchmore AV (1981) Pharmacology of human spontaneous monocyte-mediated zytotoxicity. I. Enhancement by salicylates and steroids. Arthritis Rheum 24: 774–780

    PubMed  CAS  Google Scholar 

  • Klipper A, Kolodny AL (1981) A multicenter comparison of Pirprofen and Aspirin in osteoarthritis of the knee and hip. Mitteilung gehalten auf dem Rengasil-Symposion, Paris, 15. Int Rheumatologie Kongreß, 1981

    Google Scholar 

  • Koch R (1890) Über bakteriologische Forschung. Dtsch Med Wochenschr 16: 756–757

    Google Scholar 

  • Koch-Weser J, Seilers EM (1974) Drug interactions with Coumarin anticoagulants. N Engl J Med 285: 487–498, 547–558

    Google Scholar 

  • Kogstad O (1973) A double blind cross over study of naproxen and indomethacin in patients with rheumatoid arthritis. Scand J Rheumatol [Suppl 2] 2: 159–163

    Google Scholar 

  • Köhler G, Mohing W (1980) Zur Kinetik von Diclofenac-Na in Plasma und Synovialflüssigkeit. Akt Rheumatol 5: 151–155

    Google Scholar 

  • Kolarz G, Braun F, Menzel J, Scherak O (1981) Kollagenolytische Enzyme der Haut bei chronischer Polyarthritis -Veränderungen unter D-Penicillamin Therapie. Z Rheumatol 40: 37–39

    PubMed  CAS  Google Scholar 

  • Kolarz G, Ludwig H, Sabeti M, Scherak O (1975) Autoimmunologische Phänomene unter D-Penicillamin-Therapie. Acta Med Austriaca 2: 130–133

    PubMed  CAS  Google Scholar 

  • Kölle G (1971) Zur Behandlung der juvenilen chronischen Polyarthritis und des Still-Syndroms mit einem neuen Antirheumatikum. Z Rheumaforsch 30: 227–230

    PubMed  Google Scholar 

  • König J, Fenzki JE, Meier-Dörzenbach ED, Padberg G, Schäfer H (1973) Untersuchungen über die subakute und chronische Toxizität von Butyl-malonsäure-mono-(l,2-diphenyl-hydrazid)-Calcium(Bumadizon-Calcium). Arzneim Forsch/Drug Res 23: 1237–1246

    Google Scholar 

  • Konstantinov D, Stanoeva L, Vlckova M (1976) Liehen planus medicamentosus. Acta Dermatovenerol (Jugoslav) 3: 271–273

    Google Scholar 

  • Korst JK, Van der (1981) Ein neues antirheumatisch-analgetisches Medikament: Pirprofen (Rengasil®). Huber, Bern Stuttgart Wien

    Google Scholar 

  • Kreysel HW, Kimmig J (1975) Der Einfluß des D-Penicillamin auf den DNS -Proteoglycan- und Kollagenstoffwechsel sowie den Kupferhaushalt bei der progressiven Sklerodermie. Therapiewoche 25: 5737–5751

    Google Scholar 

  • Kronhagel R (1980) Klinische Ergebnisse einer Doppelblindstudie mit dem neuen Antirheumatikum Acemetacin. Arzneim Forsch/Drug Res 30(II): 1445–1448

    Google Scholar 

  • Krüger HH (1980) Vergleichende Untersuchungen von Flurbiprofen und Indometacin in der Behandlung der rheumatoiden Arthritis. Therapiewoche 30: 5909–5913

    Google Scholar 

  • Krupp P, Menassé-Gdynia R, Ziel R (1976a) Zur Frage der Testierung von Antirheumatika. In

    Google Scholar 

  • Wagenhäuser FJ (Hrsg) Polyarthritiden. Huber, Bern Stuttgart Wien, S 269–277

    Google Scholar 

  • Krupp P, Menassé-Gdynia-R, Ziel R (1976b) Chemistry and pharmacology of Diclofenac. In: Wagenhäuser FJ (ed) Voltaren, a new non-steroid antirheumatic agent (Diclofenac); Proceedings of a Symposium held during the Vlllth European Rheumatology Congress, Helsinki 1975. Huber, Bern Stuttgart Wien, pp 13–18

    Google Scholar 

  • Krupp P, Wesp M (1975) Inhibition of Prostaglandin Synthetase by psychotropic drugs. Experientia 31: 330 – 331

    PubMed  CAS  Google Scholar 

  • Krupp P, Exer B, Menassé R, Ziel R (1975) Neue Aspekte der Entzündungshemmung durch nichtsteroide Antiphlogistika. Wirkung von Voltaren. Schweiz Med Wochenschr 105: 646–648

    PubMed  CAS  Google Scholar 

  • Kruze D, Fehr K, Böni A (1976a) Effect of antirheumatic drugs on cathepsin B1 from bovine spleen. Z Rheumatol 35: 95–102

    PubMed  CAS  Google Scholar 

  • Kruze D, Fehr K, Menninger H, Böni A (1976b) Effect of antirheumatic drugs on neutral protease from human leucocyte granules. Z Rheumatol 35: 337–346

    PubMed  CAS  Google Scholar 

  • Kuehl FA jr, Egan RW (1978) Prostaglandins and related mediators in pain. In: Miehlke K (ed) Diflunisal in clinical practice. Futura Publishing Co Inc, New York, pp 13–20

    Google Scholar 

  • Kuehl FA jr, Humes JL, Egan RW, Ham EA, Beveridge GC, Arman CG van (1977) Role of Prostaglandine endoperoxide PGG2 in inflammatory processes. Nature 265: 170–173

    PubMed  CAS  Google Scholar 

  • Kuemmerle HP, Goossens N (1973) Klinik und Therapie der Nebenwirkungen, 2. Aufl. Thieme, Stuttgart

    Google Scholar 

  • Kupffer R, Baumont M, Brocheriou C (1976) Toxidermies buccales aphtoides. Rev Stomatol Chir Maxillofac 77: 747–755

    Google Scholar 

  • Kuhlmann J (1982) Einfluß nichtsteroidaler Antirheumatika auf Resorption und Elimination von β-Acetyldigoxin. Akt Rheumatol 7: 38–43

    Google Scholar 

  • Kuhlmann J, Zilly W (1979) Acetylsalicylsäure und Antacida. Inn Med 6: 277–283

    Google Scholar 

  • Kuhlmann U, Fontana A, Briner J, Steinemann U, Siegenthaler W (1978) Akute interstitielle Nephritis mit oligurischem Nierenversagen nach Phenylbutazon-Medikation. Schweiz Med Wochenschr 108: 494–499

    PubMed  CAS  Google Scholar 

  • Kulonen E, Potila M (1975) Effects of antirheumatic drugs on sponge induced granulation tissue, rheumatoid synovial tissue, matrix-free tendon cells and fibroblast plasmamembranes in vitro. Biochem Pharmacol 24: 1671–1678

    PubMed  CAS  Google Scholar 

  • Kunkel SL, Ogawa H, Conran PB, Ward PA, Zurier RB (1981) Suppression of acute and chronic inflammation by oraly administered prostaglandins. Arthritis Rheum 24: 1151–1158

    PubMed  CAS  Google Scholar 

  • Kuntz D, Lermusiaux JL, Teyssedou JP, Ryckewaert A (1976) A double-blind study of the analgesic action of Benorylate suspension in osteo-arthritis of the hip and knee. Scand J Rheumatol [Suppl 13] 25–28

    Google Scholar 

  • Kurnick NB, Radcliffe IE (1962) Reaction between DNA and Quinacrine and other antimalarials. J Lab Clin Med 60: 669–688

    PubMed  CAS  Google Scholar 

  • Kuzell WC, Schaffarzick RW, Naugler WE, Gaudin G, Mankle EA (1953) Phenylbutazone. Further clinical evaluation. Arch Intern Med 92: 646–661

    CAS  Google Scholar 

  • Kuzell WC, Schaffarzick RW, Naugler WE, Koets P, Mankle EA, Brown B, Champlin AB (1955) Some observations on 520 gouty patients. J Chron Dis 2: 645–669

    PubMed  CAS  Google Scholar 

  • Kwan KC, Duggan DE (1977) Pharmacokinetics of Sulindac. Acta Rheumatol Belg 1:168-178 Kwan KC, Breault GO, Umbenhauer ER, McMahon FG, Duggan DE (1976) Kinetics of Indometacin absorption, elimination, and enterohepatic circulation in man. J Pharmacokin Biopharm 4: 255–280

    Google Scholar 

  • Kwan KC, Duggan DE, Arman EG van, Shen TY (1978) Sulindac: Chemistry, pharmacology, and pharmacokinetics. Eur J Rheumatol Inflamm 1: 9–11

    Google Scholar 

  • Lande K (1927) Die günstige Beeinflussung schleichender Dauerinfekte mit Solganal. Munch Med Wochenschr 74: 1132–1134

    Google Scholar 

  • Lange K, Treser G, Slobody L, Wasserman E (1959) Die langdauernde stoßweise Behandlung der Nephrose mit Steroiden. Methoden und Ergebnisse bei Kindern und Erwachsenen. Dtsch Med Wochenschr 84: 1442–1446

    PubMed  CAS  Google Scholar 

  • Lanzer G, Klein G, Schmid P, Rainer F (1978) Zur intravenösen Ketoprofen-Therapie bei chronischer Polyarthritis. Akt Rheumatol 3: 203–209

    Google Scholar 

  • Lasagna L (1978) Der Einfluß psychologischer Faktoren und spontaner Ereignisse auf die klinische Beurteilung. In: Robinson RG (Hrsg) Wirkungen und Nebenwirkungen -medikamentös bedingt oder nicht? Huber, Bern Stuttgart Wien, S 10–21

    Google Scholar 

  • Lassman HB, Kirby RE, Wilker JC, Mc Fadden AR, Aultz DE, Hoffman D, Helsley GC, Novick WJ jr (1977) Pharmacology of the new non-steroidal, anti-inflammatory agent: 6,11-dihydro-ll- oxodibenz[b,e]oxepin-2-Essigsäure (HP 549). Arch Int Pharmacodyn Ther 227: 142–154

    PubMed  CAS  Google Scholar 

  • Laver M, Fairley KF (1971) D-Penicillamin Treatment in Pregnancy. Lancet I: 1019–1020

    Google Scholar 

  • Lawrence JS (1961) Studies with radioactive gold. Ann Rheum Dis 20: 341–352

    PubMed  CAS  Google Scholar 

  • Lawson AAH, MacLean N (1966) Renal disease and drug therapy in rheumatoid arthritis. Ann Rheum Dis 25: 441–449

    PubMed  CAS  Google Scholar 

  • Lazowski Z, Janczewski Z, Polowiec Z (1978) Gonadal toxicity of alcylating agents. In: Munthe E (Hrsg) The care of rheumatic children, Eular-Monograph Series, Nr 3, Eular Publishers, Basel, pp 170–171

    Google Scholar 

  • Leach H (1976) The determination of Azapropazone in bloodplasma. Curr Med Res Opin 4: 35–43

    PubMed  CAS  Google Scholar 

  • Leden I (1981) Antimalarial drugs — 350 years. Scand J Rheumatol 10: 307–312

    PubMed  CAS  Google Scholar 

  • Lederfen® (Fenbufen) (1980). Munch Med Wochenschr [Suppl 4] 122: 141–192

    Google Scholar 

  • Lee P, Anderson JA, Miller J, Webb J, Buchanan WW (1976) Evaluation of Analgesic Action and Efficacy of Antirheumatic Drugs. Study of 10 Drugs in 684 patients with rheumatoid arthritis. J Rheumatol 3: 283–294

    PubMed  CAS  Google Scholar 

  • Lee RE, Lands WEM (1972) Cofactors in the biosynthesis of prostaglandins Fxa and F2a. Biochim Biophys Acta 260: 203–211

    CAS  Google Scholar 

  • Letenneur J, Bainvel JV, Raub J, Migne J (1974) Recherche d’une eventuelle potentialisation des anticoagulants par le 19583 RP. Vie med 14: 1797–1799

    Google Scholar 

  • Leupold H, Otto W (1954) Ergebnisse der Stickstoff-lost-Behandlung bei chronischer Polyarthritis rheumatica. Z Rheumaforsch 13: 102–108

    PubMed  CAS  Google Scholar 

  • Leuxner E, Pulver R (1956) Verabreichung von Irgapyrin bei Schwangeren und Wöchnerinnen. Munch Med Wochenschr 98: 84–86

    PubMed  CAS  Google Scholar 

  • Levy G, Leonards JR (1971) Urine pH and salicylate therapy. JAMA 217: 81

    PubMed  CAS  Google Scholar 

  • Lewis RA, Austen KF, Drazen JM, Clark DA, Marfat A, Corey EJ (1980) Slow reacting substances of anaphylaxis: identification of leukotrienes C-l and D from human and rat sources. Proc Natl Acad Sci USA 77: 3710–3714

    PubMed  CAS  Google Scholar 

  • Lewis DA, Capstick RB, Ancill RJ (1971a) The action of Azapropazone, Oxyphenbutazone and Phenylbutazone on lysosomes. J Pharm Pharmacol 23: 931–935

    PubMed  CAS  Google Scholar 

  • Lewis GP, Jusko WJ, Burke CW, Graves L (1971b) Prednisone side-effects and serumprotein levels. Lancet 2: 778–781

    PubMed  CAS  Google Scholar 

  • Lewis AJ, Gemmell DK, Stimson WH (1978) The anti-inflammatory profile of dapsone in animal models of inflammation. Agents Actions 8: 578–586

    PubMed  CAS  Google Scholar 

  • Lewis P, Hazleman BL, Hanka R, Roberts S (1980) Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine. Ann Rheum Dis 39: 457–461

    PubMed  CAS  Google Scholar 

  • Lewis GP, Piper PJ (1975) Inhibition of release of prostaglandins as an explanation of some of the actions of antiinflammatory corticosteroids. Nature 254: 308–311

    PubMed  CAS  Google Scholar 

  • Lewis RJ, Trager WF, Chan KK, Breckenridge A, Orme M, Roland M, Schary W (1974) Warfarin. Stereochemical aspects of its metabolism and the interaction with Phenylbutazone. J Clin Invest 53: 1607–1617

    PubMed  CAS  Google Scholar 

  • Lewis P, Hazleman B, Bulgen D, Arden Jones R, Franks D, Svennson R (1977) Clinical and immunological study of high dose azathioprine compared with goldtherapy. Ann Rheum Dis 36: 283

    Google Scholar 

  • Lewis DC, Ziff M (1966) Intra-articular administration of goldsalts. Arthritis Rheum 9: 682–692

    PubMed  CAS  Google Scholar 

  • Liang MH, Fries JF (1978) Containing costs in chronic disease: Monitoring strategies in the gold therapy of rheumatoid arthritis. J Rheumatol 5: 241–244

    PubMed  CAS  Google Scholar 

  • Liebling M, Lieb E, McLaughlin K, Blocka K, Fürst D, Nyman K, Paulus H (1980a) A double-blind- crossover trial of methylprednisolone pulse therapy in rheumatoid arthritis (Abstract). Arthritis Rheum 23: 711

    Google Scholar 

  • Liebling M, McLaughlin K, Boonsue S, Kasdin J, Barnett EV (1980 b) A double blind placebo- controlled trial of pulse-methylprednisolone in SLE nephritis: A preliminary report (Abstract). Arthritis Rheum 23: 711

    Google Scholar 

  • Lintz RM (1941) Toxic reactions with gold salts in treatment of rheumatoid arthritis. J Lab Clin Med 26: 1629–1634

    Google Scholar 

  • Lipsky PE (1981a) Mechanisms of action of Auranofin: Effects of Macrophage function. Mitteilung auf dem Symposium „Therapeutic innovation in Rheumatoid Arthritis: World Wide Auranofin Symposium“, Montreal, 20./21. Okt 1981

    Google Scholar 

  • Lipsky PE (1981b) Modulation of human antibody production in vitro by D-penicillamine and

    Google Scholar 

  • CuS04: Inhibition of helper T-cell function. J Rheumatol [Suppl 7] 8: 69–73

    Google Scholar 

  • Lipsky PE, Ziff M (1976) Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold sodium thiomalate. Arthritis Rheum 19: 808–812

    Google Scholar 

  • Lipsky PE, Ziff M (1977) Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds. J Clin Invest 59: 455–466

    PubMed  CAS  Google Scholar 

  • Lockshin MD (1975) Aspirin and lymphocyte transformation. N Engl J Med 292: 809

    PubMed  CAS  Google Scholar 

  • Loftus LR (1963) Peripheral neuropathy following the chloroquine therapy. Can Med Assoc J 89: 917–920

    PubMed  CAS  Google Scholar 

  • Lonauer G, Wagner H, Boernger U, Goebel KM (1981) Lonazolac-Ca-ein nicht steroidales Anti-rheumatikum. Klinische Langzeitstudie bei chronischer Polyarthritis. Z Rheumatol 40: 161–164

    PubMed  CAS  Google Scholar 

  • Lorber A, Jackson WH, Simon TM (1981) Assessment of immune response during chrysotherapy. Comparison of gold sodium thiomalate vs. auranofin. Scand J Rheumatol 10: 129–137

    PubMed  CAS  Google Scholar 

  • Lorber A (1977) Monitoring goldplasma levels in rheumatoid arthritis. Clin Pharmacokin 2: 127–146

    CAS  Google Scholar 

  • Lorber A (1981) Mechanisms of action of Auranofin: Effects of chrysotherapy on cell mediated immune responses. Mitteilung auf dem Symposium: Therapeutic innovation in Rheumatoid Arthritis. World Wide Auranofin Symp, Montreal 20. /21. 10. 1981

    Google Scholar 

  • Lorber A, Simon TM, Leeb J, Peter A, Wilcox SA (1979) Effect of chrysotherapy on parameters of immune response. J Rheumatol [Suppl 5] 6: 82–90

    Google Scholar 

  • Lowenthal DT, Briggs WA, Levy G (1974) Kinetics of salicylate elimination by anephric patients. J Clin Invest 54: 1221–1226

    PubMed  CAS  Google Scholar 

  • Luders RC, Maggio-Cavaliere MB, Egger H-P, Gum OB, Resnick O, Bartlett MF, Gaito MJ, Soo A, Li C (1977) Disposition of Pirprofen, a new anti-inflammatory drug. Clin Pharmacol Ther 21: 721–730

    PubMed  CAS  Google Scholar 

  • Ludwig G, Ache IM (1973) Untersuchungen mit 14C-markiertem Butyl-Malonsäuremono-(l,2-diphe- nyl-hydrazid)-Calcium (Bumadizon-Calcium). Stoffwechsel und Kinetik. Arzneim Forsch/Drug Res 23: 1226–1231

    CAS  Google Scholar 

  • Luftschein S, Bienenstock H, Varady JC, Stitt FW (1979) Increasing dose of Naproxen in rheumatoid arthritis: Use with and without Corticosteroids. J Rheumatol 6: 397–404

    PubMed  CAS  Google Scholar 

  • Lund-Olesen K (1977) Clotrimazole, plasmacortisol and rheumatoid arthritis. Curr Ther Res 21: 704 – 706

    Google Scholar 

  • Lund-Olesen K, Menander KB (1974) Orgotein: a new anti-inflammatory metalloprotein drug: Preliminary evaluation of clinical efficacy and safety in degenerative joint disease. Curr Ther Res 16: 706–717

    PubMed  CAS  Google Scholar 

  • Lussier A, Rouleau L, Caron M, Tetreaoult L (1980) Comparative evaluation of carprofen and indomethacin in rheumatoid patients. Int J Clin Pharmacol Ther Toxicol 18: 482–487

    PubMed  CAS  Google Scholar 

  • Luthra HS, Conn DL, Ferguson RH (1981) Felty’s syndrome: Response to parenteral gold. J Rheumatol 8: 902–909

    PubMed  CAS  Google Scholar 

  • Lüthy F (1955) Die Nervenschädigungen nach intraglutealer Injektion von Irgapyrin und ein Vorschlag zu ihrer Verhütung. Schweiz Med Wochenschr 85: 1092–1096

    PubMed  Google Scholar 

  • Luukkainen R (1980) Chrysotherapy in rheumatoid arthritis, with particular emphasis on the effect of chrysotherapy on radiographical changes and on the optimal time of initiation of therapy. Scand J Rheumatol [Suppl 34] 3–56

    Google Scholar 

  • Lyle WH (1976) Penicillamine and iron. Lancet 2: 420

    PubMed  CAS  Google Scholar 

  • Lyle WH (1979) Penicillamine. Clin Rheum Dis 5: 569–601

    Google Scholar 

  • Lyle WH (1981) Penicillamine in metall poisoning. J Rheumatol [Suppl 7] 8: 96–99

    Google Scholar 

  • Lyle WH, Kleinman RL (1977) Penicillamine at 21: Its place in therapeutics now. Proc R Soc Med [Suppl 3] 70: 1–146

    Google Scholar 

  • MacGregor RR, Sheagren JN, Lipsett MB, Wolff SM (1969) Alternate-day prednisone therapy: Evaluation of delayed hypersensitivity responses, control of disease and steroid side effects. N Engl J Med 280: 1427–1431

    PubMed  CAS  Google Scholar 

  • Mackenzie AH (1970) An appraisal of chloroquine. Arthritis Rheum 13: 280–291

    PubMed  CAS  Google Scholar 

  • Mackenzie AH, Scherbel AL (1968) A decade of chloroquine maintenance therapy: Rate of administration governs incidence of retinotoxicity. Arthritis Rheum 11: 496

    Google Scholar 

  • Mackenzie AH, Scherbel AL (1980) Chloroquine and Hydroxichloroquine in rheumatological therapy. Clin Rheum Dis 6: 545–566

    Google Scholar 

  • Mackenzie AH, Szilagyi PJ (1968) Light may provide energy for retinal demage during chloroquine treatment. Arthritis Rheum 11: 496–497

    Google Scholar 

  • Maddock J, Rees P, Holly F, Aylward M (1975) The influence of alclofenac treatment on acute-phase proteins, plasmatryptophan and erythrocytessedimentationrate in patients with rheumatoid arthritis. Curr Med Res Opin 3: 286–297

    PubMed  CAS  Google Scholar 

  • Madsen S, Möller Graabaek P, Möller Pedersen S, Graudal H (1977) The localization of gold in synovial tissue during and after chrysotherapy. Scand J Rheumatol 6: 78

    Google Scholar 

  • Mäkelä AL, Peltola O, Mäkelä P (1978) Gold serum levels in children with juvenile rheumatoid arthritis. Scand J Rheumatol 7: 161–165

    PubMed  Google Scholar 

  • Mäkelä AL, Lempiäinen M, Ylijoki H (1981) Ibuprofen levels in serum and synovial fluid. Scand J Rheumtol [Suppl 39] 15–17

    Google Scholar 

  • Mäkisara P, Nissilä M, Kajander A, Martio J, Essen R von, Antilla P, Mäkisara G-L (1978) Comparison of penicillamine and gold treatment in early rheumatoid arthritis. Scand J Rheumatol 7: 166–170

    PubMed  Google Scholar 

  • Maini RN, Berry H (1981) Modulation of autoimmunity and disease. The penicillamine experience. Clin Pharmacol Ther, I. Vol, Praeger, Eastbourne

    Google Scholar 

  • Mainland D, Sutcliffe MI (1962) Hydroxichloroquine sulfate in rheumatoid arthritis: a six month double blind trial. Bull Rheum Dis 12: 287–290

    Google Scholar 

  • Makinodan T, Santos GW, Quinn RP (1970) Immunosuppressive drugs. Pharmacol Rev 22: 189–247

    PubMed  CAS  Google Scholar 

  • Mann T, Keilin D (1939) Haemocuprein and hepatocuprein, copper-protein compounds of blood and liver in mammals. Proc R Soc Ser B 126: 303–315

    Google Scholar 

  • Mantel W, Holtz G (1975) Untersuchungen zur Wirkung von Chinolinderivaten, Nukleotiden, D- Penicillamin, Zytostatika and Antiphlogistika auf Rheumafaktoren und andere Immunantikörper. Z Rheumatol 34: 94–101

    PubMed  CAS  Google Scholar 

  • Manthorpe R, Mork Hansen T, Junker P, Lorenzen I, Utne HE (1979) Prednisone effect on microvascular permeability in patients with inflammatory rheumatic diseases. Scand J Rheumatol 8: 139–141

    PubMed  CAS  Google Scholar 

  • Manz G, Glynn JP (1975) Die Verteilung von Benorilat in Plasma, Synovialflüssigkeit und Synovialgewebe bei rheumatoider Arthritis. Z Rheumatol 34: 400–407

    PubMed  CAS  Google Scholar 

  • Marbach F (1981) Intraartikuläre Corticoidtherapie. Akt Rheumatol 6: 95–99

    Google Scholar 

  • Marberger H, Bartsch G, Huber W, Menander KB, Schulte TL (1975) Orgotein: a new drug for the treatment of radiation cystitis. Curr Ther Res 18: 466–475

    PubMed  CAS  Google Scholar 

  • Marbet GA, Duckert F, Walter M, Six P, Airenne H (1977) Interaction study between Phenprocoumon and Flurbiprofen. Curr Med Res Opin 5: 26–31

    PubMed  CAS  Google Scholar 

  • Marchant B (1981) Pharmacokinetic factors influencing variability in human drug response. Scand J Rheumatol [Suppl] 39: 5–14

    CAS  Google Scholar 

  • Mark K vd (1980) Kollagensynthese in Chondrozyten-Kulturen unter dem Einfluß von Arteparon®. In: Dettmer N, Greiling H, Sensch KH, (Hrsg) Internationales Arzneimittelsymposium Artepa¬ron. Congress Series, Eular, Basel, S 39–50

    Google Scholar 

  • Marks JS, Power BJ (1979) Is chloroquine obsolete in treatment of rheumatic disease? Lancet 1: 371–373

    PubMed  CAS  Google Scholar 

  • Marks PA, Banks J (1965) Drug-induced hemolytic anemias associated with glucose-6-phosphate dehydrogenase deficiency: A genetically heterogenous trait. Ann NY Acad Sci 123: 198–206

    PubMed  CAS  Google Scholar 

  • Marmo E (1979) Experimental and clinical pharmacology of fentiazac, a new, non-steroidal antiinflammatory agent. Curr Med Res Opin [Suppl] 6: 53–63

    CAS  Google Scholar 

  • Marsden RA, Hill H, Mowat AG, Walshe M, Vanhegan I, Ryan TJ (1977) Penicillamine-induced Pemphigus. Proc R Soc Med [Suppl 3] 70: 103–106

    Google Scholar 

  • Martin E (1965) Biological and clinical synopsis of the action of Rumalon in osteoarthrosis. 11. Int Kongr Rheumat Mar del Plata

    Google Scholar 

  • Mason M, Currey HLF, Barnes CG, Dunne JF, Hazleman BL, Strickland ID (1969) Azathioprine in rheumatoid arthritis. Br Med J 1: 420–422

    PubMed  CAS  Google Scholar 

  • Massias P (1973) Die rheumatologischen Indikationen von Depot-Tetracosactid. In: Schuppli R (Hrsg) ACTH-Eine Standortbestimmung für die Praxis. Huber Bern Stuttgart Wien, S 169–182

    Google Scholar 

  • Mastaglia GL, Owen ET (1981) A study of the response of the leukopenia of rheumatoid arthritis to gold salt therapy. J Rheumatol 8: 658–660

    PubMed  CAS  Google Scholar 

  • Mathies H (1956) Die Hyaluronidasehemmung als therapeutischer Effekt der Rheumatismusbehandlung. Fortschr Med 74: 35–36

    Google Scholar 

  • Mathies H (1959) Untersuchungen zum Wirkungsmechanismus der Hyaluronidasehemmung antirheumatischer Substanzen. Pharmacie 14: 429–434

    CAS  Google Scholar 

  • Mathies H (1966) Indometacin in der Therapie rheumatischer Erkrankungen. Eine Übersicht über eigene Ergebnisse. Med Monatsschr 20: 403–406

    PubMed  CAS  Google Scholar 

  • Mathies H (1979) Nichtsteroidale Antirheumatika. Akt Rheumatol 4: 163–171

    Google Scholar 

  • Mathies H (1979) Probleme der symptomatischen Therapie rheumatischer Erkrankungen mit Glukokortikoiden und nichtsteroidalen Antirheumatika. Internist 20: 414–425

    CAS  Google Scholar 

  • Mathies H, Jankowski A (1957) Experimentelle Untersuchungen über die Bedeutung des Nebennierenmarkes für die Hyaluronidasehemmung. Klin Wochenschr 35: 892–893

    PubMed  CAS  Google Scholar 

  • Mathies H, Kilani S (1970) Untersuchungen zur Glukokortikoid-Einsparung bei chronischer Polyarthritis durch Azapropazon. Fortschr Med 88: 942–946

    Google Scholar 

  • Mathies H, Scholze H (1962) Untersuchungen zur Beeinflussung des Hyaluronidase-Spreadings durch Derivate des Phenylbutazons. Arzneim Forsch/Drug res 12: 79–81

    CAS  Google Scholar 

  • Mathies H, Will E (1962) Zum Mechanismus der Spreading-hemmenden Wirkung des Chloroquins. Arzneim Forsch/Drug Res 12: 694–698

    CAS  Google Scholar 

  • Mathies H, Wagenhäuser FJ, Siegmeth W (1980) Richtlinien zur Therapie rheumatischer Erkrankungen, Bd 5. Compendia Rheumatologica, EULAR, Basel

    Google Scholar 

  • Matoso L, Radi I (1980) Acquisitions thérapeutiques en rhumatologie. Méd Hyg 38: 35–41

    Google Scholar 

  • Mauer EE (1955) The toxic effects of Phenylbutazone (Butazolidin). Review of the literature and report of the twenty-third death following its use. N Engl J Med 253: 404–410

    PubMed  CAS  Google Scholar 

  • Mauer I, Weinstein D, Solomon HM (1970) Acetylsalicylic acid: No chromosome damage in human leucocytes. Science 169: 198–201

    PubMed  CAS  Google Scholar 

  • Mauff G, Weinheimer B, Urbaschek B (1975) Untersuchungen zur Antigenität von synthetischem ACTH (ein β1-24-Corticotropin) bei freiwilligen Versuchspersonen. Arzneim Forsch/Drug Res 25: 1823–1826

    CAS  Google Scholar 

  • Mawdsley P (1980) Fenbufen. Clin Rheum Dis 6: 615–632

    Google Scholar 

  • May L, Swoboda W (1974) Benorylat-Therapie bei rheumatischen Erkrankungen im Kindesalter. Z Rheumatol 33: 352–360

    Google Scholar 

  • Mayrhofer F, Hoffer L, Singer F, Kolarz G, Thumb N (1981) Kniegelenkspülungen bei aktivierten Arthrosen. Therapiewoche 31: 5007–5012

    Google Scholar 

  • Mazzullo JM, Lasagna L, Griner PF (1974) Variations in interpretation of prescription instructions. The need for improved prescribing habits. JAMA 227: 929–931

    PubMed  Google Scholar 

  • Mbuyi-Muamba JM, Stevens E, Dequeker J (1981) Good response to D-Penicillamine in IgA-deficient rheumatoid arthritis. Scand J Rheumatol 10: 31–32

    PubMed  CAS  Google Scholar 

  • McAllister WAC, Vale JA (1976) Fatal marrow aplasia in patient on penicillamine. Lancet 2: 631

    PubMed  CAS  Google Scholar 

  • McConkey B, Amos RS, Durham S, Forster PJG, Hubball S, Walsh L (1980) Sulphasalazine in rheumatoid arthritis. Br Med J 280: 442–444

    PubMed  CAS  Google Scholar 

  • McConkey B, Davies P, Crockson RA, Crockson AP, Butler M, Constable TJ (1976) Dapsone in rheumatoid arthritis. Rheumatol Rehabil 15: 230–234

    PubMed  CAS  Google Scholar 

  • McCord JM (1974) Free radicals and inflammation: Protection of synovial fluid by superoxide dismutase. Science 185: 529–531

    PubMed  CAS  Google Scholar 

  • McCord JM, Fridovich I (1969) Superoxide dismutase: An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244: 6049–6055

    PubMed  CAS  Google Scholar 

  • McCord JM, Fridovich I (1978) The biology and pathology of oxygenradicals. Ann Intern Med 89: 122–127

    PubMed  CAS  Google Scholar 

  • McCormick JN, Neill WA, Sim AK (1977) Immunosuppressive effects of linoleic acid. Lancet 2: 508

    PubMed  CAS  Google Scholar 

  • McLaughlin GE, Utsinger PD, Hicks JT (1981) D-penicillamine: Before, during or after? Arthritis Rheum 24: 1453

    PubMed  CAS  Google Scholar 

  • McNiel JR (1973) The possible teratogenic effect of salicylates on the developing fetus. Brief summaries of eight suggestive cases. Clin Pediatr (Phila) 12: 347–350

    CAS  Google Scholar 

  • McQueen EG, Dykes PW (1969) Transport of gold in the body. Ann Rheum Dis 28: 437–442

    PubMed  CAS  Google Scholar 

  • Meacock SCR, Kitchen EA (1976) Some effects of non-steroidal anti-inflammatory drugs on leukocyte migration. Agents Actions 6: 320–325

    PubMed  CAS  Google Scholar 

  • Meacock SCR, Kitchen EA (1979) Effects of the non-steroid anti-inflammatory drug Benoxaprofen on leukocyte migration. J Pharm Pharmacol 31: 366–370

    PubMed  CAS  Google Scholar 

  • Meacock SCR, Kitchen EA, Dawson W (1979) Effects of Benoxaprofen and some other non-steroidal anti-inflammatory drugs on leucocyte migration. Eur J Rheumatol Inflamm 3: 23–28

    CAS  Google Scholar 

  • Medenica R, Abele I, Dobryk R, Kuzmanovic I, Junet R (1973) Klinische Prüfung im Doppelblindversuch Plazebo gegen Bumadizon-Ca bei 113 Rheumafällen. Arzneim Forsch/Drug Res 23: 1817–1822

    CAS  Google Scholar 

  • Meier-Ruge W (1965) Experimental investigation of the morphogenesis of chloroquine retinopathy. Arch Ophthalmol 73: 540–544

    PubMed  CAS  Google Scholar 

  • Melander A, Wâhlin-Boll E (1981) Interaction of glipizide and indoprofen. Eur J Rheum Inflamm 4: 22–25

    CAS  Google Scholar 

  • Melby JC (1974) Drug spotlight program: systemic corticoid therapy; pharmacology and endocrino¬logie considerations. Ann Intern Med 81: 505–512

    PubMed  CAS  Google Scholar 

  • Menander-Huber KB (1981) Orgotein in the treatment of rheumatoid arthritis. Eur J Rheum Inflamm 4: 201–211

    CAS  Google Scholar 

  • Mellstedt H, Fagrell B, Holm G, Björkholm M (1977) (D)-Penicillamine treatment in systemic sclerosis (Scleroderma). Effect on nutritional capillary circulation. Scand J Rheumatol 6: 92–96

    Google Scholar 

  • Melluish JW, Brooks CD, Ruoff G, Cross CJ, Sanborn EC (1975) Ibuprofen and visual function. Arch Ophthalmol 93: 781–782

    PubMed  CAS  Google Scholar 

  • Menassé R, Hedwall PR, Kraetz J, Pericin C, Riesterer L, Sallmann A, Ziel R, Jaques R (1978) Pharmacological properties of Diclofenac sodium and its metabolites. Scand J Rheumatol [Suppl] 22: 5–16

    Google Scholar 

  • Menguy R, Desbaillets L, Masters YF, Okabe S (1972) Evidence for a sex-linked difference in Aspirin metabolism. Nature 239: 102–103

    PubMed  CAS  Google Scholar 

  • Menkes CJ, Job Ch, Delbarre F (1978) Traitement de la polyarthrite rhumatoïde par le sulfate de zinc per os. Nouv Presse Med 7: 760

    PubMed  CAS  Google Scholar 

  • Menkes CJ, Feldmann J-L, Baptiste GJ, Delbarre F (1978) Syndrome nephrotique par glomerulite extramembraneuse induit par le levamisole au cours d’une polyarthrite rhumatoïde. Nouv Presse Med 7: 2654–2655

    PubMed  CAS  Google Scholar 

  • Menkes CJ, Job CH, Buneaux F, Delbarre F (1981) Traitement de la polyarthrite rhumatoïde par le sulfate de zinc. Resultat d’un essay en double aveugle. Revue Rhumatisme 48: 223–227

    CAS  Google Scholar 

  • Merieux P de, Spitler LE, Paulus HE (1981) Treatment of Behcet’s-Syndrome with levamisole. Arthritis Rheum 24: 64–70

    Google Scholar 

  • Merker H J, Zimmermann B, Günther T (1972) Elektronenmikroskopische Untersuchungen über die D-Penicillaminwirkung am Knorpel embryonaler Ratten (Tag 16) in vitro. Virchows Archiv [Pathol Anat] Zellpath 12: 51–60

    CAS  Google Scholar 

  • Mery C, Delrieu F, Ghozlan R, Saporta L, Simon F, Amor B, Menkes CJ, Delbarre F (1976) Controlled trial of D-Penicillamine in rheumatoid arthritis. Dose Effect and the Role of Zinc. Scand J Rheumatol 5: 241–247

    PubMed  CAS  Google Scholar 

  • Mery C, Kreplack M, Amor B, Delrieu F, Gery A de, Ghozlan R, Menkes CJ, Simon F, Delbarre F (1976) Notre expérience de la pénicillamine comme médicament de la polyarthrite rhumatoïde. „R“6: 75–91

    Google Scholar 

  • Meyer W (1963) Ist die Goldbehandlung trotz ihrer Nebenwirkungen heute noch berechtigt? Z Rheumaforsch 22: 460–467

    PubMed  CAS  Google Scholar 

  • Meyer W, Taubner A (1963) Zur praktischen Durchführung der Goldtherapie bei primär-chronischer Polyarthritis. Med Welt 14: 2278–2281

    Google Scholar 

  • Michael TA, Aiwazzadeh S (1970) The effects of acute chloroquine poisoning with special reference to the heart. Am Heart J 79: 831–842

    CAS  Google Scholar 

  • Michelson AM (1977) Toxicity of superoxide radical anions. In: Michelson AM, McCord JM, Fridovich J (Hrsg) Superoxide and superoxide dismutases. Acad Press, London New York San Francisco, pp 245–255

    Google Scholar 

  • Michelson AM, McCord JM, Fridovich J (1977) Superoxide and superoxide dismutases. Academic Press, London New York San Francisco

    Google Scholar 

  • Michot F (1976) Bericht über eine klinische Doppelblindstudie zur Frage der möglichen Interaktion zwischen Voltaren und dem oralen Antikoagulans Acenocoumarol. In: Wagenhäuser FJ (Hrsg) Voltaren® (Diclofenac). Huber, Bern, S 51–54

    Google Scholar 

  • Michot F, Ajdacic K, Glaus L (1975) A double-blind clinical trial to determine if an interaction exists between Diclofenac sodium and the oral anticoagulant Acenocoumarol (Nicoumalone). J Int Med Res 3: 153–157

    PubMed  CAS  Google Scholar 

  • Miehlke K (1972) Basistherapie der Kniearthrose mittels Gelenkspülung. Z Rheumaforsch 31: 119–128

    PubMed  CAS  Google Scholar 

  • Miehlke K (1974) Diskussionsbemerkung. In: Ott VR, Schmidt KL (Hrsg) Die Behandlung der rheumatoiden Arthritis mit D-Penicillamin. „Der Rheumatismus“, Bd 42. Steinkopff, Darmstadt, S 154

    Google Scholar 

  • Miehlke K (1975) Die Wirkung von D-Penicillamin auf den Verlauf der chronischen Polyarthritis. Acta Med Austriaca 2: 127–129

    PubMed  CAS  Google Scholar 

  • Miehlke K (1978) Diflunisal in clinical paractice. Futura Publishing Company, Mt Kisco, New York

    Google Scholar 

  • Mielants H, Veys EM (1978) A study of the hematological side effects of levamisole in rheumatoid arthritis with recommendations. J Rheumatol [Suppl 4] 5: 77–83

    Google Scholar 

  • Mielants H, Veys EM, Verbruggen G, Schelstraete K (1981) Comparison of serum salicylate levels and gastro-intestinal blood-loss between salsalate (Disalcid) and other forms of salicylates. Scand J Rheumatol 10: 169–173

    PubMed  CAS  Google Scholar 

  • Mikulikova D, Trnavsky K (1980) Effect of levamisole on lysosomal enzyme release from polymorphonuclear leukocytes and intracellular levels of cAMP and cGMP after phagocytosis of monosodium urate crystalls. Agents and Actions 10: 373–377

    Google Scholar 

  • Miller B, Merieux P de, Srinivasan R, Clements P, Fan P, Levy J, Paulus HE (1980) Double-Blind Placebo Controlled Crossover Evaluation of Levamisole in Rheumatoid Arthritis. Arthritis Rheum 23: 172–182

    PubMed  CAS  Google Scholar 

  • Millikan LE, Conway FR (1974) Effect of drugs on the Pillemer pathway-Dapsone. Paper read at 35. Meeting of the Society for Investigative Dermatology, Chicago, 1974. Zit n Adverse Reactions to Dapsone. Leading Article (1981) Lancet 2, 184–185

    Google Scholar 

  • Mills JA (1974) Non-steroidal anti-inflammatory drugs. N Engl J Med 290: 781–784

    PubMed  CAS  Google Scholar 

  • Mitchell WS, Scott P, Kennedy AC, Brooks PM, Templeton R, Jeffries MG (1975) Clinico-pharmacological studies on Ketoprofen (Orudis). Curr Med Res Opin 3: 423–430

    Google Scholar 

  • Miyamoto T, Miyaji S, Horiuchi Y, Hara M, Ishihara K (1974) Goldtherapy in bronchial asthma — special emphasis upon blood levels in gold and its teratogenicity. Nippon Noika Gakkai Zaashi 63: 1190

    CAS  Google Scholar 

  • Mjolnerod OK, Rasmussen K, Dommerud SA, Gjeruldsen ST (1971) Congenital Connective-tissue Defect probably due to D-penicillamine Treatment in Pregnancy. Lancet I: 673–675

    Google Scholar 

  • Mobarok Ali ATM, Morley J (1981) Synergism between Aspirin and Cyclosporin-A. Rheumatol Int 1: 43–45

    CAS  Google Scholar 

  • Moeschlin VS, Siegenthaler P (1960) Cholostatische Hepatose durch Gold; Analogie zum Chlorpromazin- und Androgenikterus. Helv Med Acta 5: 707–715

    Google Scholar 

  • Mohr W (1977) Pathologisch-anatomische Veränderungen als Folge der Goldtherapie. Akt Rheumatol 2: 17–28

    Google Scholar 

  • Mohr W (1982) Die Morphologie von Goldablagerungen in der Synovialmembran. Akt Rheumatol 7: 63–67

    Google Scholar 

  • Möllmann H, Klot-Heydenfeldt B v, Niemeyer DH, Alfes H (1971/1972) Vergleichende Untersuchungen der Korngrößenverteilung und Partikelbeschaffenheit einiger Corticoid-Kristallsuspensionen. Int J Clin Pharmacol 5: 434–443

    Google Scholar 

  • Möllmann H, Zwingmann K-P, Bigalke C, Kindler J (1975) Einfluß intramuskulär injizierter unterschiedlicher Glukokortikoid-Kristallsuspensionen auf den Applikationsort. Therapiewoche 35: 4575–4588

    Google Scholar 

  • Moll W (1958) Klinische Rheumatologie. Karger, Basel New York

    Google Scholar 

  • Momburg M, Stuhlsatz HW, Vögeli H, Vojtisek O, Eylau O, Greiling H (1976) Klinisch-chemische Veränderungen in der Synovialflüssigkeit nach intraartikulärer Injektion eines Glycosaminogly- kanpolysulfats. Verh Dtsch Ges Rheumatol 4: 383–390

    PubMed  CAS  Google Scholar 

  • Moncada S, Gryglewski R, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263: 663–665

    PubMed  CAS  Google Scholar 

  • Morison RAH, Woodmansey A, Young AJ (1961) Placebo responses in an arthritis trial. Ann Rheum Dis 20: 179–185

    PubMed  CAS  Google Scholar 

  • Moritz AJ (1975) Zur Kollagen-Biosynthese und zum Wirkungsmechanismus von D-Penicillamin. Wien Klin Wochenschr 87: 1–6

    PubMed  CAS  Google Scholar 

  • Morris HR, Taylor GW, Piper PJ, Tippins JR (1980) Structure of slow-reacting substance of anaphylaxis from guinea-pig lung. Nature 285: 104–106

    PubMed  CAS  Google Scholar 

  • Mowat AG (1978) Neutrophil Chemotaxis in rheumatoid arthritis. Effect of D-Penicillamine, gold salts and levamisole. Ann Rheum Dis 37: 1–8

    PubMed  CAS  Google Scholar 

  • Mowat AG, Vischer TL (1979) Levamisole. “Immunomodulation” — a new approach to basic therapy of rheumatoid arthritis. EULAR-Monograph Series 5: 7–76

    Google Scholar 

  • Multicentre study group (1978 a) Levamisole in rheumatoid arthritis. A randomiced double blind study compairing two dosage regimens of levamisole with placebo. Lancet 2: 1007–1012

    Google Scholar 

  • Multicentre study group (1978b) A multicentre randomiced double blind study compairing two

    Google Scholar 

  • dosages of levamisole in rheumatoid arthritis. J Rheumatol [Suppl 4] 5: 5–10

    Google Scholar 

  • Multicentre trial group (1974) Absence of toxic or therapeutic interaction between penicillamine and previously administered gold in a trial of penicillamine in rheumatoid disease. Postgrad Med J [Suppl 2] 50: 77–78

    Google Scholar 

  • Multicentre trial group (1973) Controlled trial of D(-)Penicillamine in severe rheumatoid arthritis. Lancet 1: 275–280

    Google Scholar 

  • Multz CV, Bernhard GC, Blechman WC, Zane S, Restifo RA, Farady JC (1974) A comparison of intermediate dose aspirin and placebo in rheumatoid arthritis. Clin Pharmacol Ther 15: 310–315

    PubMed  CAS  Google Scholar 

  • Munthe E (1976) Penicillamine, research in rheumatoid disease. Fabritius und Sonner, Oslo

    Google Scholar 

  • Munthe E, Kass E (1981) Penicillamine in rheumatic diseases: A prospective study of tolerance and efficacy. J Rheumatol [Suppl 7] 8: 107–111

    Google Scholar 

  • Murphy KC, Atkins CJ, Offer RC, Hogg JC, Stein HB (1981) Obliterative bronchiolitis in two rheumatoid arthritis patients treated with penicillamine. Arthritis Rheum 24: 557–560

    PubMed  CAS  Google Scholar 

  • Murray RM, Lawson DH, Linton AL (1971) Analgesic nephropathy: Clinical syndrome and prognosis. Br Med J 1: 479–482

    PubMed  CAS  Google Scholar 

  • Mutru O, Penttilä M, Pesonen J, Salmela P, Suhonen O, Sonck T (1978) Diclofenac sodium (Voltaren) and indomethacin in the ambulatory treatment of rheumatoid arthritis: a double-blind multicentre study. Scand J Rheumatol [Suppl 22] 51–56

    Google Scholar 

  • Myers EN, Bernstein JM, Fostiropolous G (1965) Salizylate ototoxicity. A clinical study. N Engl J Med 273: 587–590

    PubMed  CAS  Google Scholar 

  • Myles AB, Daly JR (1974) Corticosteroid and ACTH treatment. Principles and problems. Arnold, London

    Google Scholar 

  • Nagi AH, Alexander F, Barabas AZ (1971) Gold nephropathy in rats. Light and electron microscopy studies. Exp Mol Pathol 15: 354–362

    PubMed  CAS  Google Scholar 

  • Nagy E, Scegedy G, Tamasi P, Sonkoly I (1978) Immunrosettenhemmende Aktivität des Serums von Patienten mit Lupus erythematodes chronicus unter Chlorochin-Behandlung. Dermatol Monatsschr 164: 408–410

    PubMed  CAS  Google Scholar 

  • Nakamura H, Igarashi M (1977) Localization of gold in synovial membrane of rheumatoid arthritis treated with sodium auro thiomalte. Studies by electrone microscope and electrone probe X-ray microanalysis. Ann Rheum Dis 36: 209–215

    PubMed  CAS  Google Scholar 

  • Naproxen-Symposium (1973). Scand J Rheumatol [Suppl 2] 2: 5–181

    Google Scholar 

  • Naproxen-Symposium (1975). Arzneim Forsch/Drug Res 25: 277 – 332

    Google Scholar 

  • Naumann P (1971) Nil nocere! Risiken bei intraartikulärer Kortikoid-Instillation. Munch Med Wochenschr 113: 1085–1088

    PubMed  CAS  Google Scholar 

  • Nebout T, Sobel A, Lagrue G (1977) Intravenous methylprednisolone pulses in diffuse proliferative lupus nephritis. Lancet 1: 909

    PubMed  CAS  Google Scholar 

  • Nelson AM, Conn DL (1980) Glucocorticoids in rheumatic disease. Mayo Clin Proc 55: 758–769

    PubMed  CAS  Google Scholar 

  • Nelson MM, Forfar JO (1971) Association between drugs administered during pregnancy and congenital abnormalities of the fetus. Br Med J 1: 523–527

    PubMed  CAS  Google Scholar 

  • Newcombe DS, Ishkawa Y (1976) The effect of anti-inflammatory agents on human synovial fibroblast prostaglandinsynthetase. Prostaglandins 12: 849–869

    PubMed  CAS  Google Scholar 

  • Ney RL (1969) Effects of dibutyryl cyclic AMP on adrenal growth and steroidogenic capacity. Endocrinology 84: 168–170

    PubMed  CAS  Google Scholar 

  • Nies AS, Melmon KL (1968) Kinins and arthritis. Bull Rheum Dis 19: 512–517

    CAS  Google Scholar 

  • Nimni ME (1965) Accumulation of a collagen precursor in the skin of penicillamine-treated rats. Biochem Biophys Acta 111: 576–579

    PubMed  CAS  Google Scholar 

  • Nimni ME (1967) Dermalathyrism: A defect in the intramolecular and intermolecular crosslinking of collagen in soft tissues caused by Penicillamine. Arthritis Rheum 10: 301

    Google Scholar 

  • Nimni ME, Bavetta LA (1965) Collagen defect induced by Penicillamine. Science 150: 905–906

    PubMed  CAS  Google Scholar 

  • Nishikai M, Funatsu Y, Homma M (1974) Monoclonal gammopathy penicillamine-induced polymyositis systemic sclerosis. Arch Dermatol 110: 253–255

    PubMed  CAS  Google Scholar 

  • Norton WL, Donnelly RJ, Schimmelpfennig W, Harden JA (1982) PC-80, a new slow acting antirheumatoid drug. Rheumatol 9: 951–953

    CAS  Google Scholar 

  • Nowotny P, Konrad H, Preussner S, Bast G, Keysser M, Gunther I (1976) Die Beeinflussung der Leukopoese und der Granulozytenphagozytose vor und nach Gold-Therapie bei Rheumatoidarthritis. Folia Haematol (Leipz) 103: 719–725

    CAS  Google Scholar 

  • Nuotio P, Mäkisara P (1978) Pharmacokinetic and clinical study of Piroxicam. Intern Congr Symp Series, Royal Soc Med 1: 25–30

    Google Scholar 

  • Nyfos L (1979) A comparative clinical study of a new antirheumatic agent, tolfenamic acid (Clotam), and Phenylbutazone in rheumatoid arthritis. Scand J Rheumatol [Suppl 24] 5–7

    Google Scholar 

  • O’Brien WM, Wisemann EH (1978) Piroxicam. Royal Soc Med Intern Congr Symp Ser 1: 1–111

    Google Scholar 

  • O’Duffy JD, Colgan JP, Phyliky RL, Ferguson RH (1980) Frentizole therapy of thrombozytopenia in systemic lupus erythematosus and refractory idiopathic thrombocytopenic purpura. Mayo Clin Proc 55: 601–605

    PubMed  Google Scholar 

  • Oelz O (1977) Das Prostaglandin-Thromboxan-System. Schweiz Med Wochenschr 107: 753–756

    PubMed  CAS  Google Scholar 

  • Olatunde A (1976) Chloroquine and enzymes. West Afr J Pharmacol Drug Res 3: 173–177

    PubMed  CAS  Google Scholar 

  • Ongerboer Vissa BW de, Soesbergen RM van (1978) Myasthenia gravis as a complication of penicillaminetreatment in rheumatoid arthritis. Ned Tijdschr Geneeskd 122: 2055–2058

    Google Scholar 

  • Orgotein-Workshop (1981) Eur J Rheumatol Inflamm 4: 151–270

    Google Scholar 

  • Orme M, Baber N, Keenan J, Halliday L, Sibeon R, Littler T (1981) Pharmacokinetics and biochemical effects in responders and non-responders to non-steroidal anti-inflammatory drugs. Scand J Rheumatol [Suppl] 39: 19–27

    CAS  Google Scholar 

  • Orozco-Alcala J J, Baum J (1979) Regular and enteric coated aspirin: A réévaluation. Arthritis Rheum 22: 1034–1037

    PubMed  CAS  Google Scholar 

  • Orth DN, Island DP (1969) Light synchronization of the circadian rhythm in plasma Cortisol (17 OHCS) concentrations in man. J Clin Endocrinol Metab 29: 479–486

    PubMed  CAS  Google Scholar 

  • Orzalesi G, Mari F, Bertol E, Selleri R, Pisaturo G (1980) Anti-inflammatory agents: determination of Ibuproxam and its metabolite in humans. Correlation between bioavailability, tolerance and chemico-physical characteristics. Arzneim Forsch/Drug Res 30: 1607–1609

    CAS  Google Scholar 

  • Ostensen M, Husby G, Aarli J (1980) Polymyositis with acute myolysis in a patient with rheumatoid arthritis treated with penicillamine and ampicillin. Arthritis Rheum 23: 375–377

    PubMed  CAS  Google Scholar 

  • Ott H (1978) 2(lH)-Qinazolinones as novel non-acidic anti-inflammatory agents. Scand J Rheumatol [Suppl] 21: 5–7

    Google Scholar 

  • Ott H, Denzer M (1968) l-Methyl-4-phenyl-2(lH)-quinazdinone. J Org Chem 33: 4263–4267

    Google Scholar 

  • Ott H, Meier J (1978) The distribution of Proquazone and three of its metabolites in serum and synovial fluid. Scand J Rheumatol [Suppl] 21: 12–14

    CAS  Google Scholar 

  • Ott VR, Schmidt KL (1974) Die Behandlung der rheumatoiden Arthritis mit D-Penicillamine. Symposion Berlin, 1973. Der Rheumatismus, Bd 42. Steinkopff, Darmstadt, S 1–178

    Google Scholar 

  • Otte P (1974) Die pathophysiologischen Grundlagen präarthrotischer Faktoren. Z Orthop 112: 541–547

    PubMed  CAS  Google Scholar 

  • Otto W (1969) Zur kritischen Einschätzung der immunsuppressiven Therapie bei progressiv chronischer Polyarthritis. Z Gesamte Inn Med 24: 147–148

    CAS  Google Scholar 

  • Otto W, Tautenhahn B (1966) Chloroquin-Langzeitbehandlung chronisch-rheumatischer Erkrankungen. Munch Med Wochenschr 108: 999–1003

    PubMed  CAS  Google Scholar 

  • Pace N, Kantor T, MacEwen C (1964) Evaluation of an intra-articulary injected alkylating agent in arthritis. Arthritis Rheum 7: 337

    Google Scholar 

  • Pachman LM, Olufs R, Procknal JA, Levy G (1979) Pharmacokinetic monitoring of salicylate therapy in children with juvenile rheumatoid arthritis. Arthritis Rheum 22: 826–831

    PubMed  CAS  Google Scholar 

  • Page F (1951) Treatment of Lupus erythematosus with mepacrine. Lancet 261: 755–758

    CAS  Google Scholar 

  • Palmer L, Bertilsson L, Alvan G, Orme M, Sjoqvist F, Holmstedt B (1974) Indomethacin: Quantitative determination in plasma by mass fragmentography including pilot pharmacokinetics in men. In: Robinson HJ, Vane JR (eds) Prostaglandinsynthetase inhibitors. Raven-Press, New York, pp 91–97

    Google Scholar 

  • Palmer CAL (1972) Toxic amblyopia from Ibuprofen. Br Med J 3: 765

    PubMed  CAS  Google Scholar 

  • Palmoski MJ, Brandt KD (1979) Effect of salicylate on proteoglycan metabolism in normal canine articular cartilage in vitro. Arthritis Rheum 22: 746–754

    PubMed  CAS  Google Scholar 

  • Palmoski MJ, Colyer RA, Brandt KD (1980) Marked suppression by salicylate of the augmented proteoglycan synthesis in osteoarthritic cartilage. Arthritis Rheum 23: 83–91

    PubMed  CAS  Google Scholar 

  • Palosuo T, Kajander A, Essen R von, Milgrom F (1978) Precipitating autoantibody to a ubiquitous tissue antigen: association with rheumatoid arthritis treated with sodium aurothiomalate or D- penicillamine. Clin Immunol Immunopathol 10: 355–364

    PubMed  CAS  Google Scholar 

  • Panayi GS (1975) The effect of ibuprofen on lymphocyte stimulation by phytohaemagglutinin in vitro. Curr Med Res Opin 3: 513–515

    Google Scholar 

  • Panayi GS, Neill WA, Duthie JJR, McCormick JN (1973) Action of chloroquine phosphate in rheumatoid arthritis. I. Immunosuppressive effects. Ann Rheum Dis 32: 316–318

    PubMed  CAS  Google Scholar 

  • Panayi GS, Rix A (1974) The effect of phenylbutazone, indometacin and ibuprofen on lymphocyte stimulation by phytohaemagglutinin in vitro. Rheumatol Rehabil 13: 179–183

    PubMed  CAS  Google Scholar 

  • Panayi GS, Wooley P, Batchelor JR (1978) Genetic basis of rheumatic diseases: HLA-antigens, disease manifestations and toxic reactions to drug. Br Med J 2: 1326–1328

    PubMed  CAS  Google Scholar 

  • Panse P, Zeiller P, Sensch KH (1976) Verteilung und Ausscheidung eines Glycosaminoglycanpolysulfats nach parenteraler Applikation beim Kaninchen. Arzneim Forsch/Drug Res 26: 2024–2029

    CAS  Google Scholar 

  • Panush RS (1975) Effects of certain antirheumatic drugs upon normal human peripheral blood lymphocytes (P.B.L.). Inhibition of mitogen- and antigen-stimulated incorporation of tritiated thymidine (3HTdR). Arthritis Rheum 18: 418–419

    Google Scholar 

  • Panush RS, Anthony CR (1976) Effects of acetylsalicylic acid on normal human peripheral blood lymphocytes: Inhibition of mitogen- and antigen-stimulated incorporation of tritiated thymidine. Clin Exp Immunol 23: 114–125

    PubMed  CAS  Google Scholar 

  • Parizot H (1972) L’intoxication oculaire par la chloroquine et ses dérivés. Intérêt des explorations fonctionelles. E.R.G. et E.O.G. étude d’une serie de 400 cas (1964-1971). Bull Soc Belge Ophthalmol 160: 570–580

    CAS  Google Scholar 

  • Parker RA, Thomas PM (1959) Intestinal perforation and widespread arteritis in rheumatoid arthritis during treatment with cortisone. Br Med J 1: 540–542

    PubMed  CAS  Google Scholar 

  • Pasero G, Ciompi ML (1979) Thiopronine therapy in rheumatoid arthritis. Arthritis Rheum 22: 803–804

    PubMed  CAS  Google Scholar 

  • Passeri M, Ferretti G, Monica C, Fanfani A, Bergamini N (1981) Study of the possible interactions of indoprofen on the diuretic effect of furosemide. Eur J Rheumatol Inflamm 4: 36–40

    PubMed  CAS  Google Scholar 

  • Patak RV, Mookerjee BK, Benzel CJ, Hysert PE, Babej M, Lee JB (1975) Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man. Prostaglandins 10: 649–659

    PubMed  CAS  Google Scholar 

  • Patriarca G (1971) Allergy to tetracosactrin-depot. Lancet 1: 138

    Google Scholar 

  • Patzschke K, Wegner L, Kaller H, Horster FA (1977) Pharmakokinetische Untersuchungen nach oraler Applikation von radioaktiv markiertem D-Penicillamin an Probanden. Z Rheumatol 36: 96–105

    PubMed  CAS  Google Scholar 

  • Paulus HE, Whitehouse MW (1973) Nonsteroid anti-inflammatory agents. Ann Rev Pharmacol Toxicol 13: 107–124

    CAS  Google Scholar 

  • Pavelka K, Wagenhäuser F J, Geirregat R (1971) Benorylat in der Behandlung der chronisch progredienten Polyarthritis. Z Rheumaforsch 30: 45–49

    PubMed  CAS  Google Scholar 

  • Pavelka K, Geirregat R, Vojtisek O, Brémovâ A (1973 a) A study of the long-term treatment of rheumatoid arthritis with Benorylate suspension. Rheumatol Rehabil [Suppl] 12: 48–53

    Google Scholar 

  • Pavelka K, Susta A, Vojtisek O, Brémovâ A, Kankovâ D, Hândlovâ D, Malecek J (1973 b) Double blind comparison of Ibuprofen and Phenylbutazone in a short-term treatment of rheumatoid arthritis. Arzneim Forsch/Drug Res 23: 842–846

    Google Scholar 

  • Pavelka K, Vojtisek O, Susta A, Kankovâ, D, Brémovâ A, Krâlovâ M (1978) Experience with high doses of Ibuprofen in the longterm treatment of rheumatoid arthritis. J Internat Med Res 6: 355–364

    CAS  Google Scholar 

  • Pawlotsky Y, Chales G, Grosbois B, Miane B, Bourel M (1978) Comparative interaction of Aspirin with Indomethacin and Sulindac in chronic rheumatic diseases. Eur J Rheumatol Inflamm 1: 18–20

    Google Scholar 

  • Pearson C, Levy JM (1975) Immunosuppressive drugs. Mechanism of action, toxicity and clinical effects. Clinics Rheum Dis 1: 459–478

    Google Scholar 

  • Pedrazzi F, Bommartini F, Freddo J, Emanueli A (1981) A study of the possible interaction of Indoprofen with hypoglycemic sulfonyl ureas in diabetic patients. Eur J Rheumatol Inflamm 4: 26–31

    PubMed  CAS  Google Scholar 

  • Pemberton RE, Strand LJ (1979) A review of upper gastrointestinal effects of the newer nonsteroidal anti-inflammatory agents. Dig Dis Sci 24: 53–64

    PubMed  CAS  Google Scholar 

  • Penner JA, Abbrecht PH (1975) Lack of interaction between Ibuprofen and Warfarin. Curr Ther Res 18: 862–871

    PubMed  CAS  Google Scholar 

  • Penneys N, Ziboh V, Gottlieb N, Katz S (1974) New mechanisms of gold action. Clin Res 22: 556 A (Abstr)

    Google Scholar 

  • Percival SPB, Meanock I (1968) Chloroquine: ophthalmological safety and clinical assessment in rheumatoid arthritis. Br Med J 3: 579–584

    PubMed  CAS  Google Scholar 

  • Perper RJ, Oronsky AL (1974) Enzyme release from human leukocytes and degradation of cartilage matrix. Effects of antirheumatic drugs. Arthritis Rheum 17: 47–55

    PubMed  CAS  Google Scholar 

  • Persellin RH, Ziff M (1966) The effect of gold salt on lysosomal enzymes of the peritoneal macrophage. Arthritis Rheum 12: 57–65

    Google Scholar 

  • Petera P, Tausch G, Bröll H, Eberl R (1977) Double blind trial involving: Teorema®, a new antirheumatic, vs. Indometacin in rheumatoid diseases. Int J Clin Pharmacol Biopharm 15: 581–584

    PubMed  CAS  Google Scholar 

  • Peters HD, Dinnendahl V, Schönhöfer PS (1975) Mode of action of antirheumatic drugs on the cyclic 3’5’-AMP regulated glycosaminoglycan secretion in fibroblasts. Naunyn Schmiedebergs Arch Pharmacol 289: 29–40

    CAS  Google Scholar 

  • Petersen J, Halberg P, Hojgaard K, Lyon BB, Ullman S (1978) Penicillamine-induced polymyositisdermatomyositis. Scand J Rheumatol 7: 113–117

    PubMed  CAS  Google Scholar 

  • Petersen PB, Husted S, Mortensen A, Andreasen F (1979) The effect of daily administration of Naproxen on the prothrombincomplex activity in patients under long term therapy with Phenprocoumon. Scand J Rheumatol 8: 54–56

    PubMed  CAS  Google Scholar 

  • Peterson J, Moller I (1978) Milliary pulmonary infiltrates and Penicillamine. Br J Radiol 51: 915–916

    Google Scholar 

  • Pick E (1927) Versuche einer Goldbehandlung des Rheumatismus. Wien Klin Wochenschr 40: 1175–1176

    Google Scholar 

  • Pinals RS (1978) The non-hematological sideeffects of levamisole in the treatment of rheumatoid arthritis — a review. J Rheumatol [Suppl 4] 5: 71–75

    Google Scholar 

  • Pinals RS, Robertson F, Blechman WJ (1981) A double-blind comparison of high and low doses of levamisole in rheumatoid arthritis. J Rheumatol 8: 949–951

    PubMed  CAS  Google Scholar 

  • Piroxicam (1980) Akt Rheumatol (Sonderheft 1) 5: 1–70

    Google Scholar 

  • Pittman RC, Steinberg D (1977) Activatable cholesterolesterase and triacylglycerol lipase activities of rat adrenal and their relationship. Biochem Biophys Acta 487: 431–444

    PubMed  CAS  Google Scholar 

  • Pitts NE (1980) Review of clinical trial experience with Piroxicam. In: Piroxicam, a new non-steroidal anti-inflammatory agent. Proc of the 9. Europ Congr Rheumatol Academy Professional Information Services, New York, pp 48–66

    Google Scholar 

  • Pitts NE, Proctor RR (1978) Summary: Efficacy and safety of Piroxicam. Royal Soc Med Intern Congr Symp Ser 1: 97–108

    Google Scholar 

  • Planas-Bohne F (1972) Pharmakokinetische Untersuchungen an 14C-markiertem Penicillamin. Arzneim Forsch 22: 1426–1433

    CAS  Google Scholar 

  • Plostnieks J, Cressman WA, Lemanowicz EF, Migdalof BH, Tam JJS (1975) Human metabolism of tolmetin. In: Ward JR (ed) Tolmetin, a new non-steroidal anti-inflammatory agent. Exc Med, Princeton, pp 23–33

    Google Scholar 

  • Poal Ballarin JM (1976) El Butibufen en el tratamiento de la osteoartritis (Artrosis). Med Klin (Ed Esp) 180: 46–50

    Google Scholar 

  • Podell TE, Klinenberg JR, Kramer LS, Brown HV (1980) Pulmonary toxicity with gold therapy. Arthritis Rheum 23: 347–350

    PubMed  CAS  Google Scholar 

  • Popert AJ, Meijers KAE, Sharp J, Bier F (1961) Chloroquine diphosphate in rheumatoid arthritis, a controlled trial. Ann Rheum Dis 20: 18–35

    PubMed  CAS  Google Scholar 

  • Populaire P, Terlain B, Pascal S, Decouvelare B, Renard A, Thomas J-P (1973) Comportement biologique, taux seriques, excretion et biotransformation de l’acid (benzol-3-phenyl)-propionique chez l’animal et chez l’homme. Ann Pharm Fr 31: 735–749

    PubMed  CAS  Google Scholar 

  • Pottier J, Berlin D, Raynaud JP (1977) Pharmacokinetics of the anti-inflammatory tiaprofenic acid in humans, mice, rats, rabbits and dogs. J Pharm Sci 66: 1030–1036

    PubMed  CAS  Google Scholar 

  • Powell RH, Ansell BM (1974) Benorylate in management of still’s disease. Br Med J 1: 145–147

    PubMed  CAS  Google Scholar 

  • Prescott LF (1969 a) Pharmacokinetic drug interactions. Lancet 2: 1239–1243

    Google Scholar 

  • Prescott LF (1969b) Renal papillary necrosis and aspirin. Scott Med J 14: 82–85

    PubMed  CAS  Google Scholar 

  • Priestley GC, Brown JC (1980) Effects of corticosteroids on proliferation of normal and abnormal human connective tissue cells. Br J Dermatol 102: 35–41

    PubMed  CAS  Google Scholar 

  • Proesmans W, Jaeken J, Eeckels R (1976) D-penicillamine-induced IgA-deficiency in Wilson’s disease. Lancet 2: 804–805

    PubMed  CAS  Google Scholar 

  • Prohaska E, Schwägerl W, Jesserer H (1965) Über das Verhalten des Rheumafaktors unter Penicillamin- und Penicillineinwirkung bei der primär chronischen Polyarthritis (Rheumatoid Arthritis). Klin Wochenschr 43: 141–144

    PubMed  CAS  Google Scholar 

  • Proquazone, a new non-steroidal, anti-inflammatory drug (1978). Scand J Rheumatol [Suppl] 21: 5–42

    Google Scholar 

  • Prost A, Boiteau HL, Gaillard F, Hamelin J-P, Carlier N, Rossel-Renac F (1978) Osteose fluorée secondaire à un traitement très prolongé par l’acide niflumique dans deux cas de poliarthrite rhumatoïde. Rev Rhum Mal Osteoartic 45: 707–716

    PubMed  CAS  Google Scholar 

  • Prost A, Boiteau HL, Rossel-Renac F, Audran M, Caumon J-P (1980) Variations des taux de fluor ionisé plasmatique et urinaire sous l’influence de faibles doses d’acide niflumique. Application éventuelle au traitement de l’ostéoporose. Rev Rhum Mal Osteoartic 47: 635–643

    PubMed  CAS  Google Scholar 

  • Prouse PJ, Gumpel JM, Ward RJ, Howard A (1981) Placebo controlled comparison of Auranofln (S.K. F. D-39162) with gold sodium thiomalate in rheumatoid arthritis. Abstract Symposium Auranofin in Rheumatoid Arthritis 15. Int Rheumatologie-Kongress Paris, 21.-27. 6. 1981, p 2

    Google Scholar 

  • Puhl W, Biel G, Kölbel R, Hofer H (1981) Ergebnisse einer multizentrischen Orgotein-Prüfungbei Gonarthrose. Eur J Rheumatol Inflamm 4: 264–270

    PubMed  CAS  Google Scholar 

  • Pulkkinen MO (1980) Releave of menstrual discomfort and dysmenorrhea and simultaneous suppression of uterine activity by Isoxepac. Acta Obstet Gynecol Scand 59: 367–370

    PubMed  CAS  Google Scholar 

  • Pulver R, Exer B, Herrmann B (1956) Über die Beeinflussung enzymatischer Reaktionen durch Phenylbutazon und die Übertragbarkeit ferment-chemischer Befunde auf die Stoffwechselprozesse der Zelle. Schweiz Med Wochenschr 86: 1080–1085

    PubMed  CAS  Google Scholar 

  • Pütter J (1974) Zur Biochemie des D-Penicillamins. In: Ott VR, Schmidt KL (Hrsg) Die Behandlung der rheumatoiden Arthritis mit D-Penicillamin. Der Rheumatismus. Steinkopff, Darmstadt, S 115–121

    Google Scholar 

  • Pütter J (1976) Übersicht über die Pharmakokinetik der Azetylsalizylsäure. Med Welt 27: 1362–1365

    PubMed  Google Scholar 

  • Raab W, Gmeiner B (1975) D-Penicillamine in dermatology: Influence on enzymatic activities of human skin in vitro. Arch Dermatol Res 254: 87–93

    PubMed  CAS  Google Scholar 

  • Raab W, Gmeiner B, Muckenhuber P (1978) D-Penicillamine and enzymatic activities. Enzyme 23: 84–88

    PubMed  CAS  Google Scholar 

  • Rainer F, Klein G (1980 a) Klinische Erfahrungen mit Glucametacin im Vergleich zu Ibuprofen bei degenerativen Gelenks- und Wirbelsäulenerkrankungen. Therapiewoche 30: 4753–4754

    Google Scholar 

  • Rainer F, Klein G (1980b) Untersuchungen über den Einfluß von Sulindac auf den Stoffwechsel von Diabetikern mit Glibenclamid. Akt Rheumatol 5: 307–309

    Google Scholar 

  • Rainer F, Ulreich A, Klein G (1979) Zur Frage der Interaktionen von nichtsteroidalen Antirheumatika mit Coumarinderivaten, oralen Antidiabetika und anderen Pharmaka. Therapiewoche 29: 6834–6839

    Google Scholar 

  • Rainsford KD (1979) Prostaglandins and the development of gastric mucosal damage by anti-inflammatory drugs. In: Rainsford KD, Ford-Hutchinson AW (Hrsg) Prostaglandins and inflammations. Birkhäuser, Basel Boston Stuttgart, Agents and Actions [Suppl 6], pp 193–210

    Google Scholar 

  • Rainsford KD, Brune K, Whitehouse MW (1977) Aspirin and related drugs: Their actions and uses. Agents and Actions [Suppl 1]. Birkhäuser, Basel Stuttgart, pp 7–118

    Google Scholar 

  • Rainsford KD, Ford-Hutchinson AW (1979) Prostaglandins and inflammations. Birkhäuser, Basel Boston Stuttgart, Agents and Actions. [Suppl 6], pp 5–227

    Google Scholar 

  • Rance MJ, Steed KP, Shillingford JS ( 1975 ) Report to Reckitt and Colman Pharmaceutical Division. zit. n. Goldberg and Godfrey (1980)

    Google Scholar 

  • Rau R (1977) Die Gamma-Glutamyltranspeptidase bei der chronischen Polyarthritis. Z Rheumatol 36: 49–59

    PubMed  CAS  Google Scholar 

  • Rau R (1977) Die nichtsteroidalen Antirheumatika in der Behandlung entzündlich-rheumatischer Erkrankungen. Therapiewoche 27: 2636–2644

    Google Scholar 

  • Rau R (1979) Interaction study of piroxicam with cardiac glycosides. In: Huskisson EC, Miehlke K (Hrsg) Piroxicam A new non-steroidal anti-inflammatory agent. Symposium, 4.9. 1979, IX. Europ Rheumatologie-Kongreß, Wiesbaden, p 5

    Google Scholar 

  • Rau R, Georgiopoulos G, Neumann P, Gross D (1980) Die Beeinflussung des Digoxinblutspiegels durch Antirheumatika. Akt Rheumatol 5: 349–358

    Google Scholar 

  • Rau R, Gross D, Werder E (1981) Die Wirksamkeit von Flurbiprofen bei der Behandlung der Coxarthrose. Eine Doppelblind-Crossover-Vergleichsstudie gegen Indometacin. Akt Rheumatol 6: 33–36

    Google Scholar 

  • Rautenstrauch H (1977) Kontrolle der D-Penicillamin-Therapie bei Patienten mit chronischer Po-lyarthritis durch die Urindiscelektrophorese. Z Rheumatol 36: 357–363

    Google Scholar 

  • Rave O, Albrecht HJ, Vorlaender K-0 (1977) Wirkungen und Nebenwirkungen von Levamisol. Munch Med Wochenschr 119: 1509–1510

    CAS  Google Scholar 

  • Rechenberg HK v (1953) Rheumatherapie mit Butazolidin. Klinische Erfahrungen mit 3,5-Dioxo-l,2- diphenyl-4-n-butyl-pyrazolidin-Natrium, einem neuen Pyrazolderivat. Schweiz Med Wochenschr 83: 159–164

    Google Scholar 

  • Rechenberg HK v (1961) Butazolidin (Phenylbutazon). Thieme, Stuttgart

    Google Scholar 

  • Reid G, Patterson AC (1977) Pure red-cell aplasia after gold treatment. Br Med J 2: 1457

    PubMed  CAS  Google Scholar 

  • Reidenberg MM, Lowenthal DT (1968) Adverse nondrug reactions. N Engl J Med 279: 678–679

    PubMed  CAS  Google Scholar 

  • Reizenstein P, Döberl A (1973) Relevance of gastrointestinal symptoms and bloodloss after long-term treatment with a salizylate-paracetamol ester, a new anti-inflammatory agent (Benorylate). Rheumatol Rehabil [Suppl] 12: 66–71

    Google Scholar 

  • Rejholec V (1974) Die Therapie rheumatischer Erkrankungen mit Nifluminsäure. Therapiewoche 24: 1815–1819

    Google Scholar 

  • Rejholec V (1975) Langzeittherapie der rheumatoiden Arthritis mit Perclusone. Z Rheumatol 34: 141–148

    CAS  Google Scholar 

  • Rejholec V, Krälovä M (1974) Langzeit-Behandlung der Koxarthrose mit Rumalon. Vergleichsstudie von 224 Patienten, Beobachtungszeit 8 Jahre. Z Rheumatol 33: 425–436

    PubMed  CAS  Google Scholar 

  • Rejholec V, Kralova M (1975) Long-term treatment of osteoarthrosis of the hip with rumalon. (Comparative study of 224 patients; Period of observation ten years.) 8. Europ. Rheumakongress Helsinki, pp 3–20

    Google Scholar 

  • Rejholec V, Vapaatalo H, Tokola O, Gothoni G (1979 a) A comparative double-blind study on Tolfenamic acid in the treatment of rheumatoid arthritis. Scand J Rheumatol [Suppl] 24: 13–16

    Google Scholar 

  • Rejholec V, Vapaatalo H, Tokola O, Gothoni G (1979 b) Tolfenamic acid in the treatment of rheumatoid arthritis. Scand J Rheumatol [Suppl] 24: 9–12

    Google Scholar 

  • Renier JC, Bregeon CH, Bonnette CH, Boasson M, Bernât M, Basle M, Besson J, Wellinger C, Bourgeois B, Teisseire N (1978) Le devenir de sujets atteints de polyarthrite rhumatoide et traités par les immunodépresseurs entre 1965 et 1973 inclus. Rev Rhum Mal Osteoartic 45: 453–461

    PubMed  CAS  Google Scholar 

  • Renoux G, Renoux M (1971) Effect immunostimulant de l’imidothiazole dans l’immunization des suris contre l’infection par brucella abortus. Comptes Rend Acad Science Paris 272: 349–350

    CAS  Google Scholar 

  • Research sub-committee of the empire rheumatism council (1960) Gold therapy in rheumatoid arthritis. Report of a multi-centre controlled trial. Ann Rheum Dis 19: 95–119

    Google Scholar 

  • Research sub-committee of the empire rheumatism council (1961) Relation of toxic reactions in gold therapy to improvement in rheumatoid arthritis. A report. Ann Rheum Dis 20: 335–340

    Google Scholar 

  • Revach M, Freed RL, Ehrlich GE (1979) Reversible proteinuria as a complication of oral goldtherapy. Arthritis Rheum 22: 1417–1418

    PubMed  CAS  Google Scholar 

  • Reynolds PMG, McLeod M, Dick WC (1979) ICI 55.897 (Clozic) in rheumatoid arthritis: a controlled comparison with gold. Abstract 9. Europ Rheumatol Kongress Wiesbaden, Abstr. Nr. 968

    Google Scholar 

  • Reynolds WJ, Shaar SF, Buik A, Lancee WJ (1979) Oxaprozin: A once-daily treatment regimen in rheumatoid arthritis. J Rheumatol 6: 345–350

    PubMed  CAS  Google Scholar 

  • Rheumatology workshop. A modern review of Geigy pyrazoles (1977). J Int Med Res [Suppl 2] 5: 2–120

    Google Scholar 

  • Rhymer AR (1979) Sulindac. Clin Rheum Dis 5: 553–568

    Google Scholar 

  • Rhymer AR, Gengos DC (1979) Indomethacin. Clin Rheum Dis 5: 541–552

    Google Scholar 

  • Richards AJ, Velvin DS, Whitmore DN, Williams EM (1976) Fatal aplastic anaemia and D-penicillamine. Lancet 1: 646–647

    PubMed  CAS  Google Scholar 

  • Richards IDG (1969) Congenital malformations and environmental influences in pregnancy. Br J Prev Soc Med 23: 218–225

    PubMed  CAS  Google Scholar 

  • Richter A (1964) Die Wirkung von Knorpel-Knochenmarks-Extrakten auf die Schwefelaufnahme des Hyalinknorpels. Z Rheumaforsch 23: 405–412

    PubMed  CAS  Google Scholar 

  • Ricken D, Schumacher K (1971) Medikamentöse Immunsuppression, 1. Arbeitstagung Bad Tölz, Thieme, Stuttgart

    Google Scholar 

  • Ridolfo AS, Nickander R, Mikulaschek WM (1979) Fenoprofen and Benoxaprofen. Clin Rheum Dis 5: 393–410

    Google Scholar 

  • Ridolfo AS, Simpson PJ, Cerimele BJ (1978) Comparison of once-daily with twice-daily dosage of benoxaprofen in arthritic patients. Clin Pharmacol Ther 23: 127 (Abstr.)

    Google Scholar 

  • Riedel R (1981) Pharmakologische Eigenschaften von Lonazolac-Ca einer neuen antiphlogistisch und antirheumatisch wirksamen Substanz. Arzneim Forsch/Drug Res 4: 655–665

    Google Scholar 

  • Riedel R, Schoetensack W (1973) Zur Pharmakologie von Butyl-malonsäure-mono-(l,2-diphenylhydrazid)-Calcium (Bumadizon-Calcium). Arzneim Forsch/Drug Res 23: 1215–1225

    CAS  Google Scholar 

  • Riess W, Stierlin H, Faigle JW, Geiger UP, Gérardin A, Schmid K, Sulc M, Wagner J, Theobald W (1976) Kinetik und Biotransformation von Diclofenac in Tier und Mensch. Therapiewoche 26: 2891–2907

    CAS  Google Scholar 

  • Riess W, Stierlin H, Degen P, Faigle JW, Gérardin A, Moppert J, Sallmann A, Schmid K, Schweizer A, Sulc M, Theobald W, Wagner J (1978) Pharmacokinetics and metabolism of the anti-inflammatory agent Voltaren. Scand J Rheumatol [Suppl] 22: 17–29

    CAS  Google Scholar 

  • Rinehart JJ, Sagone AL, Balcerzak SP, Ackerman GA, LoBuglio AF (1975) Effects of corticosteroid therapy on human monocyte function. N Engl J Med 292: 236–241

    PubMed  CAS  Google Scholar 

  • Roath S, Tobin MS (1965) Studies on the inhibition of lymphocyte transformation by Penicillamine. Clin Res 13: 542 (Abstr)

    Google Scholar 

  • Robecchi A, Cartesegna F, Daneo V (1954) Quelques considerations sur 69 cas de polyarthrite chronique évolutive traités par le chlorhydrate de méthyl-bis-beta-chloro-éthyl-amine. Rev Rhum 21: 823–828

    PubMed  CAS  Google Scholar 

  • Robertson A (1973) Benorylate-the rationale. Rheumatol Rehabil [Suppl] 12: 7–16

    Google Scholar 

  • Robertson CE, Ford MJ, Someren V van, Dlugolecka M, Prescott LF (1980) Mefenamic acid nephropathy. Lancet 2: 232–233

    PubMed  CAS  Google Scholar 

  • Robinson RG (1978) Wirkungen und Nebenwirkungen — Medikamentös bedingt oder nicht? Huber, Bern Stuttgart Wien

    Google Scholar 

  • Rocker I, Henderson WJ (1976) Transfer of gold from mother to fetus. Lancet 2: 1246

    PubMed  CAS  Google Scholar 

  • Rodnan GP, Benedek TG (1970) The early history of antirheumatic drugs. Arthritis Rheum 13: 145–165

    PubMed  CAS  Google Scholar 

  • Rojo JM, Barasoain I, Portoles A (1981) Further studies on the immunosuppressive effects of Indomethacin. Int J Clin Pharmacol Biopharm 19: 220–222

    CAS  Google Scholar 

  • Roncucci R, Simon MJ, Lambelin G, Saquet M, Gillet C, Cauwenberge H van, Lefebvre P, Daubresse J-C, Buu-Hoi NP (1971) Kinetic studies on the absorption and excretion of 4-Allyloxy-3-chloro- phenyl-aceticacid (alclofenac) in man. Eur J Clin Pharmacol 3: 176–181

    Google Scholar 

  • Roncucci R, Lambelin G (1977) Relevance of pharmacokinetic studies for the evaluation of antiinflammatory drugs: The example of alclofenac. In: Bertelli A (Hrsg) New anti-inflammatory and antirheumatic drugs. Prous-Publisher, Barcelona, p 9

    Google Scholar 

  • Rooney PJ, McLeod M, Grennan DM, Dick WC (1976) Feprazone (DA 2370): long-term experience in the management of rheumatoid arthritis complicated by severe dyspepsia. Curr Med Res Opin 3: 642–646

    Google Scholar 

  • Rosenthal M (1978) A critical review of the effect of levamisole in rheumatic disease other than rheumatoid arthritis. J Rheumatol [Suppl 4] 5: 97–100

    Google Scholar 

  • Rosenthal M (1979) Retinoid in der Behandlung von Psoriasisarthritis. Eine Pilot-Studie. Schweiz Med Wochenschr 109: 1912–1914

    PubMed  CAS  Google Scholar 

  • Rosenthal RK, Bayles TB, Fremont-Smith K (1964) Simultaneous salicylate concentrations in synovial fluid and plasma in rheumatoid arthritis. Arthritis Rheum 7: 103–109

    PubMed  CAS  Google Scholar 

  • Rosenthal M, Trabert U, Müller W (1976) Leukozytotoxic effect of levamisole. Lancet 1: 369

    PubMed  CAS  Google Scholar 

  • Rosenthal M, Breysse Y, Dixon ASTJ, Franchimont P, Huskisson EC, Schmidt KL, Schuermans Y, Veyes E, Vischer TL, Janssen PAJ, Amery WK, Brugmans J, Crepe J de, Symoens J, Magnair AL (1977) Levamisole and agranulozytosis. Lancet 1: 904–905

    PubMed  CAS  Google Scholar 

  • Rosenthal M, Plattner S (1981) The treatment of rheumatoid arthritis with OM-8930, a bacterial immunostimulating agent. Z Rheumatol 40: 228–231

    PubMed  CAS  Google Scholar 

  • Rosenthale ME, Begany AJ, Malis J, Grant NH (1969) Antiinflammatory activity of B-(4,5-Dipheny-loxazole-2-yl)propionic acid. (WY-21743) Fed Proc 28: 357 (Abstr)

    Google Scholar 

  • Rosenthale ME, Begany AJ, Dervinis A, Malis JL, Shriver DA, Datko LJ, Gluckman MJ (1974) Anti-inflammatory properties of 4,5-Diphenyl-2-oxazolepropionic acid (Oxaprozin). Agents Actions 4: 151–159

    PubMed  CAS  Google Scholar 

  • Ross WCJ (1958) In vitro reactions of biological alkylating agents. Ann NY Acad Sci 68: 669–681

    PubMed  CAS  Google Scholar 

  • Roth H, Goebel KM (1981) Pirprofen und Indometacin bei chronischer Polyarthritis — eine randomisierte Doppelblindstudie mit Placebo-Kontrolle. In: Korst JK van der (Hrsg) Ein neues antirheumatisch-analgetisches Medikament: Pirprofen (Rengasil®). Huber, Bern Stuttgart Wien, S 77–84

    Google Scholar 

  • Roth H, Levasseur YJ, Ryan R (1981) Eine kontrollierte multizentrische Studie über die Langzeitbehandlung der chronischen Polyarthritis mit Pirprofen oder Azetylsalizylsäure. In: Korst JK van der (Hrsg) Ein neues antirheumatisch-analgetisches Medikament: Pirprofen (Rengasil®). Huber, Bern Stuttgart Wien, S 61–69

    Google Scholar 

  • Rothermich NO (1979) Chrysotherapy in rheumatoid arthritis. Clin Rheum Dis 5: 631–640

    Google Scholar 

  • Rothermich NO, Thomas MH, Phillips VK, Bergen W (1981) Clinical trial of penicillamine in rheumatoid arthritis. Arthritis Rheum 24: 1473–1478

    PubMed  CAS  Google Scholar 

  • Rothfield NF (1969) General consideration in the treatment of systemic lupus erythematosus. Mayo Clin Proc 44: 691–696

    CAS  Google Scholar 

  • Rotstein J, Gilbert M, Cunningham C, Estrin I, Pincus G (1962) A study of the effect of enovid in the treatment of a selected group of patients with rheumatoid arthritis. Arthritis Rheum 5: 655–656

    Google Scholar 

  • Rowland M, Riegelman S, Harris PA, Sholkoff SD (1972) Absorption kinetics of Aspirin in men following oral administration of an aqueous solution. J Pharm Sci 61: 379–385

    PubMed  CAS  Google Scholar 

  • Rowland M, Riegelman S, Harris PA, Shokoloff SD, Eyring EJ (1967) Kinetics of acetylsalicylic acid disposition in men. Nature 215: 413–414

    PubMed  CAS  Google Scholar 

  • Royer GL, Moxley TE, Hearron MS, Miyara A, Shenker BM (1975 a) A long term double-blind clinical trial of ibuprofen and indomethacin in rheumatoid arthritis. J Int Med Res 3: 158–171

    Google Scholar 

  • Royer GL, Moxley TE, Hearron MS, Miyara A, Donovan JF (1975 b) A six-month double-blind trial of ibuprofen and indomethacin in osteoarthritis. Curr Ther Res 17: 234–248

    Google Scholar 

  • Rubin A, Warrick P, Wolen RL, Chernish SM, Ridolfo AS, Gruber CM (1973) Physiological disposition of Fenoprofen in men: III. Metabolism and Protein binding of Fenoprofen. J Pharm Exp Ther 183: 447–457

    Google Scholar 

  • Rubin A, Chernish SM, Crabtree R, Gruber CM jr, Helleberg L, Rodda BE, Warrick P, Wolen RL, Ridolfo AS (1974) A profile of the physiological disposition and gastro-intestinal effects of Fenoprofen in men. Curr Med Res Opin 2: 529–543

    PubMed  CAS  Google Scholar 

  • Rubin A, Rodda BE, Warrick P, Ridolfo AS, Gruber CM (1972) Physiological disposition of Fenoprofen in men II: Plasma and urin pharmacokinetics after oral and intravenous administration. J Pharm Sci 61: 739–745

    PubMed  CAS  Google Scholar 

  • Rubin HS (1964) Serum salicylate levels in osteoarthritis following oral administration of a preparation containing salicylsalicylic acid and acetylsalicylic acid. Am J Med Sci 248: 31–36

    PubMed  CAS  Google Scholar 

  • Ruiz-Torres A (1968) Wirkung der chronischen Penicillaminverabfolgung auf das Kollagen. Verh Dtsch Ges Inn Med 74: 597–600

    PubMed  CAS  Google Scholar 

  • Ruiz-Torres A (1974) Zur Pharmakokinetik und zum Stoffwechsel von D-L-Penicillamin. Arzneim Forsch/Drug Res 24: 914–917

    CAS  Google Scholar 

  • Runkel RA, Mroszczak E, Chaplin M, Sevelius H, Segre EJ (1978) Naproxen-probenecid interactions in men. Clin Pharmacol Ther 24: 706–713

    PubMed  CAS  Google Scholar 

  • Ruotsi A, Skrifvars B (1978) A long-term double-blind comparative study of proquazone (Biarison®) and Ibuprofen in rheumatoid arthritis. Scand J Rheumatol [Suppl] 21: 28–32

    Google Scholar 

  • Ruotsi A, Oka N, Rekonen A (1972) Tolfenamic acid in rheumatoid arthritis. Abstr X IV. Nordiska Rheumatolog Kongressen, Rönneby, Schweden

    Google Scholar 

  • Rüst O, Biland L, Thilo D, Nyman D, Duckert F (1975) Prüfung des Antirheumatikums Tolmetin auf Interaktionen mit oralen Antikoagulantien. Schweiz Med Wochenschr 105: 752–753

    PubMed  Google Scholar 

  • Russell AS, Saetre R, Davis P, Rabenstein DL (1979) A rapid, sensitive technique to assay penicillamine level in blood and urine. J Rheumatol 6: 15–19

    PubMed  CAS  Google Scholar 

  • Ruuskanen O, Remes M, Mäkelä AL, Isomäki H, Toivanen A (1976) Levamisole and agranulocytosis. Lancet 2: 958–959

    PubMed  CAS  Google Scholar 

  • Ryan JR, Jain AK, McMahon FG, Vargas R (1977) On the question of an interaction between Sulindac and Tolbutamide in the control of diabetes. Clin Pharmacol Ther 21: 231–233

    PubMed  CAS  Google Scholar 

  • Rylance HJ, Chalmers TM, Elton RA (1980) Clinical trial of intraarticular aspirin in rheumatoid arthritis. Lancet 2: 1099–1102

    PubMed  CAS  Google Scholar 

  • Rynes RI, Krohel G, Falbo A, Reinecke RD, Wolfe B, Bartholomew LE (1979) Ophthalmologic safety of long-term hydroxichloroquine treatment. Arthritis Rheum 24: 832–836

    Google Scholar 

  • Ruzicka T, Goerz G (1981) Dapsone in the treatment of lupus erythematosus. Br J Dermatol 104: 53–56

    PubMed  CAS  Google Scholar 

  • Saarni H, Tammi M, Fuorio E, Penttinen R (1980) Distribution of glycosaminoglycans in rheumatoid cultures and effects of Cortisol on it. Scand J Rheumatol 9: 11–16

    PubMed  CAS  Google Scholar 

  • Sairanen E, Vähätalo S (1973) Intestinal resorption of gold salts used for treatment of rheumatoid arthritis. Scand J Rheumatol 2: 61–64

    PubMed  CAS  Google Scholar 

  • Sams WM (1967) Chloroquine: Mechanism of action. Mayo Clin Proc 42: 300–309

    PubMed  Google Scholar 

  • Sanz MA, Martinez JA, Gomis F, Garcia-Borras JJ (1980) Sulindac-induced bone marrow toxicity. Lancet 2: 802–803

    PubMed  CAS  Google Scholar 

  • Savage O, Copeman WSC, Chapman L, Wells MV, Treadwell BLJ (1962) Pituitary and adrenal hormones in rheumatoid arthritis. Lancet 1: 232–235

    PubMed  CAS  Google Scholar 

  • Schaeffer N, Shaw CF, Thompson HO, Satre RW (1980) In vitro penicillamine competition for protein-bound gold (I). Arthritis Rheum 23: 165–171

    PubMed  CAS  Google Scholar 

  • Schäfer MP, Chirigos MA, Papas TS (1974) Inhibition of Rauscher leukemia virus and avian myeloblastosis virus DNA polymerases by Tilorone (NSC-143969) and its analogues. Cancer Chemother Rep 58: 821–827

    PubMed  Google Scholar 

  • Schattenkirchner M (1977) Die Goldbehandlung der chronischen Polyarthritis. Pharmakokinetische und klinische Untersuchungen. Compendia Rheumatologica 3, EULAR, Basel

    Google Scholar 

  • Schattenkirchner M (1981) Kombination von Basistherapeutika. Diskussionsbeitrag zur Arbeit von H. Mathies. EULAR Bull 10: 6

    Google Scholar 

  • Schattenkirchner M, Kaik B, Müller-Fassbender H, Rau R, Zeidler H (1982) Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis — a double-blind, comparative, multicenter study. J Rheumatol [Suppl 8] 9: 184–189

    Google Scholar 

  • Schatz F, Adrian RW, Mixich G, Molnarova M, Reller J, Jahn U (1970) Pharmakokinetische Untersuchungen mit dem Antiphlogistikum Azapropazon (Prolixan® 300) am Menschen. Therapiewoche 20: 2327–2333

    CAS  Google Scholar 

  • Scheinberg IH (1981) Copper penicillaminate for rheumatoid arthritis? J Rheumatol [Suppl 7] 8: 178–179

    Google Scholar 

  • Scheinberg IH, Sternlieb I (1975) Pregnancy in penicillamine-treated patients with Wilsons-disease. N Engl J Med 293: 1300–1303

    PubMed  CAS  Google Scholar 

  • Schenk H, Klein G, Haralambus I, Goebel R (1980) Coumarintherapie unter dem Antirheumaticum Sulindac. Z Rheumatol 39: 102–108

    PubMed  CAS  Google Scholar 

  • Schenker S, Olson KN, Dunn D, Breen KJ, Combes B (1973) Intrahepatic cholestasis due to therapy of rheumatoid arthritis. Gastroenterology 64: 622–629

    PubMed  CAS  Google Scholar 

  • Scherak O, Hiesberger H, Kolarz G (1978) Das Auftreten antinukleärer Faktoren bei der chronischen Polyarthritis und D-Penicillamin. Wien Klin Wochenschr 90: 95–96

    PubMed  CAS  Google Scholar 

  • Scherak O, Smolen J, Kolarz G, Kojer M, Menzel J (1979) Erste klinische Erfahrungen mit Levamisol bei der Behandlung von Patienten mit systemischem Lupus erythematodes. Wien Klin Wochenschr 91: 758–762

    PubMed  CAS  Google Scholar 

  • Scherbel AL, Schuchter SL, Harrison JWV (1957) Chemotherapy in rheumatoid arthritis: concept. Cleveland Clin Quart 24: 105–115

    PubMed  CAS  Google Scholar 

  • Scherbel AL, Mackenzie AH, Nousek JE, Atdjion M (1965) Ocular lesions in rheumatoid arthritis and related disorders with particular reference to retinopathy. A study of 741 patients treated with and without chloroquine drugs. N Engl J Med 273: 360–366

    PubMed  CAS  Google Scholar 

  • Schiavetti L, Tuzi T, Galeazzi M (1977) Trattamento a lungo termine dell’artrosi con “arumalon”. Minerva Med (Roma) 68: 1263–1267

    CAS  Google Scholar 

  • Schlumpf U, Bussmann HU, Jerusalem F (1981) Myositis bei chronischer Polyarthritis unter D- Penicillamin, medikamentös induziert? Schweiz Med Wochenschr 111: 29–35

    PubMed  CAS  Google Scholar 

  • Schmähl D, Osswald H (1970) Experimentelle Untersuchungen über carcinogene Wirkungen von Krebs-Chemotherapeutika und Immunsuppressiva. Arzneim Forsch/Drug Res 20: 1461–1467

    Google Scholar 

  • Schmidt KL, Müller-Eckhardt C (1977) Agranulozytosis, levamisole and HLA-B27. Lancet 2: 85

    PubMed  CAS  Google Scholar 

  • Schmidt KL, Müller-Eckhardt C, Breithaupt H (1978) HLA-B27, antinuclear antibodies and drug- induced agranulozytosis. Klin Wochenschr 56: 1189–1191

    PubMed  CAS  Google Scholar 

  • Schneck SA, Penn I (1971) De-novo brain tumours in renal-transplant recipients. Lancet 1: 983–986

    PubMed  CAS  Google Scholar 

  • Schneider W (1978) Tödlich verlaufene Panmyelopathie nach D-Penicillamin-Therapie. Therapiewoche 28: 3538–3544

    Google Scholar 

  • Schölzel E, Largiader F, Uhlschmid G, Binswanger U, Corrodi P, Knoblauch M (1978) Pankreatitis nach Nierentransplantation. Schweiz Med Wochenschr 108: 161–165

    PubMed  Google Scholar 

  • Schönhöfer PS (1979) Interaktionen antirheumatisch wirksamer Substanzen. Internist 20: 433–438

    PubMed  Google Scholar 

  • Schönhöfer P (1981) Wirkungsweise der Antirheumatika aus der Sicht des klinischen Pharmakologen. Therapiewoche 31: 2099–2111

    Google Scholar 

  • Schorn D, Francis MJO, Loudon M, Mowat AG (1979) Skin collagen biosynthesis in patients with rheumatoid arthritis treated with D-Penicillamin. Scand J Rheum 8: 124–128

    PubMed  CAS  Google Scholar 

  • Schorn D, Mowat AG (1977) Penicillamine in rheumatoid arthritis: wound healing, skin thickness and osteoporosis. Rheumatol Rehabil 16: 223–230

    PubMed  CAS  Google Scholar 

  • Schuermans Y (1975) Levamisole in rheumatoid arthritis. Lancet 1: 111

    PubMed  CAS  Google Scholar 

  • Schultz DR, Volanakis JE, Arnold PI, Gottlieb NL, Sakai K, Stroud RM (1974) Inactivation of CI in rheumatoid synovial fluid, purified CI- and CI-esterase by gold compounds. Clin Exp Immunol 17: 395–406

    PubMed  CAS  Google Scholar 

  • Schumacher K (1975) Grundlagen der Immunsuppressiven Wirkung von D-Penicillamin. Internist 16: 460–465

    PubMed  CAS  Google Scholar 

  • Schumacher K (1977) Einfluß von D-Penicillamin auf die humorale und zelluläre Immunantwort in vivo und in vitro. In: Kreysel H-W (Hrsg) D-Penicillamin. Chemie, Pharmakologie, therapeutische Anwendung und unerwünschte Wirkungen. Schattauer, Stuttgart New York, S 83–102

    Google Scholar 

  • Schumacher K, Maerker-Alzer G, Preuss R (1975) Effect of D-penicillamine on lymphocyte function. Arzneim Forsch/Drug Res 25: 603–606

    CAS  Google Scholar 

  • Schümm F, Wiethölter H, Fateh-Moghadam A (1981) Myasthenie Syndrom unter Chloroquin-Therapie. Dtsch Med Wochenschr 106: 1745–1747

    PubMed  Google Scholar 

  • Schutz G, Killewich L, Chen G, Feigelson P (1975) Controle of the mRNA for hepatic tryptophan oxygenase during hormonal and substrate induction. Proc Natl Acad Sci USA 72: 1017–1020

    PubMed  CAS  Google Scholar 

  • Schwartz HA (1981) Lower gastrointestinal side effects of nonsteroidal anti-inflammatory drugs. J Rheumatol 8: 952–954

    PubMed  CAS  Google Scholar 

  • Schwartz R, Stack J, Dameshek W (1958) Effect of 6-Mercaptopurine on antibody production. Proc Soc Exp Biol Med 99: 164–167

    PubMed  CAS  Google Scholar 

  • Schwarzmeier JD (1980) Akute Leukämie des Erwachsenen. Oesterr Aerzteztg 35: 741–747

    Google Scholar 

  • Scott J, Huskisson EC (1981) Comparative study of Auranofin in Rheumatoid Arthritis. Abstract Symposium “Auranofin in Rheumatoid Arthritis” 15. Int Rheumatologie Kongress Paris, 21.-27. 6. 1981, p 2

    Google Scholar 

  • Seaman WE, Plötz PH Ishak KG (1974) Aspirin-induced hepatotoxicity in patients with RA or systemic lupus erythematosus (SLE). Arthritis Rheum 17: 325 (Abstr)

    Google Scholar 

  • Segal AW, Pugh SF, Levi AJ, Loewi G (1977) Levamisole induced arthritis in Crohn’s disease. Br Med J 2: 555

    PubMed  CAS  Google Scholar 

  • Segre EJ (1979 a) Naproxen. Clin Rheum Dis 5: 411–426

    Google Scholar 

  • Segre EJ (1979 b) Drug interactions with Naproxen. Eur J Rheumatol Inflamm 2: 12–18

    Google Scholar 

  • Segre EJ, Chaplin M, Forchielli E, Runkel R, Sevelius H (1974 a) Naproxen-Aspirin Interactions in men. Clin Pharmacol Ther 15: 374–379

    Google Scholar 

  • Segre EJ, Sevelius H, Varady J (1974b) Effect of antacids on Naproxen absorption. N Engl J Med 291: 582–583

    PubMed  CAS  Google Scholar 

  • Seibold JR, Lynch CJ, Medsger TA jr (1981) Cholestasis associated with D-pencillamine therapy: Case report and review of the literature. Arthritis Rheum 24: 554–556

    PubMed  CAS  Google Scholar 

  • Seidenfeld AM, Smythe HA, Ogryzlo MA, Urowitz MB, Dotten DA (1976) Acute leukemia in rheumatoid arthritis treated with cytotoxic agents. J Rheumatol 3: 295–304

    PubMed  CAS  Google Scholar 

  • Seitz D, Hopf HCh, Janzen RWC, Meyer W (1976) Penicillamin-induzierte Myasthenie bei chronischer Polyarthritis. Dtsch Med Wochenschr 101: 1153–1158

    PubMed  CAS  Google Scholar 

  • Seiander S, Cramer K (1965) Agranulocytosis after Penicillamine and Antazoline. Br Med J 2: 171

    Google Scholar 

  • Sellers EM, Koch-Weser J (1970) Displacement of Warfarin from human albumin by Diazoxide and Ethacrynic, Mefenamic, and Nalidixic acids. Clin Pharmacol Ther 11: 524–529

    PubMed  CAS  Google Scholar 

  • Sennello LT, Sonders RC, Friedman N (1978) Effect of food on kinetics of the nonsteroidal antiinflammative, alclofenac. Clin Pharmacol Ther 23: 414–420

    PubMed  CAS  Google Scholar 

  • Serre H, Morlock G, Sany J, Dubois A, Nalet B (1975) Syndrome du Guillain Barré après chrysotherapie. Rhumatologie (Aix-les-Bains) 27: 367–372

    Google Scholar 

  • Shah GM, Muhalwas KK, Winer RL (1981) Renal papillary necrosis due to Ibuprofen. Arthritis Rheum 24: 1208–1210

    PubMed  CAS  Google Scholar 

  • Shapiro S, Siskind V, Monson RR, Heinonen OP, Kaufman DW, Slone D (1976) Perinatal mortality and birth weight in relation to Aspirin taken during pregnancy. Lancet 1: 1375–1376

    PubMed  CAS  Google Scholar 

  • Shearer RV, Dubois EL (1967) Ocular changes induced by longterm hydroxichloroquine (Plaquenil) therapy. Am J Ophthalmol 64: 245–252

    PubMed  CAS  Google Scholar 

  • Sheldrake FE (1977) Research Department Report. The Boots Comp Ltd

    Google Scholar 

  • Shen TY (1977) The expanding vistas of nonacidic antiarthritis agents. Drugs Exptl Clin Res 2: 1–8

    CAS  Google Scholar 

  • Shen TY (1979) Prostaglandinsynthetase inhibitors I. In: Vane JR, Ferreira SH (eds) Anti-inflammatory drugs. Handbuch exp Pharma 50/2. Springer, Berlin Heidelberg New York, pp 305–347

    Google Scholar 

  • Shiokawa Y, Horiuchi Y, Honma M, Kageyama T, Okada T, Azuma T (1977) Clinical evaluation of d-Penicillamine by multicentric double-blind comparative study in chronic rheumatoid arthritis. Arthritis Rheum 20: 1464–1472

    PubMed  CAS  Google Scholar 

  • Short CL, Beckman WW, Bauer W (1946) Goldtherapy in rheumatoid arthritis. N Engl J Med 235: 362–368

    PubMed  CAS  Google Scholar 

  • Shulman J (1952) Butazolidine. Lancet 263: 293

    Google Scholar 

  • Sieber SM, Adamson RH (1975) Toxicity of antineoplastic agents in men: Chromosomal abberations, antifertility effects, congenital malformations, and carcinogenic potential. Adv Cancer Res 22: 57–155

    PubMed  CAS  Google Scholar 

  • Siegmeth W (1971) Unerwünschte Auswirkungen von Phenylbutazon auf das hämatopoetische

    Google Scholar 

  • Gefäß-, Blutungs- und Gerinnungssystem. Wien Med Wochenschr 121: 784–790

    Google Scholar 

  • Siegmeth W (1975) Komplikationen unter Chloroquintherapie. Acta Med Austriaca 2: 116–121

    PubMed  CAS  Google Scholar 

  • Siegmeth W, Placheta P (1976) Doppelblindstudie: Ketoprofen gegen Phenylbutazon bei akuter

    Google Scholar 

  • Gichtarthritis. Wien Klin Wochenschr 88: 535–537

    Google Scholar 

  • Siegmund H (1976) Intrahepatische Cholestase nach einer Behandlung mit D-Penicillamin und Indometacin. Med Welt 27: 172–173

    PubMed  CAS  Google Scholar 

  • Sigler JW, Bluhm GB, Duncan H, Sharp JT, Ensign DC, McCrum WR (1974) Goldsalts in the treatment of rheumatoid arthritis. A double blind study. Ann Intern Med 80: 21–26

    PubMed  CAS  Google Scholar 

  • Silbermann M, Maor G (1978) Mechanisms of glucocorticoid induced growth retardation: Impairment of cartilage mineralization. Acta Anat 101: 140–149

    PubMed  CAS  Google Scholar 

  • Silverberg DS, Kidd EG, Shnitk TK, Ulan RA (1970) Goldnephropathy. A clinical and pathologic study. Arthritis Rheum 13: 812–825

    PubMed  CAS  Google Scholar 

  • Simchowitz L, Mehta J, Spilberg I (1979) Chemotactic factor-induced generation of superoxide radicals by human neutrophils. Effect of metabolic inhibitors and anti-inflammatory drugs. Arthritis Rheum 22: 755–763

    PubMed  CAS  Google Scholar 

  • Simkin PA (1976) Oral zinc sulphate in rheumatoid arthritis. Lancet 2: 539–542

    PubMed  CAS  Google Scholar 

  • Singleton PT Jr (1980) Salsalate: Its role in the management of rheumatic disease. Clin Ther 3: 80–102

    PubMed  CAS  Google Scholar 

  • Sioufi A, Colussi D, Caudal F, Schoeller JP, Massias P (1980) Pharmacokinetics of Phenylbutazone in healthy subjects after oral administration of single and multiple doses. J Pharm Sci 69: 1413–1416

    PubMed  CAS  Google Scholar 

  • Skidmore IF, Whitehouse MW (1966) Inhibition of Histamine formation catalysed by substrate specific mammalian Histidine Decarboxylases. Drug antagonism of aldehyde binding to Protein amino groups. Biochem Pharmacol 15: 1965–1983

    PubMed  CAS  Google Scholar 

  • Skrifvars B (1979) Hypothesis for the pathogenesis of sodium aurothiomalate (Myocrisin®) induced immune complex nephritis. Scand J Rheumatol 8: 113–118

    PubMed  CAS  Google Scholar 

  • Skrifvars B, Nissilä M (1980) Immunological effects of Biarison in the treatment of rheumatoid arthritis and systemic lupus erythematosus. A preliminary report. Scand J Rheumatol 9: 33–38

    PubMed  CAS  Google Scholar 

  • Slattery JT, Levy G, Jain A, McMahon FG (1979) Effect of Naproxen on the kinetics of elimination and anticoagulant activity of a single dose of warfarin. Clin Pharmacol Ther 25: 51–60

    PubMed  CAS  Google Scholar 

  • Sloboda AE, Osterberg AC (1976) The pharmacology of Fenbufen 3-(4-Biphenylcarbonyl)-propionic acid and 4-Biphenylacetic acid, interesting anti-inilammatory-analgesic agent. Inflammation 1: 415–438

    CAS  Google Scholar 

  • Sloboda AE, Tolman EL, Osterberg AC, Panagides J (1980) Pharmakologische Eigenschaften von Fenbufen. Eine Übersicht. Arzneim Forsch 30: 716–721

    CAS  Google Scholar 

  • Slocumb CH (1952) Relative cortisone deficiency simulating exacerbation of arthritis. Bull Rheum Dis 3: 39–40

    Google Scholar 

  • Slocumb CH, Polley HF, Ward LE (1957) Diagnosis, Treatment and Prevention of Hypercortisonism in patients with rheumatoid arthritis. Proc Mayo Clin 32: 227–238

    CAS  Google Scholar 

  • Slone D, Siskind V, Heinonen OP, Lonson RR, Kaufman DW, Shapiro S (1976) Aspirin and congenital malformation. Lancet 1: 1373–1375

    PubMed  CAS  Google Scholar 

  • Sloth K, Thomsen AC (1971) Acute renal insufficiency during treatment with azathioprine. Acta Med Scand 189: 145–148

    PubMed  CAS  Google Scholar 

  • Smith RB (1977) Analysis of the side-effect patterns presenting during the course of a continuing longterm open study of Fenclofenac. Proc R Soc Med [Suppl 6] 70: 46–48

    Google Scholar 

  • Smith W, Ball GV (1980) Lung injury due to gold treatment. Arthritis Rheum 23: 351–354

    PubMed  CAS  Google Scholar 

  • Smith RJ, Iden SS (1980) Pharmacological modulation of chemotactic factor-elicited release of granule-associated enzymes from human neutrophils. Effects of prostaglandins, nonsteroid antiinflammatory agents and corticosteroids. Biochem Pharmacol 29: 2389–2395

    PubMed  CAS  Google Scholar 

  • Smith B, O’Grady F (1966) Experimental chloroquine myopathy. J Neurol Neurosurg Psychiatry 29: 255–258

    PubMed  CAS  Google Scholar 

  • Smith JB, Willis AL (1971) Aspirin selectively inhibits prostaglandin production in human platelets. Nature (New Biol) 231: 235–237

    CAS  Google Scholar 

  • Smith RT, Peak WP, Kron KM, Hermann IF, DelToro RA (1958) Increasing the effectiveness of gold therapy in rheumatoid arthritis. JAMA 167: 1197–1204

    CAS  Google Scholar 

  • Smith MJH, Ford-Hutchinson AW, Elliott PNC (1975 a) Prostaglandins and the anti-inflammatory activities of aspirin and sodium salicylate. J Pharm Pharmacol 27: 473–478

    Google Scholar 

  • Smith MJH, Hoth M, Davis K (1975b) Aspirin and lymphocyte transformation. Ann Intern Med 83: 509–511

    PubMed  CAS  Google Scholar 

  • Smith GL, Goulbourn RA, Burt RAP, Chatfield DH (1977) Preliminary studies of absorption and excretion of benoxaprofen in men. Br J Clin Pharmacol 4: 585–590

    PubMed  CAS  Google Scholar 

  • Smith PR, Brown GMM, Meyers OL (1982) Open comparative study of auranofm vs. gold sodium thiomalate. J Rheumatol [Suppl. 8] 9: 190–196

    Google Scholar 

  • Smyth CJ, Bravo JF (1975) Antirheumatic drugs: Clinical, pharmacological and therapeutic aspects. Drugs 10: 394–425

    PubMed  CAS  Google Scholar 

  • Sodomann C-P, Gropp C (1979) Wie groß ist die Malignomgefahr durch Immunosuppresiva? Internist 20: 571–584

    PubMed  CAS  Google Scholar 

  • Sondervorst M (1979) Azapropazone. Clin Rheum Dis 5: 465–480

    Google Scholar 

  • Soren A (1978) Cinetique de salicyles du sang vers le liquide articulaire. Rev Rhum Mal Osteoartic 45: 165–169

    PubMed  CAS  Google Scholar 

  • Sparrow GP (1978) Penicillamine Pemphigus and the nephrotic syndrome occurring simultaneously. Br J Dermatol 98: 103–105

    PubMed  CAS  Google Scholar 

  • Special Symposium on Indoprofen (1981). Eur J Rheumatol Inflamm 4: 1–150

    Google Scholar 

  • Spector WG, Willoughby DA (1968) The pharmacology of inflammation. Grüne and Straton, New York

    Google Scholar 

  • Speer F (1975) Aspirinallergy: A clinical study. South Med J 68: 314–318

    PubMed  CAS  Google Scholar 

  • Spooner JB (1973) Side effects encountered with Benorylate. Rheumatol Rehabil [Suppl] 12: 75–80

    Google Scholar 

  • Spühler O, Zollinger HU (1953) Die chronisch-interstitielle Nephritis. Z Klin Med 151: 1–50

    PubMed  Google Scholar 

  • Srinivasan R, Miller BL, Paulus HE (1979) Long-term chrysotherapy in rheumatoid arthritis. Arthritis Rheum 22: 105–110

    PubMed  CAS  Google Scholar 

  • Stafanger G, Larsen HW, Hansen H, Sorensen K (1981) Pharmacokinetics of Ketoprofen in patients with chronic renal failure. Scand J Rheumatol 10: 189–192

    PubMed  CAS  Google Scholar 

  • Stafford BT, Crosby WH (1978) Late onset of gold-induced Thrombocytopenia. With a practical note on the injections of dimercaprol. JAMA 239: 50–51

    PubMed  CAS  Google Scholar 

  • Stambaugh JE, Gordon RL, Geller R (1980) Leukopenia and thrombocytopenia secondary to Clinoril therapy. Lancet 2: 594

    PubMed  Google Scholar 

  • Stancikovä M, Trnavsky K, Keilovä H (1977) The effect of antirheumatic drugs on collagenolytic activity of cathepsin B1. Biochem Pharmacol 26: 2121–2124

    PubMed  Google Scholar 

  • Stanworth DR, Johns P, Williamson N, Shadforth M, Felix-Davies D, Thompson R (1977) Drug-induced IgA deficiency in rheumatoid arthritis. Lancet 1: 1001–1002

    PubMed  CAS  Google Scholar 

  • Steigerwald JC (1978) Piroxicam and rheumatoid arthritis: A double-blind 16-week study comparing Piroxicam and indomethacin. Eur J Rheumatol Inflamm 1: 360–364

    Google Scholar 

  • Stein HB, Patterson AC, Offer RC, Atkins CJ, Teufel A, Robisnon HS (1980) Adverse effects of D-Penicillamine in rheumatoid arthritis. Ann Intern Med 92: 24–29

    PubMed  CAS  Google Scholar 

  • Stein HB, Urowitz MB (1976) Gold induced enterocolitis. Case report and literature review. J Rheumatol 3: 21–26

    PubMed  CAS  Google Scholar 

  • Steinbrocker O (1953) Caution in use of Phenylbutazone. JAMA 151: 143

    Google Scholar 

  • Steinbrocker O, Berkowitz S, Carp S, Ehrlich M, Elkind M (1952) Therapeutic observations on Butazolidin (Phenylbutazone) in some Arthritides and related Conditions. Ann Rheum Dis 11: 300–301

    Google Scholar 

  • Steinbrocker O, Berkowitz S, Ehrlich M, Elkind M, Carp S (1952) Phenylbutazone therapy of Arthritis and other painful musculoskeletal Disorders. JAMA 150: 1087–1091

    CAS  Google Scholar 

  • Stendhal O, Molin L, Dahlgren C (1978) The inhibition of polymorphonuclear leucocytezytotoxicity by Dapsone. J Clin Invest 62: 214–220

    Google Scholar 

  • Stephens RW, Ghosh P, Taylor TKF (1975 a) The characterisation of synovial fluid hyaluronidase and inhibition by gold thiomalate. Scand J Rheumatol [Suppl 8] 4:(Abstr 03-12)

    Google Scholar 

  • Stephens RW, Ghosh P, Taylor TKF (1975 b) The inhibitory effects of anti-inflammatory drugs on the degradation of hyaluronate by rheumatoid synovial fluid polysaccharidases. Clin Exp Pharmacol Physiol 2: 422

    Google Scholar 

  • Stephens WH, El-Ghobarey AF, MacLeod MM, Buchanan WW (1979) A double-blind, crossover trial of mefenamic acid, sulindac and flurbiprofen in rheumatoid arthritis. Curr Med Res Opin 5: 754–758

    PubMed  CAS  Google Scholar 

  • Stephens WH jr, El-Ghobarey AF, Capell HA, MacLeod M, Spencer DG (1979) High incidence of side-effects in patients with psoriatic arthritis receiving levamisole. R 8: 387–389

    Google Scholar 

  • Sternlieb I, Bennett B, Scheinberg IH (1975) D-Penicillamin induced Goodpasture’s Syndrome in Wilson’s disease. Ann Intern Med 82: 673–676

    PubMed  CAS  Google Scholar 

  • Stevenson AC, Bedford J, Hill AGS, Hill HFH (1971) Chromosomal studies in patients taking phenylbutazone. Ann Rheum Dis 30: 487–500

    PubMed  CAS  Google Scholar 

  • Stierlin H, Faigle JW, Colombi A (1978) Pharmacokinetics of Diclofenac sodium (Voltaren) and metabolites in patients with impaired renal function. Scand J Rheumatol [Suppl] 22: 30–35

    Google Scholar 

  • Stillman JS (1977) Salicylate-a review. Arthritis Rheum 20: 510–512

    Google Scholar 

  • Stojanovic I, Budimir M, Nikolic J, Maksimovic B, Berovic Z (1978) Duration of improvement of rheumatoid arthritis after good response to cyclophosphamide treatment. Scand J Rheumatol 7: 1–2

    PubMed  CAS  Google Scholar 

  • Stone CA, Arman VJ van, Lotti VJ, Minsker DH, Risley EA, Bagdon WJ, Brokelman DL, Jensen RD, Mendlowski B, Tate CL, Peck HM, Zwickey RE, McKinney SE (1977) Pharmacology and toxicology of Diflunisal. Br J Clin Pharmacol 4: 19S–29S

    PubMed  Google Scholar 

  • Straube W (1976) Indikationen und Differentialindikationen der Psychopharmaka bei Erkrankungen des rheumatischen Formenkreises. Akt Rheumatol 1: 49–56

    Google Scholar 

  • Stuhlsatz HW, Greiling H (1979) Zum biochemischen Wirkungsmechanismus von Proquazon unter besonderer Berücksichtigung des Bindgewebsstoffwechsels (biochemische Untersuchungen zur Prüfung der antiphlogistischen Wirksamkeit). Z Rheumatol 38: 99–105

    PubMed  CAS  Google Scholar 

  • Sulindac, Special Symposium (1978). Eur J Rheumatol Inflamm 1: 3–68

    Google Scholar 

  • Sunkel C, Cillero F, Armijo M, Pina M, Alonso S (1978) Synthesis and pharmacological properties of eterylate, a new derivative of acetylsalicylic acid. Arzneim Forsch/Drug Res 28: 1692–1694

    CAS  Google Scholar 

  • Suschke J, Pöhlmann R, Schattenkirchner M, Wilhelm R (1980) Zur Wirkungsweise von Chloroquin. Akt Rheumatol 5: 125–130

    Google Scholar 

  • Sutton BM, McGusty E, Walz DT, Martino MJ di (1972) Oral Gold. Antiarthritic properties of alkylphosphinegold coordination complexes. J Med Chem 15: 1095–1098

    PubMed  CAS  Google Scholar 

  • Svartz N (1942) A. Therapeutic results in rheumatic polyarthritis. B. Therapeutic results in ulcerative colitis. C. Toxic Manifestations in treatment with sulfanilamide and preparations. Acta Med Scand 110: 577–598

    Google Scholar 

  • Svendsen LB, Hansen OH, Johansen AA (1981) A comparison of the effects of HP549 (Isoxepac), Indomethacin and Acetylsalicylic acid (Aspirin®) on gastric mucosa in men. Scand J Rheumatol 10: 186–188

    PubMed  CAS  Google Scholar 

  • Swain MC, Goldberg AAJ, Smith DW (1980) Fenclofenac: a review of drug-associated effects and their relationship to diagnosis and age. Royal Soc Med Internat Congr Symp Ser 28: 73–77

    Google Scholar 

  • Swinson DR, Zlosnick J, Jackson L (1981) Double-blind trial of Dapsone against Placebo in the treatment of rheumatoid arthritis. Ann Rheum Dis 40: 235–239

    PubMed  CAS  Google Scholar 

  • Symoens J, DeCree J, Bever W van, Janssen PAJ (1979) Levamisole, an agent with multiple actions. In: Goldberg ME (ed) Pharmacological and Biochemical properties of drug substances, vol 2. American Pharmaceutical Association, Washington, pp 407–464

    Google Scholar 

  • Symoens J, Rosenthal M (1977) Levamisole in the modulation of the immune response: The current experimental and clinical state. A review. J Reticuloendothel Soc 21: 175–221

    PubMed  CAS  Google Scholar 

  • Symoens J, Schuermans Y (1979) Levamisole. A basic antirheumatic drug. Clin Rheum Dis 5: 603–629

    Google Scholar 

  • Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G, Pieton R (1977) Asthmatic attacs induced in aspirin-sensitive patients by diclofenac and naproxen. Br Med J 3: 231–232

    Google Scholar 

  • Szita M, Gachalyi B, Tornyossy M, Kaldor A (1980) Interaction of Phenylbutazone and Tolbutamide in man. Int J Clin Pharmacol Biopharm 18: 378–380

    CAS  Google Scholar 

  • Tait GBW, Lim CM, Highton TC, Keary PJ, Laurent MR (1978) Diflunisal in the treatment of osteoarthrosis: a double-blind study comparing diflunisal with acetylsalicylic acid. In: Miehlke K (ed) Diflunisal in clinical practice. Futura Publishing, New York, pp 43–56

    Google Scholar 

  • Takesue EI, Perrine JW, Trapold JH (1976) The anti-inflammatory profile of Proquazone. Arch Int Pharmacodyn Ther 221: 122–131

    PubMed  CAS  Google Scholar 

  • Tala E, Jalava S, Nurmela T, Vuori K (1979) Pulmonary infiltrates associated with goldtherapy. Report of a case. Scand J Rheumatol 8: 97–100

    PubMed  CAS  Google Scholar 

  • Tamassia V, Corvi G, Moro E, Tosolini GP, Fuccella LM (1977) Effect of food on absorption of Indoprofen administered oraly to man in two dosage forms. Int J Clin Pharmacol 15: 389–393

    CAS  Google Scholar 

  • Tamisier JN (1979) Ketoprofen. Clin Rheum Dis 5: 381–391

    Google Scholar 

  • Tan SY, Mulrow PJ (1977) Inhibition of the renin-aldosterone response to furosemide by indomethacin. J Clin Endocrinol Metab 45: 174–176

    PubMed  CAS  Google Scholar 

  • Tausch G, Eberl R, Tuschl P (1976) Klinische Erfahrungen und Ergebnisse klinisch experimenteller Untersuchungen mit Voltaren® bei rheumatischen Erkrankungen. Wien Med Wochenschr 126: 132–137

    PubMed  CAS  Google Scholar 

  • Tausch G, Teherani DK, Bröll H, Eberl R, Altmann H (1978) Einfluß von D-Penicillamin auf Zinkspiegel im Blut und Harn bei Patienten mit chronischer Polyarthritis. Z Rheumatol 37: 148–152

    PubMed  CAS  Google Scholar 

  • Tausch G, Bröll H, Petera P (1979) Fingergangrän und Proteinurie während D-Penicillamin-Therapie bei chronischer Polyarthritis. Akt Rheumatol 4: 1–3

    Google Scholar 

  • Tempero KF, Cirillo VJ, Steelman SL (1977) Diflunisal: A review of pharmacokinetic and pharmacodynamic properties, drug interactions and special tolerability studies in humans. Br J Clin Pharmacol [Suppl 1] 4: 31s–36s

    Google Scholar 

  • Tempero KF, Cirillo VJ, Steelman SL (1978) The clinical pharmacology of Diflunisal. In: Miehlke K (ed) Diflunisal in clinical practice. Futura Publishing Co, Mount Kisco New York, pp 23–39

    Google Scholar 

  • Tepe H-J, Blumberger W (1978) Erfahrungen mit einem transkutan wirksamen Antirheumatikum. (Etofenamat). Ergebnisse einer Feldstudie an 7863 Patienten. Med Welt 29: 448–451

    PubMed  CAS  Google Scholar 

  • The Cooperative Clinics Committee of the ARA (1973) A controlled trial of goldsalt therapy in rheumatoid arthritis. Arthritis Rheum 16: 353–358

    Google Scholar 

  • Thienpont D, Vanparijs OFJ, Raeymaekers AHM, Vandenberk J, Demoen PJA, Allewijn FTN, Marsboom RPH, Niemegeers CJE, Schellekens KHL, Janssen PAJ (1966) Tetramisole (R 8299), a new potent broad spectrum anthelmintic. Nature 209: 1084–1086

    PubMed  CAS  Google Scholar 

  • Thilo D, Nyman D, Duckert F (1974) A study of the effects of the anti-rheumatic drug Ibuprofen (Brufen) on patients being treated with the oral anti-coagulant Phenprocoumon (Marcoumar). J Int Med Res 2: 276–278

    Google Scholar 

  • Thuillier J, Bessin P, Gefroy F, Godfroid J-J (1968) Chimie et pharmacologic de la Clofezone. Bull Chim Ther 1: 53–67

    Google Scholar 

  • Thumb N (1972) Die immunsuppressive Therapie der chronischen Polyarthritis. Wien Z Inn Med [Suppl zuH 12] 52: 1–53

    Google Scholar 

  • Thumb N (1975 a) Nebenwirkungen der immunsuppressiven Therapie. Acta Med Austriaca 2: 134–140

    Google Scholar 

  • Thumb N (1975 b) Organschäden durch antirheumatische Arzneimittel. Therapiewoche 25: 4212–4220

    Google Scholar 

  • Thumb N (1981) Ein Fall einer Myasthenia gravis unter D-Penicillamin bei einer Patientin mit chronischer Polyarthritis. Persönliche Beobachtung

    Google Scholar 

  • Thumb N, Eibl M, Vormittag W, Michalek P (1970) Goldtherapie der progredient chronischen Polyarthritis. Wien Klin Wochenschr 82: 384

    Google Scholar 

  • Thumb N, Mayrhofer F (1980) Wirkung und Verträglichkeit von Piroxicam aus klinischer Sicht bei entzündlichen und degenerativen Gelenkerkrankungen. Wien Med Wochenschr, Sonderheft 1980, 130: 49–53

    Google Scholar 

  • Thumb N, Hoffer L, Mayrhofer F (1981) Beeinflussung der DNS-Reparatur und -synthese durch Goldsalze. Diskussionsbemerkung auf dem Symposium: Therapeutic innovation in Rheumatoid Arthritis: World Wide Auranofin-Symposium, Montreal Canada, 20/21. Okt. 1981

    Google Scholar 

  • Tillmann K (1978) Komplikationen der D-Penicillamin-Therapie bei operativen Eingriffen. Akt Rheumatol 3: 83–86

    Google Scholar 

  • Tobert JA, DeSchepper P, Tjandramaga TB, Mullie A, Meisinger MAP, Buntinx AP, Huber PB, Hall TLP, Yeh KC (1981) The effect of antacids on the bioavailability of Diflunisal in the fasting and postprandial states. Clin Pharmacol Ther 25: 385–389

    Google Scholar 

  • Tocco DJ, Breault GO, Zacchei AG, Steelman SL, Perrier CV (1975) Physiological Disposition and Metabolism of 5-(2/,4/-difluorophenyl)salizylic acid, a new salizylate. Drug Metab Dispos 3: 453–466

    PubMed  CAS  Google Scholar 

  • Toone EC jr, Hayden GD, Ellman HM (1965) Ototoxicity of chloroquine (Abstract). Arthritis Rheum 8: 475–476

    Google Scholar 

  • Townes AS, Sowa JM, Shulman LE (1972) Controlled trial of cyclophosphamide in rheumatoid arthritis (RA): an 18-month double blind crossover study. Arthritis Rheum 15: 129–130

    Google Scholar 

  • Traeger A, Stein G, Kunze M, Zaumseil J (1972) Zur Pharmakokinetik von Indomethazin bei nierengeschädigten Patienten. Int J Clin Pharmacol Biopharm 6: 237–242

    CAS  Google Scholar 

  • Traut EF, Passarelli EW (1957) Placebos in the treatment of rheumatoid arthritis and other rheumatic conditions. Ann Rheum Dis 16: 18–22

    PubMed  CAS  Google Scholar 

  • Treacher D, Warlow C, McPherson K (1978) Aspirin and bleeding-time. Lancet 2: 1378

    PubMed  CAS  Google Scholar 

  • Trnavskä Z, Mikulikovä D, Tranvsky K, Rovensky (1978) Wirkung von Levamisol auf die Kollagensynthese in vitro. Z Rheumatol 37: 221–227

    Google Scholar 

  • Trnavsky K (1980) Wirkung von Arteparon® auf die kollagenolytische Aktivität von Kathepsin B. In: Deitmer N, Greiling H, Sensch KH (Hrsg) Internationales Arzneimittelsymposium ARTE- PARON. Congress Series, EULAR, Basel, S 27–29

    Google Scholar 

  • Trnavsky K, Schultz P, Sitaj S (1974) Die Behandlung der rheumatoiden Arthritis mit Gold. Bericht über einen Doppelblindversuch. Z Rheumatol 33: 138–148

    PubMed  CAS  Google Scholar 

  • Tudor R, Goldberg AAJ, Clark DR (1977) The methodology of the fenclofenac clinical research programme and results obtained with particular reference to the therapeutic dose range. Proc RSoc Med [Suppl 6] 70: 11–15

    Google Scholar 

  • Tuffanelli D, Abraham RE, Dubois EL (1963) Pigmentation from antimalarial therapy. Arch Dermatol 88: 419–426

    PubMed  CAS  Google Scholar 

  • Turner G, Collins E (1975) Fetal effects of regular salicylate ingestion in pregnancy. Lancet 2: 338–339

    PubMed  CAS  Google Scholar 

  • Uehlinger E (1964) Aseptische Knochennekrosen (Infarkt) nach Prednisolonbehandlung. Schweiz Med Wochenschr 94: 1527–1530

    CAS  Google Scholar 

  • Ugai K, Ziff M, Lipsky PE (1979) Gold-induced changes in the morphology and functional capabilities of human monocytes. Arthritis Rheum 22: 1352–1360

    PubMed  CAS  Google Scholar 

  • Urowitz MB, Gordon DA, Smythe HA, Pruzanski W, Ogryzlo MA (1971) Azathioprine treatment of rheumatoid arthritis (RA) double-blind crossover study. Arthritis Rheum 14: 419

    Google Scholar 

  • Vaamonde CA, Hunt FR (1970) The nephrotic syndrome as a complication of goldtherapy. Arthritis Rheum 13: 826–834

    PubMed  CAS  Google Scholar 

  • Vainio JT, Lepistö PV (1978) A long-term comparison of proquazone and naproxen in the treatment of osteoarthritis of the hip. Scand J Rheumatol [Suppl] 21: 25–27

    Google Scholar 

  • Vainio K, Julkunen H (1960) Intra-articular nitrogen mustard treatment of rheumatoid arthritis. Acta Rheum Scand 6: 25–30

    PubMed  CAS  Google Scholar 

  • Vane JR (1971) Inhibition of Prostaglandin synthesis as a mechanism of action for Aspirin-like drugs. Nature New Biol 231: 232

    PubMed  CAS  Google Scholar 

  • Vane JR (1976) The mode of action of Aspirin and similar compounds. J Allergy Clin Immunol 58: 691–712

    PubMed  CAS  Google Scholar 

  • Vapaatalo H, Parantainen J, Linden I-B (1979) Penicillamine and Prostaglandin biosynthesis. In: Bonta IL, Cats A (eds) Connective tissue changes in rheumatoid arthritis and the use of penicill-amine. Agents Actions [Suppl 5] 85 – 98

    Google Scholar 

  • Verbruggen G, Veys EM (1976) Influence of sulphated glycosaminoglycanes upon proteoglycan metabolism of the synovial lining cell. Belg Tschr Reum Fys Geneesk 31: 75–92

    Google Scholar 

  • Verbruggen G, Veys EM (1979) Influence of an oversulphated Heparinoid Upon Hyaluronate Metabolism of the Human Synovial Cell in vivo. J Rheumatol 6: 554–561

    PubMed  CAS  Google Scholar 

  • Verhaegen H, Cock W de, Cree J de, Goldstein G (1980) Comparison of the in vitro effects of thymopoietin pentapeptide and levamisole on peripheral E-rosette forming cells. Thymus 1: 195–204

    PubMed  CAS  Google Scholar 

  • Vessel ES, Passananti GT, Johnsen AO (1975) Failure of Indomethacin and Warfarin to interact in normal human volunteers. J Clin Pharmacol 15: 486–495

    Google Scholar 

  • Vetter G (1978) Pyrazinobutazon bei rheumatischen Erkrankungen. Aerztl Praxis 30: 2159–2160

    Google Scholar 

  • Vetter G, Abele I (1981) Doppelblind crossover-Studie mit Lonazolac-Ca und Diclofenac-Na an 30 Patienten mit chronischer Polyarthritis. Z Allgemeinmedizin 57: 2451–2456

    CAS  Google Scholar 

  • Veys EM, Mielants H, Rosenthal M (1977) Agranulozytosis, levamisole and HLA-B27. Lancet 2: 764

    PubMed  CAS  Google Scholar 

  • Veys EM, Mielants H, Verbruggen G, Dhondt E, Goethals L, Cheroutre L, Buelens H (1981) Levamisole as basic treatment of rheumatoid arthritis. Longterm evaluation. J Rheumatol 8: 45–56

    PubMed  CAS  Google Scholar 

  • Vidler JAG (1977) D-Penicillamine chemical quality. Proc R Soc Med [Suppl 3] 70: 46–47

    Google Scholar 

  • Vinazzer H (1977) On the interactions between the anti-inflammatory substance proquazone (RU 43-715) and phenprocoumone. Int J Clin Pharmacol Biopharm 15: 214–216

    PubMed  CAS  Google Scholar 

  • Vince JD, Kremer D (1973) Double blind trial of diazepam in rheumatoid arthritis. Practicioner 210: 264–267

    CAS  Google Scholar 

  • Viol GW, Minielly JA, Bistricki T (1977) Gold nephropathy. Tissue analysis by X-ray fluorescent spectroskopy. Arch Pathol lab Med 101: 635–640

    PubMed  CAS  Google Scholar 

  • Vischer TL (1982) Pharmakogenetics in therapy with gold and other slow acting anti-rheumatic drugs. In: Schattenkirchner M, Müller W (eds) International gold Workshop, München, 14./15. Jänner

    Google Scholar 

  • Vitaus M, Franovic A, Duerrigl Th (1973) Die therapeutische Anwendung von Perclusone bei rheumatischen Erkrankungen. Schweiz Rundschau Med (Praxis) 62: 78–82

    CAS  Google Scholar 

  • Voigt K, Holzegel K (1977) Bleibende Nagelveränderungen nach Goldtherapie. Hautarzt 28: 421–423

    PubMed  CAS  Google Scholar 

  • Vojtisek O, Freund U, Greiling H (1970) Zytologische und biochemische Veränderungen in der Synovialflüssigkeit nach intraartikulärer Behandlung mit immunsuppressiven Substanzen. Z Rheumaforsch 29: 138–146

    PubMed  CAS  Google Scholar 

  • Vormittag W (1974) Zytostatische immunodepressive Therapie, chromosomale Aberrationen und karcinogene Wirkung. Wien Klin Wochenschr 86: 69–75

    PubMed  CAS  Google Scholar 

  • Vormittag W, Kolarz G (1979) Chromosomen-Untersuchungen vor und nach Infusionstherapie mit Phenylbutazon. Arzneim Forsch/Drug Res 29: 1163–1168

    CAS  Google Scholar 

  • Wacker A, Heyl W, Büechl H, Holthoff HJ (1955) Zum Wirkungsmechanismus der Antibiotica als Wuchsstoffe bei Tieren. 1. Mitteilung: Versuche mit Penicillin. Arzneim Forsch/Drug Res 5: 702–703

    CAS  Google Scholar 

  • Wagenhäuser FJ (1973) Die Arthrosen. Therapiewoche 23: 577 – 597

    Google Scholar 

  • Wagenhäuser FJ (1978) Die medikamentöse Basisbehandlung der Arthrosen. Fortbild K Rheumatol 5: 57–86

    Google Scholar 

  • Wagenhäuser FJ, Amira A, Borrachero J, Brummer L, Clausen C, Winer J (1968) Die Behandlung der Arthrosen mit Knorpel-Knochemark-Extrakt. Schweiz Med Wochenschr 98: 904–907

    PubMed  Google Scholar 

  • Wagenhäuser FJ, Ciccolunghi SN, Dhir KS (1978) Der Einfluß medikamentenunabhängiger Faktoren auf die klinische Prüfung von Antirheumatika. In: Robinson RG (Hrsg) Wirkungen und Nebenwirkungen — medikamentös bedingt oder nicht? Huber, Bern Stuttgart Wien, S 22–35

    Google Scholar 

  • Wagenhäuser FJ, Hauser E, Fellmann N (1960) Ergebnisse und Erfahrungen in der Arthrosebehandlung mit einem neuen Organextrakt. Schweiz Med Wochenschr 90: 1164–1169

    Google Scholar 

  • Wagenhäuser FJ, Narozna H (1982) Der Einfluß von Lonazolac-Ca (Irritren®) auf aktivierte Arthrosen. Ergebnisse einer Doppelblind-Crossover-Studie im Vergleich zu Naproxen. Akt Rheumatol 7: 194–198

    Google Scholar 

  • Wagner J, Sulc M (1979) Bindung von Diclofenac-Na (Voltaren®) an Serumproteine verschiedener Spezies und Interaktionen mit anderen Pharmaka. Akt Rheumatol 4: 153–162

    Google Scholar 

  • Wagner H, Junge-Hülsing G, Wirth W, Hauss WH (1969) Zur Wirkung von Aurothioglukose auf den Stoffwechsel der sulfatierten Mukopolysaccharide des Bindegewebes. Z Rheumaforsch 28: 287–298

    PubMed  CAS  Google Scholar 

  • Walker JR, Dawson W (1980) Inhibitory effect of Benoxaprofen and BW 755 C on rabbit PMN leucocyte lipoxygenase. In: Inflammation: Mechanisms and Treatments. Proceedings of future trends in inflammation IV. Lancaster: MTP, zit. nach Higgs et al. (1980)

    Google Scholar 

  • Waller ES, Massarella JW, Crout JE, Yakatan GJ (1979) The half-life of gold sodium thiomalate. Arthritis Rheum 22: 1418–1419

    PubMed  CAS  Google Scholar 

  • Walravens M, Dequeker J (1976) Comparison of gold and orgotein treatment in rheumatoid arthritis. Curr Ther Res 20: 62–69

    PubMed  CAS  Google Scholar 

  • Walsh JC (1970) Goldneuropathy. Neurology (Minneap) 20: 455–462

    CAS  Google Scholar 

  • Walshe JM (1956) Penicillamine, a new oral therapy for Wilson’s disease. Am J Med 21: 487–495

    PubMed  CAS  Google Scholar 

  • Walz DT, DiMartino MJ, Griswold DE (1979) Immunopharmacology of Auranofin and gold sodium thiomalate. Effects on humoral immunity. J Rheumatol [Suppl 5] 6: 74–81

    Google Scholar 

  • Walz DT, DiMartino MJ, Griswold DE (1982) Mechanisms of action of Auranofin: Effects on humoral immune responses. J Rheumatol [Suppl 8] 9: 32–36

    Google Scholar 

  • Walz DT, Griswold DE, DiMartino MJ, Bumbier EE (1980) Pharmacokinetics of gold following administration of Auranofin (SK andF D-39162) and myochrysine to rats. J Rheumatol 7: 820–824

    PubMed  CAS  Google Scholar 

  • Ward PA (1966) The chemosuppression of Chemotaxis. J Exp Med 24: 209–225

    Google Scholar 

  • Ward JR (Hrsg) (1975) Tolmetin, a new Non-steroidal Anti-inflammatory Agent. Exc Med, Princeton, pp 1–182

    Google Scholar 

  • Warnatz H, Scheiffarth F, Gutmann W (1975) Langzeitbehandlung der primär chronischen Polyarthritis. Erfahrungen mit D-Penicillamin im Vergleich mit Goldpräparaten und Immunsuppressiva. Med Klin 70: 1509–1515

    PubMed  CAS  Google Scholar 

  • Wasner CK (1978) Ibuprofen, Meningitis and systemic lupus erythematosus. J Rheumatol 5: 162–164

    PubMed  CAS  Google Scholar 

  • Webley M, Coomes EN (1979) An assessment of penicillamine therapy in rheumatoid arthritis and the influence of previous gold therapy. J Rheumatol 6: 20–24

    PubMed  CAS  Google Scholar 

  • Weh L, Dahmen G, Fröschle G (1981) Einfluß einiger intraartikulär applizierbarer Pharmaka auf die mechanischen Gelenkknorpeleigenschaften in vitro. Akt Rheumatol 6: 175–180

    Google Scholar 

  • Weigel W, Jasinski B (1962) Über die Beeinflussung des Knorpelstoffwechsel durch einen Knorpel- Knochenmark-Extrakt. Pathol Microbiol (Basel) 25: 400–408

    CAS  Google Scholar 

  • Weisman MH (1981) Early clinical trails with Auranofin. Mitteilung auf dem Symposium Therapeutic innovation in Rheumatoid Arthritis: World Wide Auranofin-Symposium, Montreal, 20./21. Okt 1981

    Google Scholar 

  • Weisman MH, Hannifin DM (1979) Management of rheumatoid arthritis with oral gold. Arthritis Rheum 22: 922–925

    PubMed  CAS  Google Scholar 

  • Weiss AS, Markenson JA, Weiss MS, Kammerer WH (1978) Toxicity of D-Penicillamine in rheumatoid arthritis. A report of 63 patients including two with aplastic anaemia and one with the nephrotic syndrome. Am J Med 64: 114–120

    PubMed  CAS  Google Scholar 

  • Weissmann G (1964) Labilization and stabilization of lysosomes. Fed Proc 23: 1038–1044

    PubMed  CAS  Google Scholar 

  • Whisnant JP, Espinosa RE, Kierland RR, Lambert EH (1963) Chloroquine neuromyopathy. Proc Staff Meetings Mayo Clin 38: 501–513

    CAS  Google Scholar 

  • Whitsett ThL, Barry JP, Czerwinski AW, Hall WH, Hampton JW (1977) Doppelblindstudie zur Frage einer möglichen Interaktion zwischen Tolmetin und dem Cumarinderivat Warfarin. In: Ward JR (Hrsg) Tolmetin, ein neuer nichtsteroidaler entzündungshemmender Wirkstoff. Exc Med, Amsterdam, S 77–93

    Google Scholar 

  • WHO (1976) Weekly epidem Rep, Nr 24, pp 181–200

    Google Scholar 

  • Wibell L, Nilsson P, Lindström B (1981) Kinetics of Indoprofen in patients with renal insufficiency (a preliminary report). Eur J Rheumatol Inflamm 4: 16–21

    PubMed  CAS  Google Scholar 

  • Widhammer M, Frenger W (1973) Wirksamkeit und Verträglichkeit von Bumadizon-Ca bei Erkrankungen des rheumatischen Formenkreises. Vergleich mit Oxyphenbutazon. Arzneim Forsch/Drug Res 23: 1813–1816

    CAS  Google Scholar 

  • Wiggins J, Scott DL (1981) Hepatic injury following Feprazone therapy. Rheumatol Rehabil 20: 44–45

    PubMed  CAS  Google Scholar 

  • Wilhelmi G (1976) Einfluß von Tribenosid auf die spontane Arthrose der Maus. Arzneim Forsch/ Drug Res 26: 382–386

    CAS  Google Scholar 

  • Wilhelmi G (1977) Untersuchungen zur Frage einer prophylaktischen Wirkung von Tribenosid auf die spontane Arthrose der Maus. Z Rheumatol 36: 112–119

    PubMed  CAS  Google Scholar 

  • Wilhelmi G (1978) Fördernde und hemmende Einflüsse von Tribenosid und Acetylsalicylsäure auf die spontane Arthrose der Maus. Arzneim Forsch/Drug Res 28: 1724–1726

    CAS  Google Scholar 

  • Wilhelmi G (1978) Effect of C 21524-Su (Pirprofen) on spontaneous osteoarthrosis in the mouse. Pharmacology 16: 268–272

    PubMed  CAS  Google Scholar 

  • Williams IA (1976) Levamisole and agranulocytosis. Lancet 1: 1080–1081

    PubMed  CAS  Google Scholar 

  • Williams I A, Baylis EM, English J (1981) High dose intravenous methyl prednisolone (pulse therapy) in the treatment of rheumatoid disease. Scand J Rheumatol 10: 153–155

    PubMed  CAS  Google Scholar 

  • Willis JV, Kendall MJ, Jack DB (1980) A study of the effect of Aspirin on the pharmacokinetics of oral and intravenous Diclofenac sodium. Eur J Clin Pharmacol 18: 415–418

    PubMed  CAS  Google Scholar 

  • Willis JV, Jack DB, Kendall MJ, John VA (1981b) The influence of food on the absorption of diclofenac as determined by the urinary excretion of the unchanged drug and its major metabolites during chronic administration. Eur J Clin Pharmacol 19: 39–44

    PubMed  CAS  Google Scholar 

  • Willis JV, Kendall MJ, Jack DB (1981a) The influence of food on the absorption of diclofenac after single and multiple oral doses. Eur J Clin Pharmacol 19: 33–37

    PubMed  CAS  Google Scholar 

  • Wilson DE (1974) Prostaglandins: Their action on the gastrointestinal tract. Arch Intern Med 133: 112–118

    PubMed  CAS  Google Scholar 

  • Winder CV, Wax J, Scotti L, Scherrer RA, Jones EM, Short FW (1962) Anti-inflammatory, antipyretic and antinociceptive properties of N-(2,3,-Xylyl)anthranilic acid (mefenamic acid). J Pharm Exp Ther 138: 405–413

    CAS  Google Scholar 

  • Winter CA, Risley EA, Nuss GW (1963) Anti-inflammatory and antipyretic activities of indomethacin, l-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid). J Pharm Exp Ther 141: 369–376

    CAS  Google Scholar 

  • Winter ChA (1971) Der Wirkungsmechanismus nichtsteroider entzündungshemmender Präparate. Arzneim Forsch/Drug Res 21: 1805–1811

    CAS  Google Scholar 

  • Winzum C van, Verhaest L (1979) Diflunisal. Clin Rheum Dis 5: 707–731

    Google Scholar 

  • Wiontzek H, Schmidt J (1970) Allergische-cholestatische Hepatose nach Goldbehandlung einer sero-negativen progredient-chronischen Polyarthritis. Z Rheumaforsch 29: 46–48

    PubMed  CAS  Google Scholar 

  • Wiseman EH (1980) Wissenschaftliche Basis von Piroxicam (Felden®). Pharmakologische Eigenschaften und Wirkungsmechanismus. Sonderheft: Aspekte zur Behandlung entzündlich-degenerativer Erkrankungen — unter besonderer Berücksichtigung einer neuen nicht-steroidalen Substanz (Piroxicam). Wien Med Wochenschr 130: 27–31

    PubMed  CAS  Google Scholar 

  • Wiseman EH, Boyle JA (1980) Piroxicam (Feldene). Clin Rheum Dis 6: 585–613

    Google Scholar 

  • Wissmüller HF (1971) Untersuchungen über die cytogenetische Wirkung von Phenylbutazon an menschlichen Lymphozyten in vitro. Arzneim Forsch/Drug Res 21: 1738–1750

    Google Scholar 

  • Witthauer K (1899) IV. Aspirin, ein neues Salizylpräparat. Heilkunde 3: 396–398

    Google Scholar 

  • Wohlenberg H (1972) Aplastische Anämie nach Goldbehandlung. Bericht über eine Spätreaktion mit einer Übersicht über 32 Fälle der Weltliteratur. Med Welt 23: 971–974

    PubMed  CAS  Google Scholar 

  • Wojtecka-Lukasik E, Dancewicz AM (1974) Inhibition of human leucocyte collagenase by some drugs used in the therapy of rheumatic diseases. Biochem Pharmacol 23: 2077–2081

    PubMed  CAS  Google Scholar 

  • Wolfe JD, Metzger AL, Goldstein RC (1974) Aspirin hepatitis. Ann Intern Med 80: 74–76

    PubMed  CAS  Google Scholar 

  • Woodland J, Mason RM, Harris J, Dixon AStJ, Currey HLF, Browjohn AMM, Davies J, Owen-Smith BD (1974) Trial of Azathioprine, cyclophosphamide and gold in rheumatoid arthritis. Ann Rheum Dis 33: 399–400

    PubMed  CAS  Google Scholar 

  • Woods JE, Anderson CF, deWeerd JH, Johnson WJ, Donadio JV Jr, Leary FJ, Frohnert PP (1973) High dosage intravenously administered methylprednisolone in renal transplantation: a preliminary report. JAMA 223: 896–899

    PubMed  CAS  Google Scholar 

  • Wooley PH, Griffin J, Panayi GS, Batchelor JR, Welsh KI, Gibson TJ (1980) HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-Penicillamine in patients with rheumatoid arthritis. N Engl J Med 303: 300–302

    PubMed  CAS  Google Scholar 

  • Wosilait WD (1976) Theoretical analysis of the bindings of salicylate by human serum albumin: The relationship between free and bound drug and therapeutic levels. Eur J Clin Pharmacol 9: 285–290

    PubMed  CAS  Google Scholar 

  • Wozniak KD, Boensch G (1977) Atrophische Narbenbildung nach lokaler Corticosteroid-Injektion. Med Sport (Berlin) 17: 297–299

    Google Scholar 

  • Wright V (Hrsg) (1980) Proceedings of the International Symposium on Benoxaprofen. J Rheumatol [Suppl 6] 7: 5–143

    Google Scholar 

  • Wyburn-Mason R (1976) Clotrimazole and rheumatoid arthritis. Lancet 1: 489

    PubMed  CAS  Google Scholar 

  • Yackel DB, Kempers RD, McConahey WM (1966) Adrenocorticosteroid therapy in pregnancy. Am J Obst Gynecol 96: 985–989

    CAS  Google Scholar 

  • Yoshizawa H, Tada Y, Naruke T, Mizumara M (1974) Concentration of Fenbufen and its metabolites in human serum. Jakurito Chiryo 2: 31–38

    Google Scholar 

  • Yu TF, Gutman AB (1959) A study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man. J Clin Invest 38: 1298–1315

    PubMed  CAS  Google Scholar 

  • Yu DTY, Clements PJ, Paulus HE, Peter JB, Levy J, Barnett EV (1974) Human lymphocyte subpopulations: Effect of corticosteroids. J Clin Invest 53: 565–571

    PubMed  CAS  Google Scholar 

  • Zaun H (1978) Toxisches Effluvium nach Goldbehandlung. Akt Dermatol 4: 169–170

    Google Scholar 

  • Zazgornik J, Schmidt P, Turner J, Kopsa H, Deutsch E (1975) Klinik und Therapie der Pilzinfektionen nach Nierentransplantation. Dtsch Med Wochenschr 101: 2082–2086

    Google Scholar 

  • Zeile G, Wandel E, Bork K, Krönig B (1979) Lyell-Syndrom mit passagerer Knochenmarksdepression nach Oxyphenbutazon. Munch Med Wochenschr 121: 949–952

    CAS  Google Scholar 

  • Zilko PJ, Dawkins RL, Cohen ML (1977) Penicillamine treatment of rheumatoid arthritis. Relationship of proteinuria and autoantibodies to immune status. Proc R Soc Med [Suppl 3] 70: 118–122

    Google Scholar 

  • Zimmermann F, Friedrich L (1975) Pharmakologie und Pharmakokinetik des D-Penicillamin und seine Beziehung zu lathyrogenen Substanzen. Therapiewoche 25: 3720–3731

    CAS  Google Scholar 

  • Zöller H, Gutmann W, Gross W (1974) Die Wirkung von D-Penicillamin auf das Blutgerinnungssystem. Dtsch Med Wochenschr 99: 694–696

    PubMed  Google Scholar 

  • Zucker MB, Perterson J (1970) Effect of acetylsalycylic acid, other nonsteroidal anti-inflammatory agents, and dipyridamole on human blood platelets. J Lab Clin Med 76: 66–75

    PubMed  CAS  Google Scholar 

  • Zuckner J, Auclair RJ (1976) Fenoprofen Calcium Therapy in Rheumatoid Arthritis. J Rheumatol [Suppl 2] 3: 18–25

    Google Scholar 

  • Zuckner J, Uddin J, Ramsey RH, Gantner GE Jr, Ahern AM, Dorner RW (1964) Intraarticular administration of the alkylating agent, thio-tepa, in rheumatoid arthritis. Arthritis Rheum 7: 355 (Abstr)

    Google Scholar 

  • Zuckner J, Uddin R, Ramsey RH, Gantner GE, Ahern AM, Dorner RW (1966) Evaluation of intraarticular thiotepa in rheumatoid arthritis. Ann Rheum Dis 25: 178–183

    PubMed  CAS  Google Scholar 

  • Zurier RB, Sayadoff DM, Torrey SB, Rothfield NF (1977) Prostaglandin treatment of NZB/NZW- mice. I. Prolonged survival of female mice. Arthritis Rheum 20: 723–728

    PubMed  CAS  Google Scholar 

  • Zurier RB, Damjanov I, Miller PL, Biewer BF (1978) Prostaglandin-E treatment prevents progression of nephritis in murine lupus erythematosus. J Clin Lab Immunol 1: 95–98

    CAS  Google Scholar 

  • Zutshi D, Mason M (1976) Ketoprofen in rheumatoid arthritis: Its tolerance and therapeutic effect. Scand J Rheumatol [Suppl] 14: 77–84

    Google Scholar 

  • Zvaifler NJ (1979) Gold and antimalarial therapy. In: McCarty (Hrsg) Arthritis and allied conditions, 9. edn. Lea and Febiger, p 357

    Google Scholar 

  • Zvaifler N, Rubin M (1962) The metabolism of chloroquine. Arthritis Rheum 5: 330 (Abstr)

    Google Scholar 

Download references

Authors
  1. N. Thumb
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik Herzoghöhe, Kulmbacher Str. 103, D-8580, Bayreuth, Germany

    G. L. Bach

  2. Gentzgasse 14/12/4, A-1180, Wien, Germany

    R. Czurda

  3. Klinik für innere und physikalische Medizin, Staatliches Rheumakrankenhaus, Rotenbachtalstr. 5, D-7570, Baden-Baden, Germany

    J.-M. Engel

  4. Arbeitsgemeinschaft für krebsbekämpfung, Königsallee 175, D-4630, Bochum 1, Germany

    O. Fischedick

  5. Staatliches Rheumakrankenhaus, Klinik für innere und physikalische Medizin, Rotenbachtalstr. 5, D-7570, Baden-Baden, Germany

    M. Franke

  6. Rheuma-Zentrum, Röntgeninstitut, D-8403, Bad Abbach, Germany

    K. Meythaler

  7. Rheuma-Zentrum, II. Medizinische Klinik, D-8403, Bad Abbach, Germany

    H. Müller-Faßbender

  8. Deutsche Klinik Für Diagnostik, Aukammallee 33, D-6200, Wiesbaden 1, Germany

    P. Pfannenstiel

  9. Ludwig-Boltzmann-Institut für Rheumatologie und Fokalgeschehen, Kaiser-Fraz-Ring 8, A-2500, Baden, Germany

    N. Thumb

  10. Rheuma-Zentrum, Orthopädische Klinik, D-8403, Bad Abbach, Germany

    D. Wessinghage

  11. Rheuma-Zentrum, I. Medizinische Klinik, D-8403, Bad Abbach, Germany

    H. Mathies

  12. Medizinische Fakultät der Rheinisch-Westfälischen Technischen Hochschule, Klinisch-Chemisches Zentrallaboratorium, Goethestr.27-29, D-5100, Aachen, Germany

    H. Greiling , A. Gressner  & K. Kleesiek ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Thumb, N. (1983). Medikamentöse Therapie. In: Bach, G.L., et al. Rheumatologie A. Handbuch der inneren Medizin, vol 6 / 2 / A. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68647-4_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-68647-4_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-68648-1

  • Online ISBN: 978-3-642-68647-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation